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ABSTRACT OF THE DISSERTATION
A Gnotobiotic Mouse Model for Studying the Effect of Human Gut Community Ecology on a 
Pathobiont, Bacteroides fragilis 
by 
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Washington University in St. Louis, 2015
Professor Jeffrey I. Gordon, Chair
Childhood undernutrition represents a pressing global health challenge. Epidemiologic studies 
have shown that undernutrition is not due to food insecurity alone, but rather represents a com-
plex set of interactions between intra- and intergenerational factors. The gut microbiota has been 
implicated as one such factor. This thesis tested the hypothesis that enteropathogen burden af-
fects the structure and expressed functions of the gut microbiota, and reciprocally, the gut micro-
biota affects susceptibility to the effects of enteropathogen invasion. To examine this hypothesis, 
groups of adult germ-free C57Bl/6 mice were colonized with fecal microbiota sampled from two 
24-month-old members of a birth-cohort living in an urban slum in the Mirpur district of Dhaka, 
Bangladesh: one child had a healthy growth phenotype as judged by anthropometry, and the un-
dernourished child was severely stunted and underweight and exhibited relative microbiota imma-
turity. The microbiota of both children contained Bacteroides fragilis, a pathobiont. Both groups 
of colonized mice were fed three diets that embodied the diets consumed by the population from 
which the microbiota donors were selected. Mice harboring the intact uncultured microbiota from 
the stunted donor exhibited severe weight-loss, while those receiving the healthy donor’s mi-
crobiota maintained weight on these diets. Clonally-arrayed, sequenced collections of cultured 
viii
anaerobic bacteria strains, generated from the donors’ fecal microbiota, transmitted (i) the discor-
dant weight phenotypes within and across generations of animals (in a diet-dependent fashion), as 
well as (ii) distinct host metabolic phenotypes (manifest by marked differences in tissue organic 
acid, amino acid and ceramide profiles as defined by mass spectrometry). The B. fragilis strain 
in the stunted donor’s culture collection was enterotoxigenic (ETBF), while the two B. fragilis 
strains in the healthy donor’s culture collection were non-toxigenic (NTBF). Through a series of 
experiments in which mice were colonized with either the stunted or healthy culture collection ± 
ETBF or ± NTBF, I demonstrated that ETBF was associated with weight loss as a member of the 
stunted donor’s community, but not the healthy donor’s community. Microbial RNA-Seq analysis 
revealed marked differences in ETBF gene expression in the two different community contexts, 
and as a function of the presence or absence of NTBF. Strikingly, ETBF induced expression of a 
large repertoire of virulence factor genes encoded in the genomes of the healthy culture collection 
members; these effects were mitigated when NTBF was present. The effects of ETBF on host me-
tabolism were also community context-dependent. These results provide preclinical evidence that 
enteropathogen effects on host physiology and metabolism are greatly impacted by gut community 
ecology and illustrate the value of combining gnotobiotic mouse models, human diet embodi-
ments, and ‘personal’ culture collections for dissecting microbial-microbial and microbial-host 
interactions. A parallel study using gnotobiotic mice and subsets of the culture collection from 
the healthy donor revealed how turmeric, a culturally relevant spice in the Bangladeshi diet, and 
microbial bile acid production/metabolism interact to impact gut motility.
1Chapter 1
Introduction
2Chapter 1: Introduction
The Gut Microbiota
The human gut microbiota is composed of tens of trillions of microorganisms from all three do-
mains of life (Bacteria, Archaea, and Eukarya), plus their viruses. In healthy individuals, this 
microbial ‘organ’ takes approximately 2 years to assemble following birth (1-3). In healthy adults, 
it is dominated by members of the domain Bacteria, notably members of the phyla Bacteroidetes 
and Firmicutes. A study of healthy adult monozygotic and dizygotic twins and their mothers (4) 
revealed that family members had phylogenetically more similar bacterial assemblages compared 
to unrelated individuals. Moreover, monozygotic twin pairs did not exhibit significantly more 
similar overall phylogenetic configurations in their fecal microbiota compared to dizygotic pairs, 
implying that early environmental exposures are important determinants of microbial community 
structure in adults. In followup studies, Faith et al. conducted a time series study of these twin 
pairs: he demonstrated that on average 60% of the bacterial strains in a community remain present 
in an individual for at least five years (5). Specifically, the stability of an individual’s microbiota 
fits a power-law function, leading to the proposal that once acquired, bacterial strains have the 
capability to persist for decades, and thus may have durable effects on our metabolic, physiologic, 
and immune phenotypes (6). 
Even though there is significant interpersonal variation in the bacterial species and strains 
that comprise the human gut microbiota, a large proportion of microbial genes in our gut microbi-
omes are shared, including those involved in various facets of nutrient biosynthesis and metabo-
lism (3, 4). Disorders such as obesity have been associated with reductions in bacterial diversity in 
adulthood, while childhood undernutrition has, as noted below, been associated with perturbations 
in community assembly (development) (4, 7-11). 
3Historical perspective
The fecal microbiota has long been recognized as important to the health of the host. The 4th Cen-
tury Chinese writer Ge Hong described the use of fecal slurries as a treatment for patients with 
diarrhea and food poisoning (12). Theodor Escherich, discoverer of E. coli, recognized certain 
bacteria were essential for normal development of infants, while other bacteria would be indica-
tive of an abnormal state (13). Escherich’s contemporary, Élie Metchnikoff, postulated that lactic-
acid fermenting bacteria in the human gut played a role in “prolonging life” through inhibition 
of putrefaction, the process of organic matter decomposition by bacteria. Today, fecal microbiota 
transplants (FMT) from healthy humans are used to treat patients suffering from the potentially 
lethal sequelae caused by Clostridium difficile infection (CDI), and preclinical experiments have 
demonstrated how the microbiota mediates resistance to CDI(14, 15). Additionally, the effects of 
FMT on the activity of inflammatory bowel disease are now being tested (16). While the long-term 
impact of FMT remains unknown, these studies provide clinical proof-of-concept that the gut mi-
crobiota is causally related to disease pathogenesis and/or is a therapeutic target. 
The advent of massively-parallel DNA sequencing has allowed culture-independent char-
acterization of the microbiota and microbiomes associated with a variety of body habitats, at dif-
ferent stages of the human lifecycle, as a function of different lifestyles, geographic locations, 
and health states (1, 3, 17-21). These surveys focus primarily on bacteria and have allowed us to 
correlate the community composition with intra- and interpersonal variations in physiology, me-
tabolism and/or immunity. However, despite the allure of descriptive studies, it is critical that this 
field advance to establish causal relationships between microbiota and microbiome configuration 
and expressed functions and host biology.
Establishing causal relationships between gut microbial community ecology and host 
biology using gnotobiotic mice
Gnotobiotic, from the Greek ‘gnostos’ meaning known and ‘bios’ signifying life, animals are 
raised germ-free (GF) in a sterile environment and can be subsequently colonized with determined 
4microbial communities. Plant physiologists pioneered this approach, with Émile Duclaux success-
fully growing germ-free peas and beans in a sterile environment (22). Duclaux’s efforts were met 
with interest and inspired continued work by several researchers over the next 30 years. In 1895 
Nuttall and Thierfelder used Caesarean section to deliver guinea pigs into a sterile environment 
in order to investigate whether life in the complete absence of microorganisms was possible (23). 
By 1914, Cohendy and Wollman had established nutritional protocols for maintaining healthy 
neonatal guinea pigs in a germ-free state, but it was not until 1936 that the Swedish researcher 
Gosta Glimstedt was able to perfect protocols for rearing guinea pigs in a sterile state for up to 2 
months, producing the first account of differences between healthy germ-free and conventionally-
raised animals (i.e., animals that acquired microbial communities in their body habitats from their 
environment beginning at birth) (24, 25). Germ-free animal studies made substantial progress after 
James Arthur Reyniers, an instructor of bacteriology at Notre Dame University, described a germ-
free rat model in 1946, unaware of the previous work in Europe (26). The 1950s saw Reyniers, 
in the United States, and Bengt Gustafsson, in Sweden, establish the first colonies of GF rats and 
mice (27, 28).
Gnotobiotics remains a power tool for determining the specific contributions of the gut 
microbiota to host physiology. Broadly, microbial communities harvested from conventionally-
raised (CONV-R) animals with defined genotypes and phenotypes are introduced to germ-free 
recipients. If a transmissible donor-specific phenotype is observed in recipient animals, further 
investigations can unlock microbe-microbe and microbe-host interactions. Comparisons of germ-
free versus CONV-R animals have provided direct evidence for the role of the microbiota, and in 
some cases specific bacterial species, in shaping a large number of facets of host biology.
Growth and nutrition
While investigating the difference in physiology between CONV-R and germ-free rats, Wostmann 
and colleagues noted that lower O2 consumption and cardiac output were significantly lower in the 
latter. Furthermore, for germ-free animals to achieve a growth rate comparable to, and an adult 
5body mass equivalent to their CONV-R counterparts, they had to consume 30% more calories/
day (29). Our lab supported these findings when Bäckhed and colleagues found that compared to 
CONV-R mice, germ-free animals were leaner and had lower oxygen consumption, yet consumed 
29% more food (30, 31). Sjorgren et al. showed that bone mass was increased in germ-free mice 
compared to their CONV-R counterparts; the mechanism remains unclear although they presented 
evidence for microbiota effects on specific immune cell populations in the bone marrow (32). 
Carbohydrate metabolism
Humans have a limited capacity for digesting complex dietary carbohydrates (29) since our ge-
nomes lack the variety of genes encoding glycoside hydrolases and polysaccharide lyases needed 
to break down the dazzling array of glycoside linkages present in these glycans. While mono- and 
disaccharides are easily absorbed in the small intestine, most polysaccharides pass through the 
proximal gut undigested until they reach the distal gut. These predominantly plant-derived poly-
saccharides are fermented by members of the ileal and colonic microbiota: their genomes contain 
myriad carbohydrate active enzymes (CAZymes) (33). In the absence of these dietary polysac-
charides, members of the distal gut microbiota are able to adaptively forage host mucosal glycans 
(34).
Diet appears to function as a selective force across generations of human hosts to shape mi-
crobial community structure in ways that promote this capacity for polysaccharide utilization. For 
example, De Fillipo et al. reported that children in rural Africa who consume a significantly higher 
fiber diet than their European counterparts, have microbiota that are significantly enriched for 
bacterial taxa and genes that specialize in metabolizing plant polysaccharides: they speculated that 
these features of their microbiota/microbiomes enhance energy intake and promote gut health(17).
Protein metabolism
CONV-R rodents were found to excrete lower levels of nitrogen compared to germ-free animals, 
suggesting a role of the gut microbiota in protein metabolism (35). In 1985, MacFarlane and 
6colleagues demonstrated that casein and bovine serum albumin were degraded by human fecal 
slurries, corroborating the hypothesis, based on observations that soluble protein, ammonia, and 
branched volatile fatty acids occurred throughout the colon, that the microbiota had proteolytic 
activity (36). MacFarlane went on to identify Bacteroides and Propionibacterium as predominant 
proteolytic members, with Streptococcus, Clostridium, Bacillus, and Staphylococcus species also 
exhibiting proteolytic activity. While the classification of proteases encoded by the gut microbi-
ome is less advanced compared to CAZymes, the MEROPS database provides a valuable refer-
ence compilation of known proteases (37).
Microbial biotransformations of bile acids
Glycine- or taurine-conjugated bile acids are cholesterol derivatives synthesized in the liver and 
secreted into the small intestine; they facilitate solubilization and absorption of dietary lipids (38)� 
Bile acids (BA) provide the primary route for cholesterol excretion(39)� BA biosynthesis pro-
ceeds through two pathways: the ‘classic’ neutral pathway and the ‘alternative’ acidic pathway� 
Cholesterol 7-alpha-hydroxylase (also known as microsomal cytochrome P450 (Cyp7a1)) is the 
rate-limiting step in BA production via the neutral pathway� The products of Cyp7a1 are referred 
to as primary bile acids and differ between vertebrates: in humans and rats, the primary BAs 
are cholic and chenodeoxycholic acid, while in mice they are cholic and β-muricholic acid� To 
facilitate fat absorption, primary BAs are conjugated with glycine or taurine by the liver before 
secretion (40)� Conjugated BAs (CBA) downregulate primary BA production through repression 
of Cyp7a1 expression and activity (41)� Repression of primary BA production requires passage 
of CBAs through the intestine, suggesting a putative intestinal factor that detects the presence of 
BAs and mediates feedback regulation of BA synthesis (42)� One pathway for modulation of bile 
acid production through primary BAs involves the nuclear farnesoid receptor (FXR), which is 
expressed in liver, adrenal cortex, kidney, and the gut. FXR was originally identified as interacting 
with farnesol metabolites (43, 44). Intestinal FXR promotes secretion of fibroblast growth factor 
715 (Fgf15), which is delivered to hepatocytes via the portal circulation which then interacts with 
fibroblast growth factor receptor 4 (Fgfr4) to inhibit Cyp7a1 (45)� 
Recovery of bile acids in the distal ileum occurs through the apical sodium-dependent bile 
acid transporter (ASBT) expressed in enterocytes: this process is highly efficient, with approxi-
mately 95% of BAs being reabsorbed. Enterohepatic circulation is based on this cycle of secretion 
and recovery and is essential for dietary lipid absorption (46). The gut microbiota acts upon the re-
maining 5% of bile acids not recovered in the terminal ileum in two principal ways: (i) converting 
conjugated BA, some of which which have strong microbicidal activities, to primary BA using bile 
salt hydrolases (BSH) and/or (ii) transforming primary BAs to secondary BAs using hydroxyster-
oid dehydrogenases (45, 47-49). Because the gut microbiota can modify the BA pool, it is able to 
affect host cholesterol metabolism, regulate its own community structure, as well as alter gut mo-
tility (50) (see Chapter 3 of this thesis for details of how bacterial BSH activity influences motility) 
Protection from enteropathogens
Disruption of the host microbial ecology through antimicrobial therapy can lead to infection by 
another pathogen or a normally non-pathogenic organism. Miller and colleagues highlighted this 
experimentally when they observed that animals receiving streptomycin were susceptible to infec-
tion with orders of magnitude fewer enteropathogenic Salmonella (51). The ability of a complex 
microbiota to serve as a barrier to invasion by enteropathogens was clearly delineated in gno-
tobiotic animals when it was shown that mono-colonization with common gut symbionts could 
not clear Vibrio cholerae from the mouse gut; however a community of Escherichia coli, Pro-
teus mirabilis, and Streptococcus faecalis lead to the exclusion of V. cholerae from the host(52). 
More recently, studies have shown that (i) non-toxigenic E. coli can serve as a barrier to infection 
with Shiga toxin-producing E. coli O157:H7 and (ii) the gut microbiota mediates susceptibility to 
Salmonella-induced diarrhea (53, 54). Fukuda et al. showed that production of acetate in the gut 
by Bifidobacteria protects from infection by E. coli O157:H7 (55). Together, these findings indi-
cate that the gut microbiota plays an important role in mitigating enteropathogen infection either 
8through direct competition for niche space, or through production of metabolites that attenuate 
virulence. 
Childhood Undernutrition, Stunting, and Enteric Disease
There are an estimated 805 million people in the world that experience chronic undernutrition 
(defined as the inability acquire enough nutrients from food to meet dietary energy requirements 
for a period of at least one year). Chronic undernutrition is particularly detrimental in children un-
der five years of age where it accounts, either directly or indirectly, for almost 50% of deaths and 
where persistent sequelae such as stunting, impaired cognitive development, and immune dysfunc-
tion rob individuals of a chance to achieve their full potential. While there have been reductions 
in global food insecurity over the past two decades, the prevalence of stunting in children has 
remained largely unchanged, with little progress toward reduction (56). 
Nutritional status in children is defined by anthropometric measurements (weight and 
height as a function of age), and referencing the results to a cohort of 8440 children with healthy 
growth phenotypes studied from birth in the World Health Organization’s Multicentre Growth Ref-
erence Study (MGRS) (57)� Members of this cohort lived in six countries with distinct geographic 
locations and cultural traditions. Specifically, the length/height and weight data collected from the 
MGRS was used to determine the distributions of healthy height-for-age and weight-for-age from 
which Z-scores for individual measurements can be assigned (HAZ and WAZ, respectively): i�e�, 
a normalized Z-score can be calculated for any child to gauge his/her linear and ponderal growth 
phenotype�
Stunting in children less than 5 years of age is the most prevalent manifestation of under-
nutrition globally, with an estimated 165 million children being classified as stunted (i.e., have 
a HAZ score worse than -2) (58)� Stunting manifests as a severe societal burden, pervasively 
harming developmental potential through the long-term impact on cognitive function and adult 
economic productivity (59, 60)� While undernutrition at any stage of development can have lasting 
consequences, a population analysis in the Philippines by Glewwe and King examined whether 
9cognitive deficits associated with stunting were correlated with when an episode of chronic under-
nutrition was experienced. They found that contrary to some arguments that the first six months 
represent the most critical window, undernutrition during the second year of life had a greater 
negative impact on cognitive development (61)� Victora et al. examined WAZ, HAZ, and WHZ 
scores among children across 54 countries and found that a critical stage of growth faltering oc-
curred between 9 and 24 months of age, where mean HAZ scores declined from -1 to -2 (62)� For-
tunately, Crookston and colleagues’ analysis of a Peruvian cohort found evidence that cognitive 
deficits related to undernutrition-associated stunting can be remediated if catch-up growth occurs 
soon after faltering(63)� It is important to emphasize that severe stunting and its sequelae are not 
attributable to chronic food-insecurity alone (64-66)� There are often myriad other contributors 
including environmental enteropathy (see below), micronutrient deficiency (particularly vitamin 
A, zinc, iron, and iodine), and diarrheal disease�
Environmental Enteric Disease (EED), previously grouped with ‘tropical enteropathy’ or 
‘tropical sprue’, is a subclinical chronic inflammatory condition of the small intestine (67, 68)� 
EED is characterized by decreased villus height and lymphocytic infiltration of the lamina pro-
pria and epithelium� Since obtaining small intestinal biopsy is not feasible in most children with 
undernutrition, there has been considerable controversy about what biomarkers to use in defining 
this entity� A constellation of biomarkers is currently used including lactulose:mannitol absorp-
tion test, fecal calprotectin, myeloperoxidase, alpha-1 anti-trypsin, and Reg1, as well as plasma 
IGF-1� EED has been implicated as a contributing factor to stunting, vaccine failure, and impaired 
development (69). The pathogenesis of EED remains ill-defined (see below). There is some evi-
dence that EED is a reversible� Peace Corps workers who lived for a time in low income countries 
developed weight loss, diarrhea and small bowel histopathologic changes similar to that found in 
children with EED that were reversed when they moved back to the USA, while South Asians who 
moved to New York City became asymptomatic and manifested changes in their small intestinal 
morphology that resembed a ‘Western’ phenotype (70)� Recently, Jones et al. studied the effects of 
treating undernourished children, diagnosed with EED, with mesalazine (5-aminosalicylic acid), 
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an agent used to treat inflammatory bowel disease. The results disclosed that treatment resulted in 
modest reductions of the inflammatory markers fecal calprotectin, plasma anti-endotoxin core im-
munoglobulin, and erythrocyte sedimentation rate compared to placebo (71)� 
EED has been associated with high burden of enteropathogens� Liu and colleagues devel-
oped a TaqMan Array Card (TAC) to detect 19 diarrhea-causing pathogens simultaneously (72): 
the assay targets viruses, a diverse set of bacteria (e�g�, Clostrium difficile, Vibrio cholerae, and 
numerous Escherichia coli strains), as well as protozoans� In a worldwide multicenter study, they 
(i) found that their method had higher sensitivity, but similar specificity compared to other tech-
niques, and (ii) demonstrated that a pathogen’s strength of association with diarrheal disease was 
strongly correlated with higher load� In a prospective birth cohort study of 147 infants, Mondal 
et al� described that endotoxin core antibodies, a biomarker of EED, were associated with stunt-
ing pursuant increased incidence of diarrheal disease caused by enteropathogens (73)� Petri and 
colleagues, have proposed that it may be possible to ameliorate EED through restoration of key 
bacteria that are present in the microbiota of healthy children (7, 69)� 
Childhood Undernutrition and the Gut Microbiota
In a survey of the gut microbiomes of healthy children and adults representing three distinct socio-
economic/cultural/geographic contexts (i.e., three metropolitan areas in the USA, four rural villag-
es in Southern Malawi, and Amerindians living in the Amazonas state in Venezuela), Yatsunenko 
et al. documented (i) a shared program of change during postnatal life in the proportional represen-
tation of microbial genes involved in various aspects of nutrient biosynthesis and metabolism (e.g., 
folate, cobalamin), (ii) distinct differences in the proportional representation of genes between the 
Western and non-Western population (e.g., those encoding enzymes involved in riboflavin bio-
synthesis and glycan metabolism), and (iii) a marked reduction in bacterial diversity in the USA 
compared to other two populations (3). 
This set of observations led to the hypothesis that normal development of the microbiota/
microbiome is essential for healthy growth and that perturbations to this developmental program 
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are involved in the pathogenesis of undernutrition� A corollary hypothesis, illustrated in Figure 1, 
is that EED represents the confluence of interacting/interrelated factors: (i) impairment of normal 
gut microbiota development is influenced by enteropathogen burden; (ii) enteropathogen invasion 
in turn is increased in the face of an immature microbiota; (iii) normal development of the gut 
mucosal immune system is impaired by an immature microbiota; and (iv) an immature mucosal 
immune system impedes further development of the microbiota, even in the face of therapeutic 
food interventions� Interactions between (i)-(iv) can manifest as an impaired growth phenotype, a 
perturbed metabotype, and disrupted gut barrier/absorptive function.
Smith and colleagues used a gnotobiotic mouse model of childhood undernutrition to dem-
onstrate a causal link between the gut microbiota, diet, and weight loss (8)� They colonized germ-
free mice with fecal microbiota from Malawian twin-pairs discordant for severe acute malnutrition 
(SAM): one group of mice received the healthy co-twin’s microbiota while the other received the 
SAM co-twin’s microbial community� All mice were fed a prototypic macro- and micronutrient 
deficient Malawian diet. Mice colonized with the microbiota from the co-twin with SAM pre-
cipitously lost weight while mice receiving the healthy co-twin’s microbiota maintained weight� 
The combination of a nutrient-deficient diet and a SAM microbiota were required for weight loss: 
mice harboring the same SAM donor microbiota but fed a nutrient sufficient diet maintained body 
weight� Moreover, Smith observed that when mice with a SAM microbiota where switched from 
their Malawian diet to a peanut-based ready-to-use therapeutic food (RUTF) used to treat children 
with SAM, there was transient albeit incomplete rescue of body weight and metabolic disturbances 
(including abnormalities in carbohydrate and amino acid metabolism, as well as disruption of the 
TCA cycle in host tissues)� Moreover, the improvements produced with RUTF were not durable: 
they were lost when mice were switched back to the Malawian diet� 
These findings in a preclinical model were intriguing for a number of reasons. A clinical 
study by Chang and colleagues found that children in Malawi successfully treated for moderate 
acute malnutrition (MAM) were still at risk for relapse and death during the year following initial 
recovery(74)� A clinical trial, conducted by Trehan et al., of a Malawian population demonstrated 
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that including antibiotic treatment with RUTF significantly decreased mortality and increased the 
rate of recovery, as measured by weight gain and mid-upper-arm circumference, in children with 
SAM (75)�
Subramanian et al. used (i) 16S rRNA datasets generated from fecal samples collected 
monthly from birth through 24 months of age in a cohort of Bangladeshi children with healthy 
growth phenotypes (defined by anthropometry) and (ii) a machine learning algorithm (Random 
Forests) to identify a set of age-discriminatory bacterial strains that together describe normal gut 
microbiota development� The sparse 24-taxon Random Forests model they developed was used 
to create a metric, microbiota-for-age Z (MAZ) score, that defined microbiota ‘maturity’: i.e., the 
age of the gut microbiota in an index child compared to the microbiota configuration of chrono-
logically-aged matched children from the reference Bangladeshi birth cohort with healthy growth 
phenotypes. Bangaldeshi children with SAM or MAM have significant microbiota immaturity, 
with MAZ scores being significantly worse (lower) in those presenting with SAM (7)� Moreover 
children with SAM treated with either of two RUTFs exhibited incomplete and only transient re-
covery of their microbiota immaturity (7), suggesting that the persistent developmental abnormal-
ity exhibited by their gut microbiota may be causally related to their persistent stunting and other 
manifestations of undernutrition� A corollary was that durable repair of microbiota immaturity, 
either through food-based or microbial interventions, would be required to ameliorate some of the 
long-term sequelae of undernutrition�
Finally, Kau et al. provided additional support for the gut microbiota’s causal role in child-
hood undernutrition. They used fluorescence activated cell-sorting (FACS) to separate members 
of the gut microbiota that were targeted by mucosal IgA responses from those that were not tar-
geted (a method that was named ‘BugFACS’) (10)� They found that gnotobiotic mice colonized 
with the fecal microbiota of twin-pairs discordant for SAM and fed either a nutritionally replete 
mouse diet, or the prototypic nutrient deficient Malawian diet exhibited diet-dependent differen-
tial IgA targeting of gut bacterial taxa. Specifically, mice receiving the SAM donor’s microbiota 
had a strong IgA response to Enterobacteriaceae when fed the Malawian diet, despite its presence 
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in all four experimental groups (i�e�, mice colonized with the healthy or SAM donor microbiota 
fed the nutrient-deficient or -sufficient diets), while mice colonized with the healthy twin’s fecal 
microbiota fed a Malawian diet exhibited a distinctive IgA response to Akkermansia muciniphila 
and Clostridium scindens. Kau went on to perform experiments where IgA+ microbes purified by 
BugFACS from the fecal microbiota of mice harboring a SAM community and fed a Malawian 
diet transmitted an enteropathy to germ-free mouse recipients fed the same Malawian diet� This 
phenotype was characterized by marked disruption of the small intestinal and colonic epithelium 
(the former more so than the latter) with resulting sepsis and death� In contrast, this enteropathy 
was not observed in mice receiving the IgA+ fraction purified from the gut microbiota of mice 
harboring the healthy co-twin’s gut community and fed the Malawian diet� Moreover, addition 
of the IgA-targeted fraction from the healthy co-twin, or a combination of A. muciniphila and C. 
scindens to the IgA+ fraction purified from the SAM donor’s microbiota prevented development of 
the lethal enteropathy� Kau et al. also applied BugFACS directly to human fecal samples� Studies 
of members of a Malawian birth cohort revealed IgA-targeted bacterial taxa at 6 months of age 
significantly correlate with HAZ at 18 months: the taxa include members of Enterobacteriaceae, 
Veillonellaceae, and Lachnoclostridium (the genus to which C. scindens belongs)�
The Pathobiont Enterotoxigenic Bacteroides fragilis
Species belonging to the genus Bacteroides are critical to host nutrition as well as mucosal and 
systemic immunity (76-79). B. fragilis plays an important immunomodulatory role, but is also the 
leading anaerobic isolate in bloodstream infections and abdominal abscesses(80-82). One strain 
of B. fragilis, isolated when attempting to determine the etiology of acute diarrheal disease in 
newborn lambs in the Northern Rocky Mountains, provided the evidence that B. fragilis can be 
toxigenic. The proposed biologically active toxigenic factor was a heat-labile 20 kDa protein now 
known as Bacteroides fragilis Toxin (BFT) (83, 84); strains positive for this protein family are 
known as Enterotoxigenic Bacteroides fragilis (ETBF). Initial animal studies noted that BTF ex-
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hibited host species-specificity with the ilea of lambs and ceca of rabbits exhibiting the greatest 
secretory responses. 
The first ETBF isolates from humans came from adults living in Montana and from Navajo 
infants living in the area around Tuba City, AZ� Diarrhea was self-limiting in most of these cases 
(85). The first controlled clinical study of the association of ETBF and diarrheal disease took place 
in 1992 in the clinics of the Apache Indian reservation at Whiteriver, AZ; the results revealed that 
children under 12 months old do not develop ETBF-associated diarrhea, while children 1-5 years 
of age had ETBF isolates associated with diarrhea(86)� Followup studies have found a wide vari-
ance in ETBF carriage rates among symptomatic and asymptomatic populations(87-91)� Aside 
from inducing acute diarrhea, recent evidence suggests that chronic subclinical ETBF carriage 
could be a risk factor in colon cancer by promoting colitis through induction of inflammatory CD4+ 
Th17+ lymphocytes (92, 93)�
BFT is a 20 kDa metalloprotease encoded by a gene located within a pathogenicity island� 
Three alleles (‘subtypes’) are known: bft—1, 2, and 3, named in the order in which they were char-
acterized (84, 94, 95)� While all three alleles have a cosmopolitan distribution, bft-3 is dominant in 
B. fragilis strains isolated from Southeast Asian populations (96)� There is a second putative metal-
loprotease encoded within the BFT pathogenicity island; it is not clear whether it is biologically 
active, necessary for the production of BFT, or even expressed in vivo (97)� 
The biologic activity of BFT has been assayed only in epithelial cell lines, (largely intes-
tinal) which are capable of forming polarized monolayers� Addition of BFT to these monolayers 
results in rapid morphological changes with swelling, rounding, and loss of cell-cell contact occur-
ring within 15 minutes of exposure (98)� The accumulated evidence points to BFT being non-lethal 
and non-cytotoxic, as cellular protein synthesis is stimulated and DNA synthesis remains unaltered 
in its presence (99, 100)� Interestingly, BFT exhibits ‘polar activity’ characterized by increasing 
permeability more rapidly when administered basolaterally compared to presentation at the apical 
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membranes of monolayers. BFT results in basolateral release of proinflammatory cytokines along 
with NF-κB (101)�
The molecular mechanisms through which BFT produces colitis and diarrhea are not thor-
oughly understood� The only known cellular protein demonstrated to be cleaved by BFT in the 
colonic epithelium is the zonula adherens associated protein E-cadherin� Cleavage of E-cadherin 
has only been observed in intact living cells as the proteolytic event requires cellular ATP(102)� 
Proteolysis in response to BFT induces nuclear localization of β-catenin, c-myc transcription and 
cellular proliferation (103). ETBF induction of intestinal inflammation likely happens through 
two pathways: submucosal inflammation through exposure to luminal bacterial antigens due to 
increased intestinal permeability, along with BFT-stimulated release of proinflammatory IL-8, 
CCL2, MCP-1, and CXCL1 (101, 104)� 
Sears proposed a mechanism of action for ETBF (97) where adherence of the bacterium to 
the colonic mucosa results in local secretion of BFT, its binding to apical membrane proteins pres-
ent in colonic epithelial cells, cleavage of E-cadherin, beta-catenin translocation to the nucleus and 
induction of a variety of transcriptional cascades� E-cadherin cleavage along with reorganization 
of the actin cytoskeleton results in epithelial morphologic changes that result in increased perme-
ability, allowing gut mucosal immune cells access to luminal bacterial antigens, thereby promoting 
chemokine expression and inflammatory responses. Finally, it is important to note that BFT is not 
implicated in pathogenesis outside of its direct role in affecting colonic epithelial cell biology� The 
epidemiology of ETBF carriage compared to the occurrence of clinical symptoms, together with 
this proposed model for ETBF-induced colitis/diarrhea suggest that this organism operates as a 
pathobiont whose virulence is related to a number of factors� This thesis tests the hypothesis that 
one such factor is the configuration of the gut microbiota. 
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Examining the role of the gut microbial ecology in defining the pathologic effects of B. 
fragilis
This thesis describes the development of a gnotobiotic mouse model that examines the interactions 
of members of the gut microbiota of healthy versus stunted Banglaldeshi children, their diet and 
ETBF. Mice received intact uncultured microbiota from one of two 24-month-old children: one 
with a healthy growth phenotype and a normal MAZ score; the other with severe stunting with 
significant microbiota immaturity. The ability of their microbiota to effect the weight, metabolic 
and immune phenotypes of gnotobiotic mice was tested in the context of three embodiments of a 
Bangladeshi diet that I designed based on diet records obtained from the donor population. A key 
strategy was to determine whether the phenotypes transmissible by the intact uncultured micro-
biota were also transmissible using the culturable components of these donor’s microbiota (105, 
106). To do so, I generated clonally arrayed collections of anaerobic bacterial strains from each 
donor and sequenced all members of each collection – in essence capturing the history of microbial 
exposures and bacterial strain co-evolution that had transpired in a given host. The results revealed 
that the undernourished child harbored a strain of ETBF while the child with the healthy growth 
phenotype possessed two strains of NTBF. It is notable that the ETBF was not detected through 
standard pathogen screens. 
Mice receiving the intact microbiota or culture collection from the severely stunted donor 
exhibited marked weight loss; this phenotype could be transmitted across generations of gnoto-
biotic mice and was diet-dependent� The two microbiota also transmitted discordant metabolic 
phenotypes with the stunted donor community producing pronounced and reproducible effects 
on lipid, amino acid and ceramide metabolic profiles. The clonally-arrayed culture collections 
allowed me to deliberately manipulate the community context in which ETBF existed: i�e�, germ-
free mice were colonized with the healthy community containing NTBF, or with ETBF substituted 
for NTBF, or with both ETBF and NTBF strains, or with the stunted community with or without 
ETBF� The community context in which ETBF was delivered had marked effects on the commu-
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nity’s expression of virulence factors (and other expressed functional features of the community 
meta-transcriptome), as well as on community and host metabolism� 
The approaches used in Chapter 2 are applied in the study described in Chapter 3, where 
subsets of the healthy donor’s culture collection are introduced into germ-free animals to deter-
mine the effects of the interaction between (i) turmeric, a commonly used culturally relevant spice 
in the Bangladeshi diet, and (ii) bacterial strains with and without bile salt hydrolase activity, on 
gut transit time� Together, these experiments show how microbial community context and diet de-
fine the expressed properties and host effects of gut bacterial strains. Given the remarkable strain 
level diversity that exists in the human gut microbiota, the experimental approaches that I describe 
in this thesis should be useful for addressing a number of fundamental questions related to com-
munity assembly, dynamic operations, and responses to various perturbations of the microbiota� 
In principle, they should also provide an opportunity for developing new ways to deliberately 
manipulate bacterial community properties in order to improve health�
Environmental Enteric
Dysfunction (EED)
Growth/metabotype/
gut barrier function
Maturation of gut
microbiota
Co-development
of microbiota and
immune system
Enteropathogen
burden
Figure 1. A view of the pathogenesis of Environmental En-
teric Dysfunction (EED). In this conceptualization, EED rep-
resents the confluence of interacting/interrelated factors: (i) 
impairment of normal gut microbiota development is influ-
enced by enteropathogen burden; (ii) enteropathogen invasion 
in turn is increased in the face of an immature microbiota; (iii) 
normal development of the gut mucosal immune system is im-
paired by an immature microbiota; and (iv) an immature mu-
cosal immune system impedes further development of the mi-
crobiota, even in the face of therapeutic food interventions. Interactions between (i)-(iv) result in 
impaired growth, perturbed host metabolic phenotypes, and disrupted gut barrier and absorptive 
function.
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ABSTRACT 
Childhood undernutrition is a pressing global health challenge representing a complex set of in-
teracting factors including those involving the gut microbiota. To examine how the effects of en-
teropathogens are impacted by gut microbial community structure, we colonized groups of germ-
free C57BL/6 mice with intact uncultured fecal microbiota samples obtained from two 24-month 
old members of a Bangladeshi birth-cohort, one with a healthy growth phenotype and the other 
severely stunted and underweight, or with members of clonally-arrayed, sequenced collections 
of cultured anaerobic bacterial strains generated from these microbiota. Mice were fed diets that 
embodied those consumed by the population from which the donors were selected. The gut com-
munity from the stunted/underweight but not healthy donor transmitted a weight loss phenotype 
to recipient animals and subsequently to their offspring. The discordant weight phenotypes were 
accompanied by discordant host metabolic phenotypes. The Bacteroides fragilis strain in the stunt-
ed/underweight donor’s culture collection was enterotoxigenic (ETBF), while the two B. fragilis 
strains in healthy donor’s culture collection were non-toxigenic (NTBF). A series of experiments 
in which mice were colonized with either the stunted/underweight culture collection with and 
without ETBF, or the healthy culture collection with and without ETBF, revealed that ETBF was 
causally related to weight loss as a member of the stunted/underweight donor’s culture collec-
tion but not when introduced into the healthy donor’s community. Microbial RNA-Seq revealed 
marked differences in ETBF gene expression in the two different community contexts, as a func-
tion of the presence or absence of NTBF. Strikingly, ETBF induced expression of a large repertoire 
of virulence factor genes encoded in the genomes of healthy culture collection members that was 
mitigated when NTBF was present. The effects of ETBF on host metabolism were also community 
context-dependent. These results demonstrate how B. fragilis acts as a pathobiont and illustrate a 
generalizable way of dissecting intra- and interspecies interactions that define niche space (the sum 
of functional occupancies) of enteropathogens in a gut community.
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INTRODUCTION
Undernutrition is the leading cause of childhood mortality worldwide and reflects a broad and 
complex set of interrelated factors that operate within and across generations (1-4). The gut micro-
biota is a metabolic organ that develops in an age-dependent fashion (5). A recent culture-indepen-
dent study of Bangladeshi birth cohorts identified age-dependent changes in the representation of 
bacterial strains that occurred during the first two years of postnatal life in biologically unrelated 
healthy infants/children. These age-discriminatory strains together defined a developmental pro-
gram for the microbiota (6). Remarkably, children with moderate or severe undernutrition exhibit 
disruptions in this program that result in microbial communities which appear younger than those 
of chronologically age-matched healthy individuals. Moreover, this microbiota immaturity is not 
repaired by existing food-based therapeutic interventions. 
A large enteropathogen burden is a major risk factor for undernutrition (7, 8). Deciphering 
the effects of perturbations in gut microbial community development on enteropathogen invasion 
and burden, and reciprocally, the effects of enteropathogens on the gut microbiota and host in 
children who have healthy growth phenotypes versus those that are undernourished, is challeng-
ing. Preclinical models are needed to help dissect the complex and dynamic interactions between 
enteropathogens, members of the microbiota, and host in order to obtain insights about disease 
pathogenesis, and develop new strategies for disease treatment and ultimately prevention. 
Bacteroides species provide attractive ‘subjects’ for such preclinical studies. They are not 
only critical for processing a variety of dietary polysaccharides but also influence maturation and 
function of the immune system (9, 10). They function as pathobionts. For example, non-toxigenic 
B. fragilis (NTBF) strains are prominently represented in the initial phase of recovery following 
Vibrio cholera infection in adults (11). This recovery recapitulates the normal pattern of initial as-
sembly of the gut microbiota in healthy infants and adults. In contrast, enterotoxigenic B. fragilis 
(ETBF) strains are endemic to countries such as Bangladesh (12) where the burden of undernutri-
tion is great, and are associated with diarrheal disease in children (13). ETBF produces diarrhea 
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and gut inflammation through BFT (also known as fragilysin), a zinc-dependent metalloprotease 
that cleaves E-cadherin at epithelial cell adherence junctions (14). 
“Niche space” can be defined as the sum of functional occupancies of a species/strain in 
a community – a context-dependent view where a strain influences and is influenced by competi-
tors, resources, and host traits (15, 16). The present study describes a gnotobiotic mouse model 
for defining the niche space occupied by B. fragilis. We started with fecal samples collected from 
Bangladeshi children who were participants in a previously completed birth-cohort study (17). Us-
ing anthropometric metrics to define healthy growth versus stunting and wasting (18), and a PCR-
based assay that targeted bft, we selected two chronologically age-matched individuals, one mark-
edly stunted, underweight, and ETBF-positive, and the other ETBF-negative (and NTBF-positive) 
with a healthy growth phenotype. We transplanted intact fecal microbiota samples, collected from 
these two children at 24-months-of-age, into germ-free mice; mice were fed cooked diets contain-
ing ingredients embodying those consumed by the population from which the microbiota donors 
were selected. Finding that these microbiota transmitted discordant weight phenotypes to recipient 
animals and subsequently to their offspring, we performed follow-up transplant studies using clon-
ally arrayed collections of sequenced anaerobic bacterial strains cultured from the donors’ intact 
uncultured fecal samples. These culture collections allowed us to dissect microbe-microbe and 
host-microbe interactions by testing the effects of (i) removing the ETBF strain from the stunted 
donor’s cultured community, and (ii) introducing the ETBF strain into the healthy donor’s culture 
collection together with or in lieu of its own NTBF strains, on microbiota community structure 
and gene expression, microbial and host metabolism, plus body weight and immune phenotypes. 
Our approach demonstrates how ETBF functions as a pathobiont with markedly different effects 
produced in the healthy versus undernourished donor community contexts.
RESULTS
We used anthropometric data collected from members of a now completed birth cohort study of 
100 children living in Mirpur thana in Dhaka, Bangladesh, to define whether they were healthy or 
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undernourished. Those with height-for-age Z (HAZ) scores greater than or equal to -2 were classi-
fied as ‘healthy’ while those with scores less than or equal to -3 were deemed severely stunted: at 
18 months, 30 and 25 children satisfied these criteria for healthy versus severely stunted, respec-
tively, while at 24 months, 27 and 20 received these designations; the remaining children were 
classified as moderately stunted (HAZ scores between -2 and -3). 
A PCR-based screen for ETBF was performed using DNA isolated from fecal samples that 
had been collected from these children at 18 months and 24 months of age; the PCR primers tar-
geted all three fragilysin gene subtypes (14). The results revealed that ETBF was variably present 
across individuals and within a given individual over time, with a total of 25% of 18-month old and 
14% of 24-month old children having a positive test (Table S1): there was no significant difference 
in HAZ score associated with ETBF carriage at either age (p=0.8 and p=0.4 at 18 and 24 months, 
respectively; two-tailed Student’s t-test).
Using the anthropometric and PCR data, we selected fecal samples collected at 24 months 
from two individuals: (i) a healthy child (ID 7114 in Table S1) with an HAZ of -0.71, a weight-
for-age Z (WAZ) score of -1.49, and weight-for-height Z (WHZ) score of -1.62 who was ETBF-
negative at the two time points tested, and (ii) a severely stunted and moderately underweight child 
(ID 7004) with a HAZ of -3.02, a WAZ of -2.51, WHZ =-1.34 who was ETBF-positive at both 
time points. Of the 35 individuals with a positive ETBF test at either time point, only this stunted/
underweight child was positive at both 18 and 24 months of age. 
To create a representative gnotobiotic mouse model to determine the effects of these micro-
biota on host biology, we generated three embodiments of the diets consumed by the population 
represented by the donors. To design these embodiments, we first selected ingredient types (e.g., 
cereals, leafy vegetables, fruits, meat) and determined their relative daily caloric contributions 
based on a study by Arsenault and coworkers (19). Selection of specific food items as representa-
tive of each ingredient type was based on consumption incidence surveys tabulated by Islam et 
al (20) and incorporated into a database consisting of 54 food ingredients. Using the R statistical 
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programming language, we filtered this database to remove items consumed by <20% of house-
holds and categorized each of the remaining 39 items (see Methods for details). From the resulting 
diet ingredient matrix, we randomly sampled (without replacement) one item each from cereals, 
pulse vegetables, roots/tubers, leafy vegetables, fruits, and fish, plus three non-leafy vegetables, 
to populate three separate diet lists. Using the USDA National Nutrient Database for Standard 
References (21), we determined the caloric information for each ingredient and subsequently cal-
culated proportions required to match the pre-determined contributions of each ingredient type. 
Food items were cooked in a manner intended to simulate Bangladeshi practices, and the resulting 
three embodiments of a Bangladeshi diet were sterilized by irradiation prior to administration to 
germ-free mice. The composition and nutritional analyses of the three Bangladeshi diet embodi-
ments are described in Table S2A. The nutritional requirements of mice and children are compared 
in Table S2B.
Separate groups of 8-9 week old germ-free male C57BL/6 mice were gavaged with the in-
tact uncultured fecal microbiota samples obtained from the healthy or stunted/underweight donors. 
Gavage occurred 2 days after mice had been switched from an irradiated, nutritionally complete, 
low-fat/high plant polysaccharide (LF/HPP) mouse chow that they had received since weaning to 
the first of the three embodiments of the Bangladeshi diet. Animals were subsequently fed embodi-
ment 1 (ad libitum) for one week, followed by embodiment 2 for one week, followed by embodi-
ment 3 for one week, with frequent sampling of their fecal microbiota during the course of each 
diet (n=4 singly-housed mice/donor microbiota/experiment; 2 independent experiments; see Fig-
ure S1A for time points when fecal samples were collected and mice were weighed). Sequencing 
PCR amplicons generated from variable region 4 (V4) of bacterial 16S rRNA genes present in the 
donor fecal sample and in fecal samples collected over time from recipient gnotobiotic mice pro-
vided an in vivo assay of bacterial viability/colonization efficiency for each human donor sample. 
16S rRNA sequencing reads were grouped into operational taxonomic units based on a threshold 
of ≥97% nucleotide sequence identity (97%ID OTUs; Table S3). The results revealed that at the 
conclusion of the experiment 65.8±2.5% of OTUs in the stunted/underweight donor’s fecal micro-
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biota sample and 68.4±8.8% of the OTUs in the healthy donor’s microbiota were detectable in re-
cipient mice (i.e., each OTU had a relative abundance of ≥0.1% in ≥1% of fecal samples obtained 
from the mice; Table S3B).
While gnotobiotic animals colonized with the healthy donor’s fecal microbiota maintained 
weight, recipients of the severely stunted/underweight donor’s microbiota exhibited progressive 
and significant weight loss (p<0.005, paired two-tailed Student’s t-test, comparing final versus ini-
tial weights; Figure 1A). Mice that received the stunted donor’s microbiota first exhibited statisti-
cally significant degrees of weight loss by 11 days post gavage (dpg), during consumption of diet 
embodiment 2; weight loss worsened progressively reaching 31±6% of original starting weight by 
dpg 17 (p<0.0001; repeated measures ANOVA in which weight was the dependent variable while 
‘dpg’ and ‘microbiota’ were within-group and between-group variables, respectively; Figure 1A). 
Importantly, food consumption was not different between the two treatment groups when their 
weight phenotypes diverged significantly. Mice were sacrificed on dpg 17 based on the extent of 
weight loss allowable by our approved animal studies protocol and the fact that animals harboring 
the stunted/underweight community had begun to exhibit reductions in feeding in the preceding 
1-2 days.  
The relative abundance of B. fragilis, defined by V4-16S rRNA sequencing, was signifi-
cantly greater in mice colonized with the stunted/underweight donor microbiota than in mice colo-
nized with the healthy donor microbiota (p=1.9x10-6, Student’s two-tailed t-test; Figure 1B). The 
negative correlation between relative abundance of B. fragilis and weight (the latter expressed as 
a proportion of the baseline value just prior to colonization) was significant (p=0.01, rho = -0.55, 
Spearman’s rank correlation; Figure S2B). 
Assaying the functional properties of clonally-arrayed collections of anaerobic bacterial 
strains cultured from healthy and stunted/underweight donor microbiota
The 16S rRNA sequence data did not allow us to distinguish the number of NTBF versus ETBF 
OTUs that had been transferred to gnotobiotic mice, nor would transplantation of intact uncul-
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tured microbiota allow us to (i) describe the contribution of individual strains in the transplanted 
community to the community meta-transcriptome or (ii) test the effects of deliberately adding or 
subtracting individual members on community structure, community function, or host biology. 
Therefore, to further characterize microbe-microbe and microbe-host interactions, anaerobic bac-
terial strains were cultured from the healthy and stunted/underweight donors’ fecal samples (22, 
23). Each collection of cultured strains was clonally arrayed in multi-well plates so that each well 
contained a monoculture of a given bacterial isolate (22). Each culture collection consisted of 
organisms that had co-existed in a single donor’s gut and thus were the products of the donor’s his-
tory of environmental exposures to various microbial reservoirs (including those of family mem-
bers and various enteropathogens endemic to the Mirpur thana), as well as the selective pressures 
and evolutionary events (e.g., immune, antibiotic, food, horizontal gene transfers) placed on and 
operating within their microbiota. 
Individual isolates in the clonally arrayed culture collection were grouped into ‘strains’ if 
they shared an overall level of nucleotide sequence identity of >96% across their assembled draft 
genomes. Based on this criteria and the results of full length and V4-16S rRNA sequencing of the 
isolates, we determined that the healthy and stunted donors’ culture collections contained 53 and 
37 strains, respectively, representing 21 and 17 of the 97%ID OTUs captured in mice receiving 
the intact uncultured human donor fecal samples. Only one strain was shared between the two 
culture collections: Bifidobacterium breve hVEW9. (See Table S4A,B for a list of all isolates in 
the culture collection derived from the stunted/underweight child plus a summary of KEGG-based 
annotations of their sequenced genomes, and (23) for details about the healthy donor’s culture col-
lection.) 
ETBF strains contain one of three alleles of the toxin-encoding gene bft (bft1, bft2, bft3) in 
their 6 kb pathogenicity island (BfPAI). Two B. fragilis strains present in the healthy donor’s cul-
ture collection (B. fragilis hVEW46 and hVEW47) lacked a BfPAI and were therefore classified 
as NTBF. The stunted donor’s collection contained a single B. fragilis strain (B. fragilis mVEW4); 
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its genome contained a bft-3 allele (Table S1A). ETBF strains of this type are globally distributed, 
most commonly in Southeast Asia (24). 
We colonized 8-week-old adult male germ-free C57BL/6 mice with all members of ei-
ther of these two culture collections (n=6 singly caged mice/culture collection; all mice receiv-
ing a given culture collection were maintained in a single gnotobiotic isolator). As a control, we 
also colonized mice with the corresponding intact uncultured fecal microbiota samples; they were 
housed in separate isolators from those used for the culture collection transplants. All mice were 
given each of the three embodiments of the Bangladeshi diet, each for one week, in the same order 
described for the previous experiments. 
As with the intact uncultured microbiota, the corresponding culture collections transmitted 
discordant weight phenotypes to recipient animals (p<0.0001, repeated measures ANOVA; Figure 
1C). Moreover, the weight phenotypes (change in body weight over time as a percentage of initial 
weight before gavage) between mice receiving intact fecal microbiota or the derivative culture 
collection from the same human donor were not significant (p>0.05, repeated measures ANOVA; 
Figure 1C).
The weight phenotypes first became statistically significantly different between the two 
groups of mice midway through consumption of diet embodiment 2 and again were not attribut-
able to differences in food consumption; the differences continued to increase into the final phases 
of diet embodiment 3 where in the terminal days of the experiment mice harboring the stunted/
underweight but not healthy donor culture collection manifested reduced food intake (Figure 1C). 
To test whether the discordant weight phenotype was sensitive or robust to diet embodiment-
type, the complete clonally-arrayed bacterial culture collections from the healthy or stunted/under-
weight donors were gavaged into separate groups of 8-week-old adult male germ-free C57BL/6 
mice who were monotonously fed Bangladeshi diet embodiment 1, 2, or 3 for three weeks (n=6 
singly caged recipient mice/culture collection/diet embodiment). The discordant weight phenotype 
observed previously was preserved irrespective of the Bangladeshi diet embodiment consumed 
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(p<0.0001, repeated measures ANOVA comparing recipients of the healthy versus stunted/under-
weight culture collections across all three diet embodiments; n=18 mice/culture collection; Figure 
1E). Moreover, no significant differences in weights were noted between groups of mice colonized 
with the same culture collection but fed different diet embodiments (repeated measures ANOVA; 
Tukey-adjusted p=0.75, p=0.99, and p=0.61 for embodiments 1 versus 2, 1 versus 3, and 2 versus 
3 for mice receiving the stunted/underweight donor’s culture collection, respectively, and adjusted 
p=0.99 for each of these three comparisons in mice colonized with the healthy donor’s culture col-
lection; Figure 1E). We concluded that in our model, the gut microbiota was a more significant 
determinant of body weight phenotype than the particular diet embodiment consumed.
Transmission of strains was defined by short read shotgun sequencing of DNA isolated 
from fecal samples collected at the end of the experiment. This method, known as COmmunity 
PROfiling by Sequencing (COPRO-Seq), maps reads onto the draft genome assemblies of com-
munity members; at the depth of sequencing employed (354,352 ± 23,216 (mean ± s.e.m.); 50 nt 
unidirectional reads/fecal DNA sample), it can reliably detect strains whose relative abundance is 
≥0.1% (for further details, see (25) and Methods). COPRO-Seq demonstrated that transplantation 
of the culture collections was efficient and reproducible, with 98.1 ± 0.6% and 94.5 ± 1.6% (mean 
± s.e.m.) of strains in the collections derived from the healthy and stunted donors, appearing in 
recipient animals, respectively. The abundance of ETBF in the fecal microbiota of mice containing 
the stunted/underweight donor’s culture collection was significantly greater than the cumulative 
relative abundance of the two NTBF strains in recipients of the healthy culture collection (Figure 
2B). This difference in the total relative abundance was significant irrespective of the diet embodi-
ment consumed (p=2.8x10-9, two-tailed Student’s t-test; Figure S2C), and abundance negatively 
correlated with weight relative to baseline (p=5.4x10-5, rho = -0.45, Spearman’s rank correlation; 
Figure S2B). Moreover, the relative abundances of the ETBF strain in recipients of the stunted/
underweight donor’s culture collection, the two NTBF strains in the healthy donor’s collection, 
and all other Bacteroides species did not differ significantly between diet embodiments (p>0.5, 
ANOVA; illustrated using indicator species analysis (26-28) in Figure S2C). 
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To assess whether this discordant weight loss phenotype was transmissible across genera-
tions of mice, two males from the transplant experiment, one containing the stunted/underweight 
donor’s intact uncultured microbiota or derived culture collection, the other the healthy donor’s 
intact microbiota or derived culture collection, were switched to and subsequently maintained on 
an irradiated nutritionally enhanced mouse breeder chow from 21 to 48 days post-colonization, at 
which time they were each co-housed with two germ-free 6-week old females that had received 
breeder chow since weaning. Seven days after co-housing, each male mouse was withdrawn from 
each mating trio, and the females were subsequently maintained on breeder chow throughout their 
pregnancy and as their pups completed the suckling period (Figure S1B). Male pups (n=3-4/lit-
ter) were then weaned onto an irradiated, nutritionally sufficient LF/HPP chow until they were 
9-weeks old, at which time they were switched to the Bangladeshi diets (10 days/diet; order of 
sequential presentation of the embodiments as before). The efficiency of transmission of 97% ID 
OTUs from mothers to offspring was high: e.g., 96±1.8% and 88±2.3% (mean ± s.e.m.) in the case 
of the healthy and stunted/underweight donor’s intact uncultured donor microbiota, respectively 
(Figure S3). 
Mice born to mothers colonized with either of these intact uncultured fecal microbiota or 
arrayed culture collections experienced identical weight gain profiles while consuming the nutri-
tionally complete LF/HPP chow (p=0.9, two-tailed Student’s t-test comparing weights between 
the two treatment groups; Table S5). However, once they were transitioned to the sequence of 
three Bangladeshi diet embodiments (consumed from postnatal days 56 to 86), a discordant weight 
loss phenotype was again observed with mice born to mothers harboring a stunted/underweight 
microbiota exhibiting significantly greater weight loss (p<0.001; repeated measures ANOVA). In 
mice colonized with the culture collections, the efficiency of ETBF and NTBF transmission from 
parents to pups was 100%: the total relative abundance of the two NTBF strains in fecal samples 
obtained from recipients of the healthy donor’s culture collection was 4.2±0.7% at the conclusion 
of the LF/HPP diet period and 4.6±0.9% at the conclusion of the Bangladeshi diet embodiment 
sequence, while the relative abundance of ETBF for these two time points were 34.3±4.2% and 
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50.0±0.7%, respectively, in mice colonized with the stunted/underweight donor’s culture collec-
tion. Based on these results, we concluded that the weight loss phenotype was transmissible across 
generations and evocable by embodiments of a Bangladeshi diet.
We used targeted mass spectrometry to quantify levels of amino acids, organic acids, ac-
ylcarnitines, and acyl-CoAs in liver and serum harvested from mice in the two treatment groups, 
each of which had been monotonously fed diet embodiment 2. Animals were not fasted prior to 
euthanasia. 
The combination of this embodiment of the Bangladeshi diet and a stunted/underweight 
culture collection was associated with significant increases in hepatic levels of succinate, malate, 
and fumarate compared to mice colonized with the healthy culture collection (p<0.03; Figure 
S4A), indicating that the former group had impaired TCA cycle activity. Pyruvate, the end product 
of glycolysis that feeds into the TCA cycle, was also significantly decreased, as was lactate, which 
is converted to pyruvate in energy-deficient states (p<0.005; Figure S4A) (29). 
Long-chain fatty acid (LCFA) CoA synthetase converts fatty acids to fatty acylCoAs, a car-
nitine-dependent first step in fatty acid transport through the outer and inner membranes of mito-
chondria into the mitochondrial matrix (30). Undernutrition is associated with carnitine deficiency 
(31) and decreased ability to utilize LCFAs (29): carnitines are converted to acylcarnitines in the 
mitochondrial inter-membrane space as part of LCFA transport. Carnitine can be synthesized from 
lysine and methionine (32). Compared to mice harboring the healthy donor culture collection, 
those colonized with the ETBF-containing stunted/underweight donor culture collection exhibited 
(i) increased concentrations of lauroyl-, myristoyl-, palmitoyl-, oleoyl-, and linoleoyl-CoAs in 
their livers (p<0.03, FDR-adjusted Student’s two-tailed t-test; Figure S4C), (ii) significantly lower 
levels of C2, C6, and C20 acylcarnitines in their livers (p<0.05, FDR-adjusted Student’s two-tailed 
t-test; Figure S4D), plus (iii) significantly lower levels of methionine in their serum (p<0.0005, 
FDR-adjusted Student’s two-tailed t-test; Figure S4B). These results are consistent with a de-
creased capacity for acylCoA utilization. 
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Niche space dictates the effects of the pathobiont ETBF on microbiota community structure 
and function
Figure 3 describes a series of manipulations we performed involving (i) removal of the ETBF 
strain from the stunted/underweight donor’s culture collection (to allow comparison of the re-
sponses of the community as well as host to its presence or absence), and (ii) addition of the ETBF 
strain to the healthy donor’s culture collection with or without subtraction of its two NTBF strains 
(to ascertain community/host responses to ETBF, the ability of NTBF to modulate ETBF effects, 
and the effects of ETBF on NTBF). C57BL/6 male mice in each of the five different treatment 
groups were 8-9 weeks of age at the time of colonization; all were placed on diet embodiment 2 
for two days prior to gavage and subsequently maintained on this diet for 13 days until they were 
euthanized (n=5 animals/treatment group; all singly caged; treatment groups maintained separate 
gnotobiotic isolators). Fecal samples were collected as described in Figure S1D. Host weight, 
metabolic, and immune phenotypes were defined. Microbial communities were characterized 
structurally by COPRO-Seq analysis of fecal samples, and functionally by RNA-Seq and mass 
spectroscopic analyses of cecal samples. 
Host phenotypes – Removal of the ETBF strain from the complete stunted/underweight do-
nor’s culture collection prevented the transmissible weight loss phenotype (Figure 2C; p<0.0002, 
Tukey-corrected repeated-measures ANOVA). However, addition of the ETBF strain to the healthy 
donor’s culture collection did not produce significant weight loss, regardless of whether the NTBF 
strains were present or absent (p=0.9, repeated-measures ANOVA; Figure 2C). 
The metabolic effects of these microbial community manipulations were studied by assay-
ing serum, liver, gastrocnemius muscle, and cecal contents by targeted mass spectrometry. Results 
are summarized in Table S6H. Mice colonized with the complete (unmanipulated) stunted/un-
derweight donor’s culture collection were unique among the treatment groups in having elevated 
hepatic levels of two known inhibitors of mitochondrial electron transport complex IV, C16 and 
d18:1/16:0 ceramides, (p<0.0006 and p<0.05, respectively, using FDR-adjusted Student’s two-
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tailed t-test; Figure 2D), and significantly elevated levels of lactate in their gastrocnemius muscle 
(p<0.04, FDR-adjusted Student’s two-tailed t-test) consistent with decreased oxidative metabo-
lism. Ceramides are involved in key intracellular stress response pathways (33), including those 
associated with immuno-inflammatory responses (34) (see below). 
The effects of removing ETBF from the stunted/underweight donor’s culture collection 
and of adding ETBF to the healthy donor’s culture collection included changes in multiple metabo-
lite classes (Table S6H). Among the >100 metabolites characterized by targeted mass spectrom-
etry, including multiple bile acid species, the presence of ETBF in these two community contexts 
resulted in just one identified common metabolic response - a significant increase in cecal levels 
of acetate (p<0.02, FDR-adjusted Student’s two-tailed t-test) but not other short-chain fatty acids 
(e.g. propionate, butyrate). Intriguingly, acetate has been linked to the regulation of virulence, as 
illustrated by its effect on Shiga toxin-producing E. coli in gnotobiotic mice co-colonized with 
an age-discriminatory bacterial species in the developing human gut microbiota, Bifidobacterium 
longum (35). Such a limited metabolic signature of ETBF might be explained by the fact that two 
communities that only shared only one member.
To assess the effects of ETBF on host immune phenotype, we performed FACS analysis 
of immune cell populations in the colons, mesenteric lymph nodes, and spleens of four groups 
of mice: those colonized with the stunted/underweight donor’s culture collection with or without 
ETBF; and those containing the transplanted unmanipulated healthy donor’s culture collection or 
the manipulated collection where ETBF had been substituted for NTBF. Consistent with a previ-
ous study of gnotobiotic mice mono-colonized with an ETBF isolate (36), colonic CD4+ Th17+ T-
lymphocyte populations were significantly increased in animals colonized with ETBF(+) healthy 
and ETBF(+) stunted/underweight culture collections compared to ETBF(–) healthy and ETBF(–) 
stunted culture collections (p<0.001 and p<0.02 for, respectively, Student’s t-test; Figure S5B). 
The presence of ETBF was not associated with significant differences in the size of the anti-in-
flammatory FoxP3+ regulatory T-cell population in mesenteric lymph nodes in either the stunted/
underweight or healthy community contexts (p>0.05, ANOVA corrected for multiple hypotheses; 
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Figure S5C). Based on these cellular phenotypes, the immune response to the presence of ETBF 
could not be readily correlated with the observed weight loss phenotypes.
Microbial community responses to ETBF – COPRO-Seq analysis revealed that recipients 
of the unmanipulated stunted donor’s culture collection had fecal microbiota dominated by ETBF 
(relative abundance 62.3±4.0%). Removal of ETBF led to significant increases in the relative 
abundances of Bifidobacterium breve, Bifidobacterium, Enterococcus lactis, and Enterococcus 
gallinarum (p<0.02, two-tailed Student’s t-test; Figure 4A). (Note that no other Bacteroides spe-
cies were present in this culture collection). 
In contrast, the fecal microbiota of recipients of the unmanipulated ETBF(–) NTBF(+) 
healthy donor’s culture collection were dominated by (i) the two NTBF strains [total B. fragilis rel-
ative abundance 14.5±3.0% (mean ± s.e.m.), with strains Bacteroides fragilis hVEW46 and Bacte-
roides fragilis hVEW47 comprising 1.1% and 13.5%, respectively; Figure 4A] and (ii) two other 
Bacteroides (B. thetaiotaomicron and B. caccae), plus Bifidobacterium breve and Enterococcus. 
Addition of ETBF to the healthy donor’s culture collection did not produce significant changes in 
the relative abundance of the B. fragilis component of the recipient’s microbiota [B. fragilis strains 
comprised 18.4±0.9% (mean ± s.e.m.) of the community, with the NTBF and ETBF equivalently 
represented at relative abundances 8.9±0.5% and 9.5±0.4% respectively]. Remarkably, this rela-
tive abundance value for B. fragilis held (i.e. was not significantly different) in all three versions 
of the transplanted healthy donor community examined (the unmanipulated ETBF(–) NTBF(+), 
plus the manipulated ETBF(+) NTBF(–), and ETBF(+) NTBF(+) types) was remarkable (Figure 
4A; p>0.5, two-tailed Student’s t-testing) suggesting that a restricted niche space for B. fragilis 
is imposed by other members of this healthy donor’s culture collection. In line with this notion, 
we observed that the fecal microbiota of mice colonized with the ETBF(+) NTBF(–) manipulated 
healthy culture collection had significantly higher relative abundances of B. thetaiotaomicron, B. 
caccae, and Bifidobacterium breve, and significantly lower relative abundance of Enterobacte-
riaceae compared to the fecal microbiota of mice harboring the manipulated ETBF(+) NTBF(+) 
version (p<0.05, Student’s two-tailed t-test; Figure 4A). 
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Integrating the weight phenotypes with these observations also suggested that both intra-
species and inter-species interactions are critical in determining whether ETBF colonization re-
sults in weight loss. Therefore, we turned to microbial RNA-Seq to assess (i) the effects of the 
stunted/underweight versus the healthy community on ETBF, (ii) the effects of intra-species com-
petition (NTBF on ETBF and vice versa) in the healthy community context, and (iii) the effects of 
co-colonization with ETBF on other Bacteroides and other bacterial members that do not belong 
to this genus in the healthy community context. 
The results of a comparison of the ETBF transcriptome in the transplanted unmanipulated 
stunted/underweight versus the manipulated ETBF(+) NTBF(–) healthy donor cultures collec-
tion are summarized in Figure 5 in the form of a volcano plot where the x-axis represents the 
fold-difference in expression of ETBF genes in the context of the two communities and the y-axis 
shows the FDR-corrected p-value of the significance of the difference as determined by the exact 
negative binomial test, as well as a heatmap where rows show Z-score normalized transcript lev-
els (read counts per million reads) of differentially expressed transcripts whose protein products 
had assignable Pfam annotations. A variety of ETBF genes involved in carbohydrate uptake, me-
tabolism and biosynthesis were differentially expressed, including components of polysaccharide 
utilization loci (PULs) and capsular polysaccharide biosynthesis (CPS) loci (Figures 5B and S6).
Intriguingly, our transcriptional analysis of ETBF responses showed that expression of its 
key virulence and colonization determinant, bft-3 (37-39), varied significantly based on commu-
nity context. In a manipulated healthy community where ETBF was present but NTBF was absent, 
bft-3 expression in the cecal meta-transcriptome was increased 120-fold compared to a community 
where both ETBF and NTBF were present (p<1x10-21, Figure S6C, Table S7B).The importance 
of bft in colonization and virulence was further highlighted when we abrogated fragilysin (bft-3) 
expression within ETBF isolate mB11 through insertional mutagenesis (Figure S10). Though this 
mutant grew robustly in vitro, when we attempted to colonize germ-free gnotobiotic mice (n=5) 
with a manipulated version of the stunted donor’s culture collection where the isogenic bft-knock-
out strain had been substituted for the existing wild-type ETBF strain, we saw no ETBF∆bft-3 
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colonization of the mutant: the number of reads mapping to the bft knockout strain was no greater 
than background; failed colonization (as opposed to low level colonization) was confirmed by a 
negative PCR assay that used B. fragilis-specific bft primers (40). 
Given the critical role played by ETBF in mediating our weight-loss phenotype, we turned 
to our transcriptomic data for insights into how NTBF might be mediating regulation of the key 
colonization/virulence factor bft-3 in ETBF. Comparing the healthy community with or without its 
NTBF strains revealed that the presence of the two NTBF strains affected a number of features of 
ETBF gene expression (Table S7B). One of these factors is LuxQ, which serves as a key signaling 
protein in the detection of the quorum-sensing molecule AI-2 (Autoinducer-2). We observed that 
expression of three of the four luxQ homologs in ETBF were decreased when NTBF was present in 
the context of the healthy donor’s culture collection (p<0.005, log2(fold-change) of -2.8, -4.4, -9.5; 
Table S7B): comparing the mice colonized with the unmanipulated NTBF(+) with the manipu-
lated ETBF(+), NTBF(+) versions of the healthy donor’s culture collection revealed differential 
regulation of three other luxQ transcripts encoded by Bacteroides members of the healthy commu-
nity (one each in B. thetaiotaomicron hVEW3, B. caccae hVEW52, and B. caccae hVEW52, Table 
S7D). Recent studies in gnotobiotic mice have (i) demonstrated that AI-2 signaling by members 
of the human gut microbitoa can alter the virulence factor expression of enteropathogens (11) and 
(ii) linked AI-2 signaling modulation of levels of Bacteroidetes in the gut (41). The healthy culture 
collection contains a total of five Bacteroides strains; two representatives of B. fragilis, one of B. 
thetaiotaomicron and two B. caccae (Table S4A). Intriguingly, the relative abundances of the lat-
ter three strains but not the NTBF strains were significantly altered when ETBF was added (see 
above). 
The AI-2 signaling system in Bacteroides has not been well characterized. Genomic analy-
sis of the type strains of six Bacteroides species revealed that majority of their genomes did not 
encode the AI-2 synthase luxS, but did contain many luxQ homologs. Furthermore, this analysis 
revealed few putative downstream luxP, luxU, and luxO genes (11). While much work remains to 
be done to characterize the mechanisms behind how AI-2 regulates gene expression and fitness of 
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Bacteroides in the gut, the changes in species-level abundances and expression of components of 
quorum-sensing regulatory systems which occur in the context of ETBF-NTBF interactions in the 
healthy donor’s community suggest that cell-cell communication may play a role in the communi-
ties structural and functional configuration in the gut.
The volcano plot and heatmaps shown in Figure S7 summarize the myriad effects of ETBF 
on the NTBF transcriptome. As with ETBF, NTBF responds to the presence of its conspecific 
(ETBF) strain by changing expression of multiple features of carbohydrate utilization and biosyn-
thesis, including several of its capsular polysaccharide biosynthesis (CPS) loci and polysaccharide 
utilization loci (PULs) (Figure S7B).
The effects of incorporating ETBF in lieu of the two strains of NTBF in the transplanted 
healthy culture collection on B. thetaiotaomicron and B. caccae are depicted in Figures S8 and 
S9 and include significant increases in expression of a luxQ locus in B. thetaiotaomicron and de-
creased expression of two luxQ loci in one of the two strains of B. caccae (B. caccae hVEW51) 
plus induction and suppression of several PULs and CPS loci (also see Table S7D).
Effects of ETBF on gene expression by other members of the microbiota – We proceeded 
to further elucidate the transcriptional responses in the community during its reorganization as a 
result of pathogenic ETBF invasion. To do this, we examined genes known to be related to infec-
tion, colonization, and virulence in pathogenic organisms by BLAST searches of the genomes of 
members of both culture collections for genes within the Virulence Factor (VF) database (putative 
virulence factor representation by strain listed in Table 1). 
We used our microbial RNA-Seq data to compare the expression of genes related to vir-
ulence processes in five different transplanted cultured community contexts: the stunted/under-
weight donor’s community with or without ETBF; the un-manipulated ETBF(–) NTBF(+) healthy 
donor’s community; and the manipulated healthy donor’s community with ETBF and NTBF, or 
with ETBF in lieu of NTBF. None of the 105 genes with annotations in the VF database encoded 
in the genomes of the members of the transplanted stunted/underweight donor’s culture collection 
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underwent significant changes in expression when ETBF was not present (Figure 4B and Table 
S8B). Addition of ETBF to the healthy donor’s culture collection when its NTBF strains were 
present produced only 7 (0.7%) significant changes in gene expression in vivo in four of its 53 
member strains (Table S8D). In stark contrast, removal of the two NTBF strains ‘allowed’ ETBF 
to have a very large and generalized effect on community expression, with 254 (25%) of the 993 
VF database annotated genes encoded by 9 of the 53 members of this manipulated community 
exhibiting significant changes in their expression (Table S8D). The distribution of these ETBF-in-
duced virulence factors among community members is shown in Table 1 and Figure 4B, with the 
majority of those induced present in Enterobacteriaceae hVEW34 (134 of its 320 encoded VFs) 
and Enterococcus gallinarum hVEW37 (36 of its 292 VFs) (Table 1, Table S8), and the majority 
of those suppressed belonging to Bifidobacterium breve hVEW45 (11 of its 14 virulence factors). 
We identified numerous genes related to stress responses, including the key general stress 
response sigma factor rpoS (42), and genes related to DNA repair such as recD, suggesting that 
community members may undergo a regulated general stress response to ETBF invasion that is 
ameliorated by the presence of NTBF.
Genes responsible for iron acquisition and metabolism were also upregulated during inva-
sion by ETBF, suggesting one possible area of species competition leading to metabolic stress 
within the community. An Enterobacteriaceae homolog of the E. coli BasSR system component 
BasS that is induced under high iron conditions is also repressed during ETBF invasion (43). This 
is also concordant with previous work in model bacterial systems suggesting that RpoS positively 
controls carbon source transport and iron acquisition (44), suggesting that competition with ETBF 
for iron by members of the health donor’s-derived community is important during ETBF invasion. 
Intriguingly, numerous genes related to prophage and mobile DNA element biology were 
also up-regulated as a response to ETBF invasion (Figure 4B). Prophage activation in bacteria as 
a function of stress has been shown previously, with some studies postulating that phage induction 
and subsequent lysis of resident commensal microbes may lead to a shift in community structure 
to favor an increased proportion of pathobionts via “community shuffling” (45).
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The mechanisms by which NTBF can suppress the effects of ETBF on gene expression in 
other community members are unclear, including the role played by inter-species quorum sensing 
(e.g. by luxQ regulation). Nonetheless, these changes reveal/report inter-specific interactions that 
are profoundly shaped by intra-specific competition (46, 47). 
DISCUSSION
The approach described in this study, involving generation of sequenced, clonally arrayed culture 
collections from the fecal microbiota of 24-month old healthy and stunted/underweight Bangla-
deshi children and subsequently introducing these consortia, with or without addition or subtrac-
tion of B. fragilis strains, into germ-free mice fed embodiments of the diets consumed by the mi-
crobiota donors, allowed us to characterize how an enterotoxigenic strain functions as a pathobiont 
in a microbial community context-dependent manner. 
In ecology, zero net-growth isoclines (ZNGI) are used to describe the conditions necessary 
for a habitat to sustain a given population size of a given species; they can also be used to predict 
what alterations could be made to extirpate an organism from the niche described by the ZNGI. 
The parameters required to calculate a ZNGI for a given species are the abundance of competi-
tors and/or resource availability. Gnotobiotic mouse models like that created for the present set of 
experiments provide a way to model a ZNGI for various members of the human gut microbiota 
including pathobionts such as ETBF (16). 
The ability of the community of bacterial strains cultured from the healthy donor’s gut 
microbiota to accommodate ETBF is vividly illustrated by the intraspecific interactions between 
NTBF and ETBF: simulating invasion of ETBF into a healthy host’s community by introducing 
it into the culture collection prior to colonization of mice a regulated stress and iron metabolism 
response that was only apparent when NTBF was removed. The power of marrying gnotobiotics 
with clonally arrayed culture collections to deliberately and systematically alter the membership 
of communities assembled in mouse models of human donors’ gut ecosystems creates an oppor-
tunity to conduct future experiments in which (i) ETBF is added to various subsets of the healthy 
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donor’s culture collection ± NTBF and introduced into germ-free mice to identify the intra- and in-
terspecific interactions that lead to or prevent different pathological outcomes and how diet shapes 
this rich community transcriptional response. Similarly, testing the ability of other NTBF strains, 
cultured from different Bangladeshi children living in Mirpur or other geographic locations within 
Bangladesh to mitigate ETBF effects, or reciprocally, examining different isolated ETBF strains 
in the presence of a given NTBF strain in this healthy donor’s community context, should be in-
formative. An analogous series of combinatorial experiments could also be performed involving 
introduction of different NTBF strains (in the context of various ETBF strains) into the stunted/
underweight donor’s culture collection. Other levels of generalization can be envisioned with this 
approach: our study was limited to characterizing the microbiota of two donors representing a sin-
gle population where the burden of childhood undernutrition is great; clonally arrayed culture col-
lections obtained from healthy and undernourished donors from other populations where burden 
of disease is also great, could be used for these types of addition/subtraction/subset experiments 
to better understand how inter/intra-specific competition and niche space determine the effects of 
enteropathogens in different diet contexts on disease pathogenesis. One hoped for outcome from 
these types of analyses is development of new food and microbe-based interventions that more ef-
fectively treat and ultimately help prevent childhood undernutrition.
MATERIALS AND METHODS
Birth cohort study
The birth cohort study design and sample collection protocols have been described previously (17). 
bft PCR assay 
Confirmation of blastn results of B. fragilis toxin (bft) in B. fragilis strains in the stunted donor’s 
culture collection and screening DNA isolated from fecal samples collected at 18 and 24 months 
of age from members of the birth-cohort was achieved by PCR using primer pair: 5’-GAACCTA-
AAACGGTATATGT-3’ (GBF-201) and 5’-GTTGTAGACATCCCACTGGC-3’ (GBF-210) (48) 
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and OneTaq 2x master mix (New England Biolabs) under the following thermocycling conditions: 
after initial melting at 95°C for 30 s, 30 cycles of 95°C for 30 s, 53°C for 30 s, and 68°C for 30 s, 
with a final annealing time of 7 min at 68°C.
Preparation of human fecal samples for transplantation
Under anaerobic conditions (77%N2, 20%CO,, 3%H2), 1 g aliquots of previously frozen fecal 
samples were resuspended in 15 mL of gut microbiota medium (GMM) (22) and homogenized at 
the ‘high’ setting in a sterilized blender (Waring, Torrington, CT). Homogenates were clarified by 
passage through 100 mm pore-diameter nylon filters (BD Falcon, Franklin Lakes, NJ). Five mL of 
sterile 2 mm-diameter glass beads were added and remaining cell clumps were disrupted by vor-
texing (four on/off cycles, each 30 s). A final filtration through a 40 mm pore-diameter nylon filter 
(BD Falcon, Franklin Lakes, NJ) was performed before storage in GMM with 15% glycerol at 
-80°C in 2 mL amber glass vials with a crimp-top butyl septum (Wheaton Scientific, Millville, NJ).
Production of Bangladeshi Diet Embodiments
Diet embodiments were prepared in 15 kg batches, with ingredient composition and nutritional 
content given in Table S1. Tilapia fish filets (Whole Foods Markets, St. Louis, MO) were sim-
mered for 30 min in a 20 L stainless steel pot over a Corning hotplate (temperature setting 4). 
Fruits and vegetables were combined and simmered in a separate pot for 45 min on a Corning 
hotplate (temperature set at ‘4’). Parboiled rice (Delta Star, Stuttgart, AR) was cooked in a rice 
cooker (KRUPS, Medford, MA). Lentils were simmered for 90 min (temperature set at ‘2’). All 
ingredients for a given diet embodiment were combined in a vertical cutter-mixer (Robot Coupe 
Model R23, Jackson, MS) and pureed for 5 min. Aliquots were cooled for 12 hours in large plastic 
containers at 4°C; thereafter, 500 g aliquots were vacuum-sealed in 8”x10” plastic bags (U-line, 
Pleasant Prairie, WI). The vacuum-sealed food paste was placed in a second 8”x10” plastic bag (as 
an added barrier against incidental contamination), and the contents of the packages were steril-
ized by irradiation (20-50 kGy) within 24 h of food production (Steris Co, Chicago, IL). Sterility 
was verified by culturing samples of the irradiated diet in BHI medium for 5 days at 37°C under 
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anaerobic and aerobic conditions as described previously (23). In addition, B. subtilis spore strips 
that had been included along with the food during the irradiation were cultured under the same 
conditions. Final nutritional profiles of the diets were obtained by submitting 100 g samples of 
each embodiment to Nestle Purina Analytical Labs (St Louis, MO). 
Clonally arrayed bacterial culture collections
Clonally arrayed bacterial culture collections were generated from frozen fecal samples using pre-
viously published methodologies (22). Diluted bacterial cultures were arrayed in Coy chambers 
under strict anaerobic conditions (77%N2, 20%CO, 3%H2) using protocols executed on a Preci-
sion XS liquid handling robot (BioTek, Winooski, VT). The bacteria occupying each well were 
first grouped into 100%ID OTUs based on the results of V4-16S rRNA amplicon sequencing. 
Most OTUs were observed more than once across an arrayed library. Next, 3-4 isolates represent-
ing each OTU were picked robotically from the 384-well arrays and struck out individually onto 
8-well agar plates containing GMM (22): DNA from isolates was subjected to whole genome shot-
gun sequencing, plus sequencing of full-length 16S rRNA gene amplicons generated by primer 
pairs 8F and 1391R. Isolates sharing ≥99% nucleotide sequence identity in their 16S rRNA genes, 
and ≥96% sequence identity throughout their genomes (as determined by NUCmer (49) were 
defined as a unique strain. Full-length 16S rRNA sequences were used to define taxonomy (Ribo-
somal Database Project (RDP) version 2.4 classifier (50)). Whole genome shotgun sequencing was 
performed using an Illumina HiSeq 2000 instrument (101 nt paired-end reads) or a MiSeq machine 
(150 nt paired-end reads). Sequences were assembled using MIRA (51), version 4.02 (parameters: 
“-NW:cnfs=warn, -NW:cmrnl=no, –GE:not=4”; template_size = “150 500 autorefine”). Cover-
age of strains from the severely stunted/underweight donor’s culture collection was 38.6±5.0-fold 
(mean±SEM) with an N50 contig length of 28.5±3.5kb (mean±SEM) (Table S3B). The corre-
sponding values for members of the healthy donor’s collection are described in (23). Genes were 
annotated using Prokka v1.10 (52). Predicted genes in each isolate’s genome assemblies were 
mapped to KEGG pathways and assigned KEGG Ortholog (KO) groups by querying the KEGG 
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reference database (release 72.1) (BLAST 2.2.29+, blastp E-value ≤10-10, single best hit defined by 
E-value and bit score) (53, 54). 
Clonally arrayed, sequenced culture collections were stored in GMM/15% glycerol at 80o 
C in 96-well plates (TPP Tissue Culture Test Plates, Switzerland).
Generation of a bft-3:pGERM mutant in the ETBF strain cultured from the stunted donor’s 
microbiota — Bft gene disruption was accomplished using the Bacteroides suicide vector pGERM 
(55). We introduced a 380-bp fragment of the 5’ end of bft-3 into BamH1-digested pGERM suicide 
vector using the Gibson Assembly Cloning Kit (NEB) (56). Primers to create the PCR product 
for the Gibson reaction were created using the NEBuilder Assembly Tool (v1.7.2). Assembled 
constructs were introduced by electroporation into kanamycin-resistant, electrocompetent E. coli 
DH5-a RK231 (57). Transformants were plated on LB-agar containing IPTG/Xgal (SigmaAl-
drich, St. Louis, MO) and ampicillin (100 mg/mL). Individual colonies were picked and grown 
in ampicillin-treated LB medium; successful transformation was verified by PCR. The pGERM-
transformed E. coli DH5-a RK231 and the ETBF strain were conjugated by filter-mating on BHI-
blood agar plates incubated under anaerobic conditions at 37° C for 24h (58). A scraping of the 
resultant lawn was plated on BHI agar plates containing erythromycin/gentamycin (25 mg/mL 
and 100 mg/mL, respectively) which were incubated under anaerobic conditions at 37° C for 48 
h. Picked colonies were sequenced to confirm successful pGERM insertion into bft-3 and positive 
colonies were stored as TYG/15% glycerol stock. 
The mutant and wild-type strains were cultured in TYG liquid media to mid-log phase in 
medium at 37oC under anaerobic conditions. Cells were harvested, and RNA was extracted using 
Trizol reagent (Life Technologies, Carlsbad, CA). To confirm that bft expression had been disrupt-
ed, cDNA was generated from the extracted RNA (see RNA-Seq section below) to enable a PCR-
based assay for detection of bft transcripts in vitro. PCR was performed using ReddyMix PCR 
Mastermix (ThermoFisher Scientific, Waltham, MA) under the following thermocycler conditions: 
94°C for 10 minutes followed by 30 cycles of 94°C for 30 seconds, 56°C for 30 seconds, 72°C 
54
for 60 seconds, with a final extension of 72°C for 5 minutes, and the following primers were used: 
forward primer that spans the vector insertion site and 5’-ATGAAGAATGTAAAGTTACTTTTA-
ATGCTAGGAACCG-3’ and the reverse primer that is 3’ to the crossover site in order to confirm 
successful bft disruption 5’-CTCCACTTTGTACTTTATACTACTGAATATGCTTG-3’. 
Assembling consortia of cultured bacterial strains for gavage
Archived 96-well culture collection plates were thawed in an anaerobic chamber and aliquots of 
each well inoculated into 600 mL of GMM in 1 mL 96-deep-well culture plates (ThermoScientific, 
Rochester, NY). Cultures were grown anaerobically to stationary phase at 37°C before pooling 
100 mL aliquots of selected isolates using a Precision XS liquid handling robot (BioTek, Winooski, 
VT). For healthy culture collection pools where ETBF was to be added, separate cultures of ETBF 
were grown under the same conditions as the 96-well format and added in the same volume to the 
pool manually. Final pools were mixed 1:1 with sterile PBS (15% glycerol final concentration) 
and aliquoted (1 mL each) into 2 mL butyl septum-stoppered amber glass vials (Wheaton, Melville 
NJ).
Gnotobiotic mouse experiments 
All mouse experiments were performed using protocols approved by Washington University Ani-
mal Studies Committee. Prior to the initiation of experiments, germ-free adult male C57BL/6 mice 
were maintained in plastic flexible film gnotobiotic isolators under a strict 12-hour light cycle and 
fed an autoclaved low-fat, high-plant polysaccharide (LF/HPP) chow ad libitum (B&K Universal, 
East Yorkshire, U.K; diet 7378000). 
Feeding Bangladeshi diet embodiments was initiated two days prior to colonization with 
either uncultured fecal microbiota samples or pools generated from arrayed bacterial culture col-
lections. Diets were extruded as a paste from their plastic bags into food trays. Fresh 30 g aliquots 
of the paste were provided to each singly caged animal/day; this amount was never fully consumed 
. In the final 1-2 days of a given experiment, the amount of residual diet in the cages of mice 
already experiencing weight loss rose to represent up to 50% of the administered daily volume. 
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Due to the paste-like consistency of these diet embodiments, exact quantification of the amount 
of consumed diet versus diet discarded from the tray into the bedding could not be performed. 
For experiments where diet embodiments were changed, autoclaved Aspen hardwood lab bedding 
(NEPCO, Warrensburg, NY) was replaced at the start of each embodiment transition to minimize 
carryover of ingredients between embodiment exposures. 
For the intergenerational transmission experiments, male pups (n=3-4/ for intact donor mi-
crobiota communities; n=5/culture collections), representing the combined litter from trio matings 
were weaned onto LF/HPP chow and transitioned to the three Bangladeshi diet embodiments at 8 
weeks of age (embodiments 1à2à3; 10 d/diet phase). 
Microbial community profiling
Multiplex sequencing of 16S rRNA PCR amplicons — Genomic DNA was extracted from mouse 
fecal pellets and snap-frozen cecal contents using a phenol-chloroform and beat-beating protocol 
previously described (50, 59). Barcoded 16S primers 515F and 806R were used to generate PCR 
amplicons covering the V4 region of 16S rRNA genes present in the samples. Equimolar pools of 
these sample-barcoded V4-16S rRNA amplicon libraries underwent multiplex sequencing via the 
Illumina MiSeq platform to generate 250 bp paired-end Illumina reads, which were trimmed in 
silico to 200 bases using prinseq-lite v0.15 (in order to retain only the highest-quality base calls) 
(60), assembled with the software FLASH v1.2.11 (61), and de-multiplexed in QIIME v1.8.0 (62).
QIIME v1.8.0 was used to analyze the resulting V4-16S rRNA datasets (63). The 16S rRNA 
sequence datasets were first analyzed using open-reference OTU picking (97%ID OTUs) utiliz-
ing uclust-ref against the Greengenes reference database (64). 98.7% of the 26,419,497 sequences 
that passed QIIME’s default quality filters were successfully clustered with a reference sequence 
of ≥97%ID. For all subsequent analyses, OTU tables were rarefied to 4000 reads per sample and 
filtered to retain only those OTUs whose relative abundances in fecal microbiota were ≥0.1% in 
≥1% of all samples sequenced. Taxonomies were assigned using RDP classifier 2.4 trained on the 
manually curated Greengenes database ‘Isolated named strains 16S’ (64). 
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Community profiling by sequencing (COPRO-Seq) in mice colonized with unmanipulated 
and manipulated culture collections – 75-nt unidirectional reads were obtained by sequencing 
fecal and cecal DNA samples on an Illumina MiSeq platform and trimmed to 50 nt to preserve 
the highest quality reads before mapping onto the genomes of culture community members. The 
analytic pipeline is described in (25) and freely available at https://github.com/nmcnulty/COPRO-
Seq. 
Microbial RNA-Seq - Procedures for performing microbial RNA-Seq are described in-
depth in previous publications (25, 65, 66). Cecal contents aliquots (~50 mg), collected at sacrifice 
(14 days post colonization) and stored at -80° C, were suspended in 500 mL of extraction buffer 
(200 mM NaCl, 20 mM EDTA), 210 mL of 20% SDS, 500 mL phenol:chloroform:isoamyl alco-
hol (pH 4.5, 125:24:1, Ambion/Life Technologies, Carlsbad, CA), and 150 mL acid-washed glass 
beads (212-300 mm diameter, Sigma-Aldrich, St. Louis, MO). Cells were lysed by mechanical 
disruption using a bead beater (maximum setting; 5 min at room temperature; BioSpec Products, 
Bartlesville, OK), followed by phenol:chloroform:isoamyl alcohol extraction and isopropanol pre-
cipitation on ice. After treatment with RNAse-free TURBO-DNAse (Ambion/Life Technologies, 
Carlsbad, CA), MEGAClear columns (Life Technologies, Carlsbad, CA) were utilized to remove 
5S rRNA and tRNAs. A second DNAse treatment (Baseline-Zero DNAse; Epicentre/Illumina, San 
Diego, CA) was performed before a second MEGAClear purification followed by rRNA depletion 
using the Ribo-zero rRNA removal kits (Epicentre/Illumina, San Diego, CA). cDNA was synthe-
sized using SuperScript II (Invitrogen/Life Technologies, Carlsbad, CA), and the second strand 
synthesis was performed using RNAaseH, E. coli DNA polymerase and E. coli DNA ligase (all 
from New England Biolabs). cDNA libraries were prepared by shearing samples using a BioRup-
tor Pico sonicator (Diagenode, Denville, NJ); then size-selecting 150-200 base-pair fragments for 
blunting, A-tailing, and ligating sample-specific barcoded sequencing adapters; and finally PCR 
enrichment.
cDNA libraries were pooled for multiplex sequencing using an Illumina NextSeq instru-
ment (13.4 ±4.1 million unidirectional 75 nucleotide reads/cecal sample). Analysis was performed 
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as described in previous publications (50), using a custom reference database consisting of the 
genomes of the strains that comprised the communities. 
Florescence-activated cell sorting
Cell isolation  — Cells from the spleen, MLN and colonic lamina propria were isolated as described 
previously with minor modifications (67). Spleens and mesenteric lymph nodes were harvested 
and placed in ice-cold Hank’s Balanced Salt Solution (HBSS; Gibco c/o Life Technologies, Carls-
bad, CA) containing 0.1% (w/v) bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO). 
Single-cell suspensions were prepared by passage through a cell strainer (70-μm-diameter pores; 
BD Falcon, Franklin Lakes, NJ) and resuspension in HBSS/0.1% BSA. Splenocytes were pelleted 
by centrifugation at 453g for 5 min, and the supernatant was removed. Pellet was resuspended by 
gentle flicking of the tube, and red blood cells were removed by addition of 700 μl of prewarmed 
(37°C) ammonium-chloride-potassium lysis buffer (Gibco c/o Life Technologies, Carlsbad, CA) 
to splenocytes followed by immediate vortexing. After a 3-min incubation at room temperature, 
~10 ml of HBSS/0.1% BSA was added to halt the lysis, the cell suspension was passed through a 
cell strainer (70 um-diameter pores) and centrifuged at 453g for 5 min, and the supernatant was 
removed. Spleen and mesenteric lymph node cell suspensions were stored on ice until further use. 
Colonic lamina propria cells were isolated using a previously described protocol with modifica-
tions (50). The colon was harvested immediately after sacrifice and opened longitudinally with 
scissors. Luminal contents were removed by gentle scraping, and the colon was trimmed of fat/
mesentery. The remaining tissue was minced into small pieces (~2 to 3 mm3), and the fragments 
were placed on ice in ~10 ml of HBSS/0.1% BSA until further processing. HBSS/0.1% BSA was 
aspirated, and the tissue fragments were placed in 15 ml of complete HBSS containing penicil-
lin (100 U/ml; CellGro, Manassas, VA) and EDTA (5 mM; CellGro, Manassas, VA). The mixture 
was shaken at 180 rpm for 20 min (at 37°C) in an orbital shaker, after which time the medium 
was aspirated. This step was repeated once, and the colonic tissue was washed of excess EDTA 
by placing in 10 ml of complete RPMI [RPMI 1640 (Gibco c/o Life Technologies, Carlsbad, CA) 
containing heat-inactivated fetal bovine serum (5% (v/v); Gibco c/o Life Technologies, Carls-
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bad, CA), penicillin (100 U/ml; CellGro, Manassas, VA), streptomycin (100 mg/ml; Gibco c/o 
Life Technologies, Carlsbad, CA), L-glutamine (2.0 mM; CellGro, Manassas, VA), and Hepes 
(20 mM; CellGro, Manassas, VA)] at room temperature for 5 min, after which time the medium 
was removed by aspiration. This step was repeated once, and the colonic tissue fragments were 
digested by placing in 10 ml of complete RPMI supplemented with collagenase type VIII (0.3 mg/
ml) (Sigma-Aldrich, St. Louis, MO) and dispase (0.075 U/ml) (BD Biosciences, San Jose, CA) for 
60 min at 37°C with shaking at 180 rpm. Tissue fragments were vortexed and then allowed to settle 
briefly, and the supernatant was collected by passing through a cell strainer (BD Falcon, Franklin 
Lakes, NJ; 100-μm pore diameter); an equal volume of complete RPMI with EDTA (5 mM) was 
used to wash the strainer and added to the harvested cell suspension to ensure that digestion was 
terminated. Cells were pelleted by centrifugation at 453g, the supernatant was discarded, the pellet 
was resuspended by flicking, and cells were stored on ice in 10 to 20 ml of HBSS/0.1% BSA. The 
colonic tissue fragments that remained from this initial round of digestion were subjected to an 
identical second round of digestion, and the resulting cells were pooled with those from the first 
digestion. No Percoll enrichment step was performed. 
Cell re-stimulation — Intracellular cytokine staining was performed on cell suspensions 
from the spleen, MLN and colonic lamina propria following restimulation in round bottom 96 
well plates in complete RPMI containing β-mercaptoethanol (0.05 mM; Sigma-Aldrich, St. Louis, 
MO) supplemented with 50 ng/ml phorbol-myrisotol-acetate (Sigma-Aldrich, St. Louis, MO), 750 
ng/ml ionomycin (Sigma-Aldrich, St. Louis, MO) and Brefeldin A (eBioscience, San Diego, CA) 
diluted as per manufacturers recommendations. Cells were restimulated at 37°C for 3 h in a CO2 
humidified tissue culture incubator.
Flow cytometry — Cells were washed of re-stimulation media using HBSS. Cells were first 
incubated in HBSS containing anti-CD16/CD32 [Fc block (2.4G2); BD Pharmingen, San Jose, 
CA] and Live/Dead Fixable Aqua Dead Cell Stain (Life Technologies, Carlsbad, CA) at 4°C for 
30 min. Cells were pelleted by centrifugation at 453g for 5 min (4°C). The resulting supernatant 
was discarded, and the pelleted cells were surface-stained (with anti-CD4, TCR-β) by resuspend-
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ing in HBSS/0.1% BSA containing the indicated cocktail of fluorophore-conjugated antibodies. 
Cells were stored at 4°C in the dark for 20 min and were then washed by adding 200 μl of HBSS/ 
0.1% BSA followed by centrifugation at 453g for 5 min. The supernatant was discarded, and 
the cell pellets were washed a second time with 250 ml of HBSS/0.1% BSA. Pellets were resus-
pended by vortexing and fixed in 100 ml of Fixation/Permeabilization Buffer (eBioscience, San 
Diego, CA). Cells were stored overnight at 4°C in the dark. For intracellular staining, 200 μl of 
HBSS/0.1% BSA was added, and the cells were centrifuged at 652g for 5 min. The supernatant 
was discarded, cells were resuspended by vortexing, and the step was repeated a second time. 100 
μL of permeabilization buffer (eBioscience, San Diego, CA) supplemented with normal rat serum 
[Sigma-Aldrich, St. Louis, MO; 2% (v/v)] was added, and the cells were mixed by pipetting, 
placed in the dark for 60 min at 4°C, and centrifuged at 652g for 5 min; the resulting supernatant 
was discarded, and the cells were resuspended in permeabilization buffer containing anti-IL-17A 
or supplier-matched isotype control antibody. Cells were subsequently mixed by pipetting and 
stored at 4°C for 30 min (or room temperature for 20 min). Cells were washed by addition of 200 
μl of permeabilization buffer and centrifuged at 652g for 5 min; the supernatant was discarded, 
and the cells were resuspended by vortexing. This wash step was repeated twice: first with per-
meabilization buffer and subsequently with HBSS/0.1% BSA. Cells were then resuspended in 
HBSS/0.1% BSA and analyzed with an Aria III flow cytometer (BD Biosciences, San Jose, CA). 
Data were analyzed with FlowJo software. The following antibodies were used: CD4 eFluor 450 
(GK1.5; eBioscience, San Diego, CA), CD8a allophycocyanin (53-6.7; eBioscience, San Diego, 
CA), IL-17A phycoerythrin (TC11-18H10.1; Biolegend, San Diego, CA), TCR-β Alexa Fluor 488 
(H57-597; Biolegend, San Diego, CA). 
Mass spectrometry 
Amino acids, acylcarnitines, organic acids, acyl CoAs, and ceramides were analyzed using stable 
isotope dilution techniques. Amino acids and acylcarnitine measurements were made by flow injec-
tion tandem mass spectrometry using sample preparation methods described previously (68, 69). 
The data were acquired using a Waters Acquity UPLC system (Waters, Milford, MA) equipped 
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with a TQ (triple quadrupole) detector and a data system controlled by MassLynx 4.1 operating 
system (Waters, Milford, MA). Organic acids were quantified using methods described previously 
(70) employing Trace Ultra GC coupled to ISQ MS operating under Xcalibur 2.2 (Thermo Fisher 
Scientific, Austin, TX). Acyl-CoAs were extracted and purified as described previously (71-73), 
and analyzed by flow injection analysis using positive electrospray ionization on Xevo TQ-S, 
triple quadrupole mass spectrometer (Waters, Milford, MA). Heptadecanoyl CoA was employed 
as an internal standard. Ceramides were extracted as described previously (74) and analyzed by 
flow injection tandem mass spectrometry using a Xevo TQS spectrometer (Waters, Milford, MA) 
for precursors of m/z 264.
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FIGURE LEGENDS
Figure 1. Weight phenotypes are transmissible via transplantation of intact uncultured hu-
man fecal microbiota samples and derivative culture collections into germ-free mice. (A) 
In adult germ-free mice serially fed three embodiments of a Bangladeshi diet, transplantation of 
intact uncultured fecal microbiota from a severely stunted donor (red) was associated with signifi-
cantly greater weight loss than a fecal microbiota from a donor with consistently healthy anthro-
pometry (blue). (B) Mean relative abundances (± s.e.m.) of 97%ID OTUs representing ≥1% of the 
total community in mice receiving intact fecal microbiota. OTUs present at lower abundances are 
not shown and account for the proportion not represented in each stacked barplot. (C) Transplanta-
tion of culture collections (dashed lines) generated from the fecal microbiota of healthy (blue) or 
stunted/underweight (red) donors recapitulate the weight phenotype seen with the corresponding 
intact uncultured microbiota (solid lines). (D) Relative abundances of bacterial strains summarized 
by species (as determined by COPRO-Seq) representing ≥1% of the fecal communities of mice 
colonized with the culture collections derived from either the healthy or stunted donors. Taxa pres-
ent at low abundances are not represented and account for the proportion not represented in each 
stacked barplot. (E) The weight-loss phenotype observed in recipients of the stunted/underweight 
donor’s culture collection is robust to all three Bangladeshi diet embodiments. Significant weight 
differences were seen between mice colonized with culture collections produced from the stunted/
unhealthy versus healthy donors in all three diet embodiment contexts (F) Out-of-bag (OOB) error 
rates of Random Forests models generated to predict the culture collection that was transplanted 
into mice or diet embodiment administered based on microbiota- or diet-discriminatory input OTU 
abundances, respectively. OOB error rates are high when predicting diet, suggesting that the three 
diet embodiments do not significantly differ in their impact on the microbiota. Statistical signifi-
cance was determined using repeated measures ANOVA; *, p<0.05.
Figure 2. Enterotoxigenic Bacteroides fragilis (ETBF) is necessary but not alone sufficient for 
diet-induced weight loss. (A.)Schematic illustrating the different treatment groups (and numbers 
of mice per treatment group) generated by manipulating the presence/absence of ETBF and NTBF 
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within the stunted/underweight or healthy donors’ culture collections. (B) Representation of cul-
tured Bacteroides species in healthy and stunted culture collections ± ETBF ± NTBF. (C) Removal 
of ETBF prevents weight loss in mice colonized with the stunted/underweight donor’s culture 
collection. In contrast, addition of ETBF with the simultaneous removal of NTBF does not signifi-
cant impact weight in mice colonized with the culture collection derived from the healthy child. 
D. The liver ceramides C16, d18.1.C16, and d18.1.C24.1 are present at significantly higher levels 
in mice colonized with an ETBF(+) NTBF(–) stunted culture collection compared to an ETBF(–) 
NTBF(–) stunted culture collection. The former two (red font) remain significantly different in 
a comparison between mice that lost weight (i.e., those colonized with an ETBF(+) NTBF(–) 
stunted culture collection) and all other groups depicted in (C).
Figure 3. Schematic depicting the various comparisons between treatment groups and the 
underlying experimental questions. 
Figure 4. The effects of intra-specific NTBF-ETBF interactions on community structure and 
gene expression. All mice in all treatment groups were monotonously fed diet embodiment 2. 
Cecal samples collected at the time of sacrifice 14 days after initial colonization were analyzed by 
COPRO-Seq and microbial RNA-Seq. (B) Differential expression of selected genes by members 
of the transplanted healthy culture collection ± ETBF ± NTBF. The loci depicted comprise the 
set of loci with the listed putative functions differentially expressed between two versions of the 
healthy donor’s culture collection: ETBF(–) NTBF(+) and ETBF(+) NTBF(–). Loci that are also 
expressed in the meta-transcriptome of the stunted culture collection are denoted by an asterisk (*). 
No VF database genes showed significant differences in their expression in mice colonized with 
the stunted/underweight donor’s culture collection ± ETBF. Strains are color-coded on the left; 
UniProt database annotations shown on the right.
Figure 5. Changes in the ETBF transcriptome between different community contexts. A. 
Volcano plot illustrating pathways represented by differentially expressed ETBF genes in the con-
text of being in the transplanted healthy donor’s (upper right) or stunted/underweight (upper left) 
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donors culture collections. RNA-Seq datasets were generated from cecal samples obtained from 
mice that had been monotonously fed the Bangladeshi diet embodiment 2 (n=5 mice/treatment 
group). The x-axis represents log2(expression fold-difference) in mice colonized with manipulat-
ed ETBF(+) NTBF(–) healthy donor culture collection compared to the unmanipulated ETBF(+) 
NTBF(–) stunted/underweight donor culture collection; the y-axis represents log10(FDR-corrected 
p-value of the significance of the difference as determined by the exact negative binomial test). 
Purple dots indicate transcripts with Pfam and KEGG annotations; the associated numbers refer-
ence the superscripted numbers next to the corresponding annotation for that transcript in the 
heatmap shown in panel B. (B) Z-score normalized transcript levels (counts per million) of dif-
ferentially expressed transcripts represented in panel A that are annotated in both the Pfam and 
KEGG databases. Each row represents a locus (with Pfam IDs listed in parentheses, and numeri-
cal superscript indicating the associated purple dots in panel A). Each column represents a single 
mouse. Full Pfam and KEGG annotations are provided in Table S7A.
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TABLE LEGENDS
Table 1. Summary of putative virulence factor (VF) representation, expression, and differ-
ential expression in the the cecal meta-transcriptomes of mice colonized with the stunted/
underweight donor’s culture collection ± ETBF or with the healthy donor’s culture collection 
± ETBF. Mice were monotonously fed Bangladeshi diet embodiment 2. Virulence factors were 
defined as loci in the genomes of the indicated community members with BLAST hits (E-value 
< 10-17) against the Virulence Factor database. Expressed VFs are defined as loci having non-zero 
counts after mapping RNA-Seq reads via bowtie to the custom database of genome sequences. 
Differentially expressed VFs were identified using a negative binomial exact test with FDR-cor-
rection.
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SUPPLEMENTAL MATERIALS
SUPPLEMENTAL FIGURE LEGENDS
Figure S1. Experimental designs. (A) Schematic of experimental design of groups of adult gno-
tobiotic C57BL/6 mice (n=4-6 mice per group) colonized with either intact uncultured fecal mi-
crobiota or derivative culture collections. (B) Schematic of gnotobiotic experiments examining 
whether intergenerational transmission of intact uncultured fecal microbiota or derived culture 
collections from one generation of mice to another recapitulates the weight phenotype of the pa-
rental generation. (C) Test of whether weight-loss phenotype is robust to the three different Ban-
gladesh diet embodiments. (D) Test of whether ETBF alone is not sufficient to induce weight loss. 
Figure S2. Relative abundances of the ETBF and NTBF strains plus other Bacteroides in the 
fecal microbiota of gnotobiotic mice a function of donor community. (A) Bacteroides species 
relative abundances (mean ± s.e.m.) in mice colonized with the intact fecal microbiota from two 
human donors. V4-16S rRNA analyses were performed on fecal samples collected at the time of 
sacrifice when mice were consuming diet embodiment 3 after animals had be subjected to a se-
quence of weekly exposures to embodiments 1, 2 and finally 3. B. fragilis is the most abundant 
Bacteroides species in mice harboring the transplanted intact uncultured fecal microbiota from 
the stunted/underweight donor. (B) B. fragilis abundances are inversely proportional to mouse 
weights. Green, groups of mice colonized with intact uncultured fecal microbiota from the two 
donors; orange, groups of mice colonized with the two derived unmanipulated culture collec-
tions. Data for mice harboring the uncultured communities were generated from fecal samples 
collected at sacrifice while mice were on embodiment 3, having completed the sequence of being 
fed all three embodiments, while data for mice with culture communities was generated from fecal 
samples collected after two weeks of monotonous consumption of embodiment 2. (C) While B. 
fragilis strain abundances (one ETBF strain highlighted in red, two NTBF strains highlighted in 
blue) distinguish culture collections derived from healthy versus stunted donors, indicator species 
analysis discloses that they are not specific for diet embodiment. The heatmap on the left shows 
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relative abundances of all strains in mice colonized with these culture collections; the heatmap on 
the right represents indicator scores for each strain in a given diet embodiment setting.
Figure S3. Transfer of 97%ID OTUs present in the intact uncultured human donor microbio-
ta from one generation of recipient mice to another. Heatmap: rows plot the Z-score normalized 
relative abundances in the fecal microbiota of recipient; each column represents one mouse. Data 
were by V4-16S rRNA analysis of fecal samples collected at sacrifice after mice had completed the 
sequence of exposure to all three diet embodiments. Bacteroides species are highlighted in orange.
Figure S4. Mass spectrometry-based analyses of metabolism in mice harboring the unma-
nipulated and manipulated healthy donor or stunted/underweight donor culture collections. 
Analyses were performed on the indicated biospecimens obtained at sacrifice after 2 weeks of 
consumption of diet embodiment 2.  Z-score normalized peak intensities or concentrations are 
given for (A) organic acids, (B) amino acids, (C) acyl-CoA metabolites, and (D) acylcarnitines in 
selected organs (liver, gastrocnemius, or serum).
Figure S5. The effect of ETBF on the representation of Th17+ and regulatory T cell (FoxP3+) 
cells in the colon or mesenteric lymph notes of mice colonized with four different types of cul-
ture collections. (A) Representative flow cytometry plots showing IL-17A expression in CD4+ T 
cells isolated from the colonic lamina propria of mice containing the indicated culture collections. 
The percentages shown represent frequency in the gate.  (B) Colonic Th17+ CD4+ T cell popula-
tions are increased in mice colonized with ETBF in the context of both the healthy and stunted/
underweight donors’ culture collections. (C) FoxP3+ CD4+ regulatory T cells from mesenteric 
lymph nodes 
Figure S6. Differentially expressed ETBF genes in healthy versus stunted microbial com-
munity contexts. (A) Changes in the expression of SusC and SusD paralogs present in two PULs. 
(B.) Changes in the expression of genes present in two of its capsular polysaccharide biosynthesis 
(CPS) loci. (C) Changes in the expression of fragilysin when ETBF is colonized in healthy donor-
derived culture collection ±NTBF; expression levels in the context of the manipulated versions of 
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the healthy donor’s culture collection were normalized to levels in mice colonized with the unma-
nipulated stunted donor’s culture collection. 
Figure S7. Multiple pathways represented in the NTBF transcriptome are altered by ETBF. 
(A) Volcano plot illustrating pathways represented by differentially expressed NTBF genes in 
the cecal microbiota of mice that had received two versions of the healthy donor’s culture collec-
tion: ETBF(+) NTBF(+) (upper right) or ETBF(–) NTBF(+) (upper left). The x-axis represents 
log2(expression fold-difference) between ETBF(+) NTBF(+) versus ETBF(–) NTBF(+) with the 
latter serving as the reference; the y-axis represents log10(FDR-corrected p-value of the signifi-
cance of the difference as determined by the exact negative binomial test). Purple dots indicate 
transcripts with Pfam and KEGG annotations, with associated numbers indicating the annotation 
listed in superscript in panel B. (B) Z-score normalized transcript levels (counts per million) of 
differentially expressed transcripts represented in panel A that have both Pfam and KEGG annota-
tions. Each row represents a transcript, with Pfam IDs listed in parentheses, and numerical super-
script indicating the associated purple dot in panel A. Each column represents a single mouse. Full 
Pfam and KEGG annotations are given in Table S7C.
Figure S8. Effects of ETBF in lieu of NTBF on Bacteroides thetaiotaomicron gene expression 
in the context of the healthy donor’s culture collection. . (A) Volcano plot illustrating differ-
entially expressed loci in the B. thetaiotaomicron strain genomes in the context of an ETBF(+) 
NTBF(–) (upper right) or ETBF(–) NTBF(+) (upper left) healthy donor culture collection. Data 
were generated from cecal contents obtained from mice after 14 days of consumption of diet em-
bodiment 2. The x-axis represents log2(expression fold-change) in mice colonized with ETBF(+) 
NTBF(+) compared to the ETBF(–) NTBF(+) healthy culture collection as the reference; the y-
axis represents log10(FDR-corrected p-value of the significance of the difference as determined by 
the exact negative binomial test). (B) Z-score normalized transcript levels (counts per million) of 
differentially expressed genes represented in panel A with assigned both Pfam and KEGG annota-
tions.
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Figure S9. Effects of ETBF in lieu of NTBF on Bacteroides caccae gene expression in the con-
text of the healthy donor’s culture collection. (A) Volcano plot. (B) Heatmap. 
Figure S10. Schematic of the bft locus and cloning strategy to generate the  bft knockout of the 
isolated ETBF. (A) The bft locus with the flanking regions of the B. fragilis mVEW4 genome. (B) 
The pGERM suicide-vector mediated mutagenesis strategy used to disrupt expression of complete 
bft gene sequence.
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SUPPLEMENTAL FIGURES
Figure S1.
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Figure S7B.
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B
3' exoribonuclease family, domain 1 (PF01138.16)1
Description (Pfam ID) Z-score
normalized
Aminotransferase class I and II (PF00155.16)2
ATP synthase B/B' CF(0) (PF00430.13)3
Bacterial DNA−binding protein (PF00216.16)4
Biopolymer transport protein ExbD/TolR (PF02472.11)5
Biotin−requiring enzyme (PF00364.17)6
Cell division protein ZapA (PF05164.8)7
CHC2 zinc finger (PF01807.15)8
Cytidine and deoxycytidylate deaminase zinc−binding region (PF00383.17)9
DEAD/DEAH box helicase (PF00270.24)10
DeoC/LacD family aldolase (PF01791.4)11
Elongation factor Tu GTP binding domain (PF00009.22)12
Fructose−bisphosphate aldolase class−II (PF01116.15)13
Glyceraldehyde 3−phosphate dehydrogenase, NAD binding domain (PF00044.19)14
Glycosyl hydrolases family 2, TIM barrel domain (PF02836.12)15
Glycosyl hydrolases family 35 (PF01301.14)16
Helix−turn−helix domain (PF12833.2)17
Insulinase (Peptidase family M16) (PF00675.15)18
KH domain (PF07650.12)19
KOW motif (PF00467.24)20
lactate/malate dehydrogenase, NAD binding domain (PF00056.18)21
Methylmalonyl−CoA mutase (PF01642.17)22
Mur ligase family, catalytic domain (PF01225.20)23
N−terminal domain of galactosyltransferase (PF02709.9)24
NAD dependent epimerase/dehydratase family (PF01370.16)25
NAD−dependent glycerol−3−phosphate dehydrogenase N−terminus (PF01210.18)26
NQR2, RnfD, RnfE family (PF03116.10)27
Nucleoside diphosphate kinase (PF00334.14)28
OmpA family (PF00691.15)29
Outer membrane protein transport protein (OMPP1/FadL/TodX) (PF03349.11)30
PCRF domain (PF03462.13)31
Peptidase C39 family (PF03412.10)32
Periplasmic binding protein (PF01497.13)33
Periplasmic binding protein domain (PF13407.1)34
Phage integrase SAM−like domain (PF13102.1)35
Phosphoenolpyruvate carboxykinase (PF01293.15)36
Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain I (PF02878.11)37
Phosphopantetheine attachment site (PF00550.20)38
PHP domain (PF02811.14)39
Polysaccharide biosynthesis/export protein (PF02563.11)40
Pyridine nucleotide−disulphide oxidoreductase (PF07992.9)41
Pyruvate flavodoxin/ferredoxin oxidoreductase, thiamine diP−bdg (PF01855.14)42
Quinolinate synthetase A protein (PF02445.11)43
Ribosomal L18p/L5e family (PF00861.17)44
Ribosomal L27 protein (PF01016.14)45
Ribosomal L32p protein family (PF01783.18)46
Ribosomal prokaryotic L21 protein (PF00829.16)47
Ribosomal protein L3 (PF00297.17)48
Ribosomal protein L4/L1 family (PF00573.17)49
Ribosomal protein L6 (PF00347.18)50
Ribosomal protein L7/L12 C−terminal domain (PF00542.14)51
Ribosomal protein L10 (PF00466.15)52
Ribosomal protein L11 methyltransferase (PrmA) (PF06325.8)53
Ribosomal protein L11, N−terminal domain (PF03946.9)54
Ribosomal protein L14p/L23e (PF00238.14)55
Ribosomal protein L16p/L10e (PF00252.13)56
Ribosomal protein L19 (PF01245.15)57
Ribosomal protein L20 (PF00453.13)58
Ribosomal protein L22p/L17e (PF00237.14)59
Ribosomal protein L36 (PF00444.13)60
Ribosomal protein S5, N−terminal domain (PF00333.15)61
Ribosomal protein S7p/S5e (PF00177.16)62
Ribosomal protein S9/S16 (PF00380.14)63
Ribosomal protein S10p/S20e (PF00338.17)64
Ribosomal protein S11 (PF00411.14)65
Ribosomal protein S12/S23 (PF00164.20)66
Ribosomal protein S13/S18 (PF00416.17)67
Ribosomal protein S15 (PF00312.17)68
Ribosomal protein S16 (PF00886.14)69
Ribosomal protein S17 (PF00366.15)70
Ribosomal protein S21 (PF01165.15)71
Ribosomal RNA adenine dimethylase (PF00398.15)72
RNA polymerase Rpb3/Rpb11 dimerisation domain (PF01193.19)73
S1 RNA binding domain (PF00575.18)74
S−adenosylmethionine synthetase, N−terminal domain (PF00438.15)75
Sigma−70 region 2 (PF04542.9)76
Spi protease inhibitor (PF13734.1)77
SpoU rRNA Methylase family (PF00588.14)78
Starch binding domain (PF00686.14)79
7
Starch−binding associating with outer membrane (PF14322.1)80
Sulfatase (PF00884.18)81
SusD family (PF07980.6)82
Tetratricopeptide repeat (PF00515.23)83
Thiamine pyrophosphate enzyme, C−terminal TPP binding domain (PF02775.16)84
Transcription termination factor nusG (PF02357.14)85
Translation initiation factor 1A / IF−1 (PF01176.14)86
Urocanase (PF01175.13)87
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Figure S8B.
Healthy
ETBF
NTBF
B
Description (Pfam ID)
+
+
–
–
AAA−like domain (PF12846.2)
ABC−2 family transporter protein (PF12698.2)
ABC transporter (PF00005.22)
AbgT putative transporter family (PF03806.8)
AcrB/AcrD/AcrF family (PF00873.14)
Acyl−CoA reductase (LuxC) (PF05893.9)
Aldose 1−epimerase (PF01263.15)
Amidohydrolase (PF13147.1)
Amino acid permease (PF13520.1)
Aminotransferase class I and II (PF00155.16)
AMP−binding enzyme (PF00501.23)
Asparaginase (PF00710.15)
Bacterial regulatory proteins, tetR family (PF00440.18)
Bacterial RNA polymerase, alpha chain C terminal domain (PF03118.10)
Beta galactosidase small chain (PF02929.12)
Beta−lactamase superfamily domain (PF12706.2)
Biotin−requiring enzyme (PF00364.17)
BlaR1 peptidase M56 (PF05569.6)
Carboxyl transferase domain (PF01039.17)
Class II Aldolase and Adducin N−terminal domain (PF00596.16)
Cytidine and deoxycytidylate deaminase zinc−binding region (PF00383.17)
Cytochrome c (PF00034.16)
DegT/DnrJ/EryC1/StrS aminotransferase family (PF01041.12)
DeoC/LacD family aldolase (PF01791.4)
DNA methylase (PF01555.13)
Eco57I restriction−modification methylase (PF07669.6)
Endoribonuclease L−PSP (PF01042.16)
Enoyl−(Acyl carrier protein) reductase (PF13561.1)
F5/8 type C domain (PF00754.20)
FabA−like domain (PF07977.8)
Fasciclin domain (PF02469.17)
FecR protein (PF04773.8)
Ferritin−like domain (PF00210.19)
GDSL−like Lipase/Acylhydrolase family (PF13472.1)
Glutaminase (PF04960.10)
Glycerophosphoryl diester phosphodiesterase family (PF03009.12)
Glycosyl Hydrolase Family 88 (PF07470.8)
Glycosyl hydrolase family 92 (PF07971.7)
Glycosyl hydrolases family 2, sugar binding domain (PF02837.13)
Glycosyl hydrolases family 28 (PF00295.12)
Glycosyl hydrolases family 43 (PF04616.9)
Glycosyl transferase family 2 (PF00535.21)
Glycosyl transferases group 1 (PF00534.15)
Glycosyltransferase like family 2 (PF13641.1)
Glycosyltransferase sugar−binding region containing DXD motif (PF04488.10)
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Figure S10.
bft (mB11_03740)
Hypothetical protein
mB11_03739
Hypothetical protein
mB11_03741
Hypothetical protein
mB11_03742
Hypothetical protein
mB11_03743
Putative amidoligase
mB11_03744
Hypothetical protein
mB11_03745
Hypothetical protein
mB11_03746
Disrupted bft
pGERM suicide 
vector
Introduce to B. fragilis by conjugation
B. fragilis bft locus
95
SUPPLEMENTAL TABLES
Table S1. Enterotoxigenic B. fragilis is variably present through time in a population of Ban-
gladeshi children. (A) Two cultured bacterial isolates representing a single strain of B. fragilis 
(based on 96% genome sequence identity) harbor bft gene subtype 3. (B) Results of a bft PCR as-
say of fecal microbiota collected from members of a birth cohort of 100 Bangladeshi children at 
18- and 24-months of age.
Table S2. Composition and nutritional content of Bangladeshi diet embodiments, and nutri-
tional requirements of consumer mice and humans. A. Composition and nutritional content of 
the three Bangladeshi diet embodiments modeled after diets consumed by the populations from 
which donors were sampled. Diet embodiment composition is described by food category, item, 
and caloric representation of quantities added. B. (i) Daily nutritional requirements for mice and 
human children. (ii) Nutritional analysis of Bangladeshi diet embodiments.
Table S3. DNA and RNA sequencing datasets. (A) Human microbiota donor fecal bacterial 
V4-16S rRNA sequencing datasets. (B) Mouse fecal bacterial V4-16S rRNA datasets. (C) Mouse 
fecal bacterial shotgun sequencing datasets used for COPRO-Seq analyses. (D) Cecal microbial 
RNA-Seq datasets.
Table S4. Strains present in the culture collection generated from the fecal microbiota of a 
severely stunted/moderately underweight 2-year-old Bangladeshi child living in the Mirpur 
thana in Dhaka. (A) Strains based on ≥96% overall nucleotide sequence identity genome se-
quence identity among isolates, their taxonomic annotations (based on RDP classifications), and 
their designated names. (B) KEGG annotations. 
Table S5. Weights of all individual mice as a function of diet, microbiota, and time. Weights 
are listed as both absolute measurements (grams) and relative to their weights prior to colonization 
(percentage). Metadata including microbiota donor information, MouseID, diet consumed, and 
days post colonization at the time of measurement are listed.
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Table S6. Mass spectrometry based analyses of metabolites in host tissues, serum and the 
cecal microbiota obtained from mice in the different treatment groups (A) Amino acids in (i) 
cecum, (ii) gastrocnemius muscle, (iii) liver, and (iv) serum as measured by ultra-performance liq-
uid chromatography (UPLC)-tandem mass spectrometry. (B) Organic acids in (i) cecum, (ii) gas-
trocnemius, and (iii) liver as measured by gas chromatography mass spectrometry (GC-MS). (C) 
Ceramides in (i) cecum, (ii) gastrocnemius muscle, and (iii) liver as measured by UPLC-tandem 
mass spectrometry. (D) Acylcarnitines in (i) cecum, (ii) gastrocnemius, (iii) liver, and (iv) serum 
as measured by UPLC-tandem mass spectrometry. (E) Acyl-CoAs in (i) gastrocnemius muscle and 
(ii) liver as measured by UPLC-tandem mass spectrometry. (F) Short-chain fatty acids in cecum 
as measured by GC-MS. (G) Bile acids in cecum as measured by (i) non-targeted and (ii) targeted 
UPLC-MS. (H) Concentrations or peak intensities of all metabolites measured (mean (± s.e.m) for 
each experimental group. A summary of significant differences between treatment groups is given 
to the right.
Table S7. Features of meta-transcriptomes in mice colonized with manipulated and unma-
nipulated culture collections. (A) ETBF genes differentially expressed in a healthy microbi-
ota context compared to a stunted microbiota context: ETBF(+) NTBF(–) healthy vs ETBF(+) 
NTBF(–) stunted. (B) NTBF genes differentially expressed due to ETBF, in a healthy microbiota 
context: ETBF(+) NTBF(+) healthy vs ETBF(–) NTBF(+) healthy. (C) ETBF genes differentially 
expressed due to the presence of NTBF, in the context of the healthy culture collection: ETBF(+) 
NTBF(+) vs ETBF(+) NTBF(–). (D) Bacteroides genes (excluding B. fragilis) differentially ex-
pressed due to differences in the presence of ETBF versus NTBF in a healthy microbiota context: 
ETBF(–) NTBF(+) healthy vs ETBF(+) NTBF(–) healthy.
Table S8. Differentially expressed virulence factors in the cecal communities present in the 
various groups of gnotobiotic mice. (A) Virulence factor genes found in the genomes of strains 
comprising the stunted/underweight donor’s culture collection. (B) Virulence factors expressed, 
but not significantly differently in the genomes of strains from the unmanipulated ETBF (+) ver-
sus manipulated ETBF(-) stunted/underweight donor’s culture collection after transplantation into 
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gnotobiotic mice. (C) Virulence factor genes found in the genomes of the strains from the healthy 
culture collection. (D) Significantly differentially expressed virulence factors expressed in the ge-
nomes of the strains present in the unmanipulated ETBF (-) versus manipulated ETBF(+) NTBF(-) 
healthy donor-derived culture collection after transplantation into gnotobiotic mice.
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SUMMARY 
Interactions between diets, consumers’ gut microbiota, the enteric nervous system (ENS), and 
gut motility need better resolution to understand gut health. Using a gnotobiotic mouse model of 
short-term diet changes associated with international travel, microbiota from humans represent-
ing diverse cultural/culinary traditions were transplanted into animals that were fed a sequence of 
diets representing those of all donors. While correlations between bacterial species abundances 
and transit times were diet-dependent, unconjugated bile acids correlated with faster transit. Mice 
harboring 53 cultured bacterial strains from a Bangladeshi donor’s microbiota and fed a Bangla-
deshi diet revealed that the commonly used spice, turmeric, slowed transit times. Wild-type and 
ENS-impaired Ret+/- mice, containing subsets of strains possessing high or low bile salt hydrolase 
activity, established that turmeric affects motility via bacterial bile acid deconjugation and Ret 
signaling. These results demonstrate how a traditional food ingredient interacts with a functional 
microbiota trait to regulate host physiology.
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INTRODUCTION
Gut motility, a key physiologic parameter governing digestion and absorption of nutrients, is af-
fected by diet (Cummings et al., 1976, 1978), gut microbes (Husebye et al., 1994, 2001; Wich-
mann et al., 2013), the enteric nervous system (ENS) (Edery et al., 1994; Romeo et al., 1994), and 
host genetics (Levy et al., 2000; Whorwell et al., 1986). At present, we lack detailed understanding 
of the complex and dynamic interrelationships between these factors, particularly in the global 
context of diverse cultural traditions concerning foods, their methods of preparation, and the var-
ied human gut microbiota that have evolved under these dietary conditions. Intestinal transit times 
measured in >1000 healthy individuals representing diverse populations worldwide varied within 
and between groups, likely reflecting a culmination of these factors (Burkitt et al., 1972). The ad-
vent of culture-independent methods for characterizing the structure and expressed functions of a 
gut microbiota creates an opportunity to identify new approaches for understanding gut motility 
and for optimizing the nutritional benefits derived from different dietary practices. 
In the present study, we began by modeling short-term diet changes associated with global 
human travel in gnotobiotic mice colonized with gut microbiota from healthy human donors from 
around the world. We hypothesized that with an international focus, we could conduct a screen 
of food types and microbiota for potential mediators of motility common to diverse diets and gut 
communities. Without making any assumptions regarding the healthiness of faster or slower motil-
ity, our strategy was to identify diets and microbiota whose interactions result in highly contrast-
ing transit times in order to subsequently home in on specific dietary ingredients and microbiota-
encoded metabolic capacities that affect motility. We reasoned that by generating clonally arrayed 
collections of bacterial strains cultured from donor microbiota that transmitted disparate motility 
phenotypes in different dietary settings, we could deliberately manipulate which members of the 
collection were used for colonization of mice based on specific metabolic attributes that could be 
identified from their genomes and confirmed by direct biochemical assays in vitro. Colonization 
with different subsets of the community could then be performed in the context of concurrently 
manipulated diets, either in wild-type animals or those with deliberately manipulated genetic fea-
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tures known to affect ENS function. Our immediate goal for this type of preclinical modeling was 
to decipher the mechanisms by which diet-by-microbiota interactions can regulate gut motility. 
Our long-term goal was to implement an approach that could, in principle, be generalized to dis-
sect the effects of interactions between (i) ingredients represented in established as well as emerg-
ing dietary traditions/trends, (ii) members of consumers’ gut microbiota, and (iii) gut motility and 
potentially other aspects of human physiology.
RESULTS
Modeling diet and motility changes associated with global human travel in gnotobiotic mice
In an initial ‘travel’ experiment, intact uncultured fecal microbiota samples obtained from six 
healthy adults representing different geographic locations and cultural/culinary traditions were 
transplanted into adult germ-free C57BL/6 male mice (n=6 recipient mice/donor microbiota). Mi-
crobiota donors included (i) three residents of the USA (a twin pair stably discordant for obesity 
with both co-twins consuming an American diet without self-imposed dietary restrictions (USAunre-
stricted) (Ridaura et al., 2013) plus another lean individual who had consumed a protein- and fat-rich 
primal diet for a number of years (USAprimal)), (ii) an Amerindian living in a remote rural village in 
the Amazonas State of Venezuela (Yatsunenko et al., 2012), (iii) a Bangladeshi resident of an ur-
ban slum (Subramanian et al., 2014), and (iv) a Malawian from a rural village in the southern part 
of the country (Yatsunenko et al., 2012) (see Table S1A for a description of donor characteristics 
and Table S1B for analysis of microbiota transplantation efficiency). The six groups of transplant 
recipients were fed a sequence of six sterilized diets formulated to represent those consumed by 
the microbiota donors (Figure S1, Table S1C,D), in essence simulating the varying dietary ex-
periences of humans and their microbiota during travel. In each case, the initial and final diets in 
the sequence represented the native or home diet of the donor, in order to characterize the longer 
term effects of dietary exposures during travel and the degree to which transit times recover; in 
between, travel diets were given in the same sequence, in an order chosen randomly but executed 
uniformly for all mice, as permitted by the type of home diet (Figure 1A). The starting and ending 
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home diets were given for 14 and 8 days, respectively, while each travel diet was administered for 
8 days. Intestinal transit times were measured at the end of each diet phase by gavaging mice with 
non-absorbable red carmine dye and recording the time from gavage to first appearance of the dye 
in their feces (Kashyap et al., 2013; Li et al., 2011; Yano et al., 2015) (Figure 1B, Table S2A). 
Carmine dye does not perturb the structure of the gut bacterial community; 16S rRNA analysis 
of fecal samples, collected before and after carmine administration from 9-week-old gnotobiotic 
mice colonized with a fecal microbiota from a conventionally-raised C57BL/6 donor, showed no 
significant effect of the dye as judged by weighted UniFrac distances (p>0.05, two-tailed Student’s 
t-test). Moreover, fecal samples collected on the days of transit time measurements were taken 
prior to carmine administration. 
Aggregating data from all animals at all time points of this 6-phase travel experiment 
revealed a normal distribution of transit times (Figure 1C). The average within-mouse variance 
throughout the experiment was 27.7 minutes, while the average between-mouse variance at a 
given time point was 29.3 minutes. Repeated measures ANOVA in which transit time was the de-
pendent variable demonstrated that diet (p=5.6x10-5), the donor microbiota (p=2.3x10-3), and the 
interaction of diet and microbiota (p=2.6x10-3) were all significant factors (Table S3A). The most 
contrasted diet-by-microbiota effects on transit times were documented in mice colonized with 
the Bangladeshi compared to the USAunrestricted microbiota when they consumed Bangladeshi and 
primal diets (Figure 1D). Specifically, mice colonized with the USAunrestricted microbiota had sig-
nificantly faster motility (i.e., lower transit times) when consuming the Bangladeshi diet compared 
to primal diet (p<0.002, two-tailed Student’s t-test); the opposite was observed in mice colonized 
with a Bangladeshi microbiota (p<0.006, two-tailed Student’s t-test). We tested the robustness 
of these most contrasted motility phenotypes by colonizing animals (n=5 recipient mice/donor 
microbiota) with fecal microbiota obtained from three healthy Bangladeshi adults (including the 
donor tested in the first experiment) and three healthy USAunrestricted adults (a repeat of the obese 
co-twin in the discordant pair, plus a new obese and a new lean donor; see Table S1A for donor 
characteristics). Recipients were subjected to three diet phases beginning and ending with a ‘lo-
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cal’ diet (i.e., the primal diet for mice colonized with a USAunrestricted microbiota or the Bangladeshi 
diet for mice colonized with a Bangladeshi microbiota) and including an interval ‘non-native’ diet 
(Figure S2A). The results of this 3-phase travel experiment confirmed that significantly contrasted 
transit times were imparted by the interactions of these diets and microbiota (p<2.6x10-5, F=19.8, 
ANCOVA), although the effect size and statistical significance of differences in transit time varied 
by the individual microbiota donor (Figure S2B, Table S2B). 
Correlations between the relative abundances of gut bacterial strains and transit times are 
diet-dependent 
To identify relationships between specific bacterial taxa, diet, and transit time phenotypes, we se-
quenced PCR amplicons generated from the V4 region of bacterial 16S rRNA genes present in fe-
cal microbiota collected throughout the course of the 6-phase as well as 3-phase travel experiments 
(984 fecal samples; 22,470±630 reads per sample [mean±s.e.m.]; Table S4). 16S rRNA reads were 
grouped into operational taxonomic units based on whether they shared ≥97% nucleotide sequence 
identity (97%ID OTUs). Principal coordinates analysis (PCoA) based on unweighted UniFrac, a 
phylogenetic metric that computes similarity between any two microbiota based on the degree 
to which their component OTUs share branch length on a bacterial tree (Lozupone and Knight, 
2005), indicated that community assembly was rapid and highly reproducible within a given group 
of mice that received the same donor microbiota in both the 6-phase and 3-phase travel experi-
ments (Figure S3A,C). 
The microbiota donor was the predominant factor explaining variance in unweighted Uni-
Frac distances between samples from the different experimental groups (p<0.001 within-group 
as compared to between-group similarity, PERMANOVA; Figure S3B,D). Nonetheless, diet had 
consistent effects across different treatment groups and phenotypes: 87 diet-discriminatory 97%ID 
OTUs that were robust to donor microbiota and motility phenotypes were identified by applying 
a machine learning algorithm (Random Forests) to the 16S rRNA dataset generated from all fecal 
microbiota samples collected from all mouse recipients of all human donor microbiota throughout 
105
the 6-phase travel experiment (Figure S4; Table S5). We elected to apply a decision tree-based 
algorithm for feature selection (i.e., in this case, the most diet-discriminatory OTUs) so that we 
would not have to make any distributional assumptions regarding our dataset of proportional OTU 
abundances. The Random Forests-derived model predicted which diet was being consumed in the 
subsequent 3-phase travel experiment with a mean accuracy of 83%±0.02% (range 79%-86%; 
10,000 replications), significantly better than the null distribution (p<2.2x10-16). These 87 diet-
discriminatory OTUs were not significantly correlated with transit times in either experiment. In 
an analysis of all 416 97%ID OTUs with relative abundances above the limit of detection (0.01%) 
in mouse fecal samples collected throughout both travel experiments, just a single OTU, Parabac-
teroides gordonii (OTU ID 240), was significantly correlated, after Bonferroni correction for mul-
tiple comparisons, with transit times across the highly contrasted diet-microbiota combinations 
(rho=0.3, p=0.02). This organism has not been reported to be associated with altered intestinal 
motility in humans.
In contrast, 27 OTUs present in both the USAunrestricted and Bangladeshi microbiota had 
significant diet-dependent correlations with transit times documented in the context of either the 
Bangladeshi or primal diets but not both (Table S3B). The relationships of bacteria to transit times 
were strain-specific: two strains of Eubacterium desmolans (OTU IDs 170124 and 158946) had 
opposing relationships with transit times within the setting of primal diet consumption. A single 
OTU, E. desmolans (OTU ID 158946), was significantly correlated with transit times in both di-
ets, but remarkably the correlations were opposite in the Bangladeshi versus primal diet contexts 
(p<9.3x10-6, F=9.6, ANCOVA testing interaction of E. desmolans abundance with diet). In the 
unrestricted USA diet context, yet another OTU in the USAunrestricted and Bangladeshi microbiota 
(Clostridiales, OTU ID 261590) was correlated with transit times (rho=-0.57, p=0.04). Hence, 
a hypothetical next-generation probiotic strain designed to impact motility would likely require 
simultaneous consumption of a specific diet or diet ingredient to exert its effect, much like lean-
ness-conferring microbes have been demonstrated to transmit their phenotype in a diet-dependent 
manner (Ridaura et al., 2013).
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Transit times at the ends of the initial and final home diets often varied. This finding could 
not be ascribed to increasing age (p=0.7, F=0.1, one-way ANOVA of transit time as a function of 
age). Mathematically, if we consider two functions h(m) and t(m), then h(m) need not necessar-
ily equal h(t(h(m))). We postulated that if these two functions represent the effects of home (h) 
and travel (t) diets, respectively, on a microbiota m, then the result of a home diet may depend on 
whether intervening travel diets were consumed. Indeed, an analysis comparing fecal microbiota at 
the ends of the initial and final home phases in the 6-phase travel experiment disclosed that com-
munity structure, while largely similar, always exhibited statistically significant changes (p<0.05, 
paired two-tailed Student’s t-test after Bonferroni correction) in the proportional abundances of 
one or more OTUs. For example, mice colonized with fecal microbiota from both USAunrestricted in-
dividuals exhibited a significant increase in the relative abundance of Bacteroides ovatus between 
the first and last home diet periods, while mice colonized with microbiota from the adult Bangla-
deshi donor exhibited significantly increased abundances of an OTU classified as Clostridiales and 
a decrease in Ruminococcus obeum. 
The imperfect recovery of transit time following diverse dietary exposures during travel 
could reflect not only these structural differences but also functional differences in the microbiota. 
Therefore, we characterized metabolic features of the microbiota in the context of the most highly 
contrasted motility phenotypes.
Microbially deconjugated bile acid metabolites are correlated with faster gut transit
To identify metabolic features that correlate with motility phenotypes, we applied ultra high per-
formance liquid chromatography mass spectrometry (UPLC-MS) to fecal samples collected from 
mice in the 3-phase travel experiment on the same days when their transit times were measured (3 
USAunrestricted and 3 Bangladeshi donor microbiota; 5 mice/donor microbiota; 3 fecal samples ana-
lyzed/mouse). We observed >2,500 unique m/z peaks that were present in more than one mouse. 
Spearman’s rank correlations (without Bonferroni correction) yielded 599 m/z peaks that were 
significantly correlated with transit times, of which 67 (11%) were putatively identified as bile acid 
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metabolites (Tables S6A,S7A). In mice, the predominant primary bile acids are beta-muricholic 
acid and cholic acid, while in humans they are chenodeoxycholic acid and cholic acid (Haslewood, 
1967). Prior to secretion from hepatocytes into biliary canaliculi, bile acids are conjugated with 
either taurine (predominant in mice (Falany et al., 1997)) or glycine (predominant in humans (Fa-
lany et al., 1994)) to decrease passive absorption by intestinal enterocytes. Bile acids have micro-
bicidal activity; members of the gut microbiota neutralize these effects by metabolizing host bile 
acids, beginning with deconjugation catalyzed by microbial bile salt hydrolases (BSH) (Drasar et 
al., 1966). Since bile acids are modified by the microbiota, we considered whether differences in 
bile acid metabolite profiles could explain discordant microbiota-associated motility phenotypes. 
To gain insights into the relationships between OTUs and bile acid metabolites as they pertain to 
transit times, we calculated Spearman’s rank correlation coefficients between the proportional abundances 
of 97%ID OTUs in fecal microbiota, the peak intensities of fecal bile acids, and transit times in the 3-phase 
travel experiment (Figure 2, Table S7B). After Bonferroni correction, we identified 118 OTUs with sig-
nificant correlations between their abundances and levels of one or more fecal bile acids; only one of these 
OTUs, Blautia (OTU ID 296977), also had a significant correlation between its abundance and transit 
times (slower transit) (Table S7B)� A sparse linear model, built after regressing transit times against all 
bile acid metabolite levels then simplified by applying stepwise backward feature selection, demonstrated 
that levels of just five bile acids (7-ketodeoxycholic acid, muricholic acid, taurocholic acid, tauro-beta-
muricholic acid, and tauro-muricholic acid sulfate) accurately predicted transit times in the 3-phase travel 
experiment (rho=0�54, p=1�8x10-7, Spearman’s rank correlation), out-performing a linear model built with 
an equivalent number of randomly selected non-bile acid metabolites (rho=0�17, p=0�47, Spearman’s rank 
correlation; mean values over 1,000 replications) (Figure S5, Table S8). Of these five bile acids, none was 
significantly associated with either diet. Only one bile acid species, tauro-muricholic acid sulfate, was sig-
nificantly associated with the geographic origin of the microbiota donor; it was found at significantly higher 
concentrations in fecal specimens collected from mice colonized with subjects residing in Bangladesh 
(Figure 2)� Bile acids that were correlated with faster transit times were unconjugated (7-ketodeoxycholic 
acid and muricholic acid), whereas those that correlated with slower transit times were conjugated (tauro-
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beta-muricholic acid, taurocholic acid, and tauro-muricholic acid sulfate) (Figure 2, Table S7B)� Multiple 
bile acids, including these five bile acids, were significantly correlated with multiple OTUs (Figure 2), 
underscoring the complexity of microbial bile acid metabolism� 
Turmeric alters gut motility 
Intestinal bile acid concentrations are largely dictated by dietary components (e.g., peptides and 
fats) that trigger intestinal signals (e.g., cholecystokinin), which, in turn, influence gallbladder 
contraction and release of bile into the lumen of the proximal small intestine. To further character-
ize interactions between specific OTUs, bile acid metabolism, and diet, we examined the effects of 
turmeric on transit time. We selected turmeric, a spice with cultural significance commonly used in 
Bangladeshi cuisine, because it has a dose-dependent cholekinetic effect; i.e., its active ingredient, 
curcumin, stimulates gallbladder contraction and thus increases luminal bile acid levels. The effect 
sizes of turmeric’s cholekinesis vary between reported studies, possibly due to population-based 
differences (e.g., European versus Asian subjects) or differences in how the spice was adminis-
tered (Marciani et al., 2013; Rasyid and Lelo, 1999; Rasyid et al., 2002). In a study using serial 
hydrogen breath tests to assess carbohydrate fermentation and small bowel transit time, investiga-
tors observed that turmeric-containing Japanese-style curry fed to Japanese individuals increased 
fermentation and shortened small bowel transit time compared to curry prepared without turmeric 
(Shimouchi et al., 2009). The microbial underpinnings of these observations in human subjects are 
unknown, as metagenomic or metabolomic analyses of their gut microbiota were not performed.
We initially defined the effect of turmeric in adult male C57BL/6 gnotobiotic mice colo-
nized with a collection of anaerobic bacterial strains cultured from the fecal microbiota of a healthy 
2-year-old Bangladeshi child (Table S9). We generated this culture collection from a child rather 
than an adult to avoid the potential confounding effects of chronic antecedent turmeric exposure 
on microbiota features. This child, like the three Bangladeshi adults whose microbiota were tested 
in the earlier experiments, lived in Mirpur, an urban sub-district of Dhaka. The sequenced, clon-
ally arrayed bacterial culture collection gave us the capacity to perform follow-up experiments 
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in which specific strains were selected for colonization based on their capacity to metabolize bile 
acids. 
Following gavage of the entire culture collection, composed of 53 bacterial strains (Table 
S9), mice were initially fed a Bangladeshi diet lacking turmeric for 10 days (diet phase 1), then 
the same diet containing turmeric for 10 days (diet phase 2), and finally the unsupplemented Ban-
gladeshi diet again for 10 days (diet phase 3)� A control group was maintained under germ-free 
conditions and subjected to the same sequence of diets (n=6 animals/group). To limit carryover of 
turmeric from the prior diet, old bedding was replaced with fresh new bedding at start of each diet 
phase� 
Colonization was highly reproducible between animals with community assembly com-
pleted within 3-5 days after gavage. At the end of the first diet phase, 44±1.2 (mean±s.e.m.) of 
the 53 input strains were detectable in fecal samples collected from recipient animals, based on 
community profiling by shotgun sequencing (COPRO-Seq) of fecal DNA (see Experimental Pro-
cedures). Colonized mice had significantly faster transit times at each diet phase compared to 
their germ-free counterparts (p=5�0x10-6, p<4�7x10-7, and p<1�7x10-5 for diet phases 1, 2, and 3, 
respectively, two-tailed Student’s t-test; Table S2C)� Consumption of turmeric was associated 
with a significant slowing of motility (i.e., longer transit time) (Table S2C)� UPLC-MS of fecal 
samples collected from germ-free mice at the end of each diet phase disclosed that ingestion of 
this cholekinetic spice was associated with significantly increased levels of taurohyodeoxycholic 
acid (p=0�003, one-tailed Student’s t-test) and tauro-muricholic acid sulfate (p=0�03, one-tailed 
Student’s t-test) compared to the period of unsupplemented diet consumption (Table S6B)� As 
expected, no unconjugated bile acids were detected in the germ-free group during any of the diet 
phases� We included a curcumin standard in order to quantify fecal curcumin levels; however, cur-
cumin was undetectable in all samples�
To directly test the hypothesis that microbiota with different capacities to deconjugate bile 
acids transmit distinct transit time phenotypes, we first used a UPLC-MS-based in vitro assay to 
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screen all members of the clonally arrayed culture collection for their bile salt hydrolase (BSH; EC 
3�5�1�24) activities� The screen demonstrated that OTUs representing diverse phylotypes had the 
ability to deconjugate at least one of the two primary bile acids found in mice (Table S9)� BLAST 
predictions, based on the presence in a strain’s genome of a gene or genes homologous to known 
BSH genes (E-value threshold cutoff ≤10-5) were correct in predicting in vitro BSH enzymatic ac-
tivity for 85% of the bacterial strains� Only 10 strains did not deconjugate either bile acid in vitro 
(6 members of the genus Enterococcus, 3 members of Eggerthella, and 1 belonging to Enterobac-
teriaceae)� The strains with BSH activity were largely members of the genera Bifidobacterium and 
Enterococcus� We then assembled two bacterial consortia, each composed of seven strains repre-
senting the taxonomic diversity of the BSH-positive and BSH-negative subsets within the culture 
collection: the “BSHhi“ consortium contained four members of Enterococcus and three members 
of Bifidobacterium; the “BSHlo“ consortium had five members of Enterococcus, one Eggerthella 
species, and one Enterobacteriaceae (see Table 10A for a summary of KEGG-based annotations 
of the sequenced genomes of these 14 strains)� Members of the two consortia had in vitro growth 
rates in rich medium that were not significantly different from one another (p=0�92, two-tailed 
Student’s t-test)� 
Age-matched adult male C57BL/6 gnotobiotic mice were colonized with either the BSHhi 
or BSHlo consortium (assembled prior to gavage by combining equal numbers of colony forming 
units of each component strain)� A positive control group was colonized with the entire culture col-
lection� As before, mice in each of these three groups (n=5/group) were given the unsupplemented 
Bangladeshi diet for 3 days prior to gavage of the cultured organisms� Following gavage, mice 
were maintained on the unsupplemented Bangladeshi diet for 8 days, followed by the turmeric-
supplemented diet for 8 days, and then returned to the starting Bangladeshi diet for another 8 
days. The complete culture collection produced a transit time that was significantly faster than that 
measured with the BSHlo consortium in all three diet phases (p<0�002, one-tailed Student’s t-test; 
Table S2D)� While mice harboring the BSHlo consortium had the same transit time as the BSHhi 
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consortium in the absence of turmeric, addition of this spice to the Bangladeshi diet produced 
significantly slower transit times in BSHlo animals (p=0�02, one-tailed Student’s t-test comparing 
phase 1 versus phase 2 transit times; Figure 3A) but no significant effects in BSHhi mice (p=0�7, 
one-tailed Student’s t-test). These findings indicate that a gut microbiota capable of deconjugating 
bile acids could modify the response to turmeric, which through its cholekinetic effects delivers 
increased amounts of conjugated bile acids to the proximal intestine� 
Mice colonized with the BSHlo consortium had significantly slower motility than BSHhi 
animals only in the setting of turmeric (p<0�03, one-tailed Student’s t-test; Figure 3B)� UPLC-MS 
confirmed that BSHhi mice had significantly higher total concentrations of fecal unconjugated bile 
acids (p=0�01, one-tailed Student’s t-test) and significantly lower total concentrations of conju-
gated bile acids (p=0�02, one-tailed Student’s t-test) compared to mice colonized with the BSHlo 
consortium (Figure 3C, Table S6D)� Total concentrations of the two unconjugated primary bile 
acids (cholic acid and beta-muricholic acid) were significantly negatively correlated with transit 
times (rho=-0�76, p=3�6x10-9, Spearman’s rank correlation)� COPRO-Seq revealed that turmeric 
had no statistically significant effects on the representation of any strain in either consortium when 
compared to the unsupplemented diet phases (p>0�15, two-tailed Student’s t-test)� 
Applying microbial RNA-Seq to fecal samples collected at the same time points as those 
used for the COPRO-Seq analysis, we confirmed significantly greater overall levels of community 
BSH expression in the BSHhi compared to the BSHlo consortium’s meta-transcriptome (145-fold; 
p=0�006, two-tailed Student’s t-test). However, turmeric did not result in significant changes in the 
levels of BSH transcripts in the fecal meta-transcriptomes of BSHlo and BSHhi animals (p>0�05, 
two-tailed Student’s t-test)� Enterococcus faecalis (isolate ID hG2) was the only member of the 
BSHlo consortium that expressed BSH, albeit at low levels (thus explaining the presence of fe-
cal unconjugated bile acids in these animals; Figure 3C)� In the BSHhi consortium, the principal 
contributors of BSH transcripts to the community meta-transcriptome were three Bifidobacteria 
(isolate IDs hB1, hB8, and hF8), which together accounted for 76%±1% (mean±s.e.m.) of these 
transcripts� In mice colonized with the BSHlo consortium, turmeric resulted in significant reduc-
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tions in expression of two transcripts in the meta-transcriptome assigned to the KEGG ‘dioxin 
degradation pathway’ (5�7-fold; p=0�004, two-tailed Student’s t-test): salicylate 1-monooxygenase 
(EC 1�14�13�1, a oxidoreductase that produces catechol) and 4-oxalocrotonate tautomerase (EC 
5�3�2�6; part of a metabolic pathway that generates TCA cycle intermediates)� No KEGG path-
ways were significantly differentially expressed as a function of turmeric consumption in mice 
colonized with the BSHhi consortium� Together, these results suggest that turmeric enhances the 
discordance in motility phenotypes between BSHlo versus BSHhi mice not by changing expression 
of bacterial BSH genes but rather through its cholekinetic effect, thereby providing conjugated bile 
acids to the two consortia with markedly different BSH gene content and deconjugation capacities� 
Effects of turmeric on host gene expression
To assess the effects of turmeric on host gene expression, we focused on the BSHlo consortium 
because, in the previous experiment, it transmitted a turmeric-responsive transit time phenotype. 
BSHlo mice were monotonously fed either the unsupplemented or turmeric-supplemented Ban-
gladeshi diet for 10 days. The capacity of turmeric to significantly slow motility was replicated 
in this new, single diet phase experiment (p=0.003, one-tailed Student’s t-test comparing transit 
times between the two diet-treatment groups; Figure 3D). RNA-Seq datasets were generated from 
the liver and terminal ileum, essential components of the enterohepatic circulation. Differentially 
expressed genes were identified using the exact negative binomial test. Genes that satisfied our cri-
teria for significant differences in expression (after correcting for multiple comparisons) are listed 
in Table S11. Transcriptional data generated from the livers of mice from the 10 day-long monoto-
nous diet experiment indicated that turmeric consumption was followed by a homeostatic response 
designed to maintain bile acid pool size at constant levels: i.e., consistent with the increased fecal 
bile acid levels elicited by turmeric consumption, Cyp7a1 (cholesterol 7α-hydroxylase) expres-
sion was 3.3-fold lower (p=0.00002). Cyp7A1 converts cholesterol into 7α-hydroxycholesterol in 
the rate-limiting first step of hepatic bile acid synthesis, a step subject to feedback inhibition by 
increased bile acid concentrations. In the terminal ileum, multiple genes involved in gut mucosal 
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immune/barrier function, including a subset implicated in protection against helminthic infections, 
exhibited significant differential expression in the face of turmeric consumption (Table S11A; see 
Supplemental Information). 
Interplay of the microbiota, bile acids, and the ENS
To assess the degree to which the effect of turmeric on motility was dependent upon ENS-based 
signaling (Alemi et al., 2013), we turned to mice heterozygous for a null allele of the Ret receptor 
(Tsuzuki et al., 1995). Ret, which encodes a transmembrane protein that binds glial cell-derived 
neurotrophic factor family ligands, is the gene most commonly implicated in Hirschsprung’s dis-
ease (Edery et al., 1994; Romeo et al., 1994), a developmental disorder associated with absent 
peristalsis in the distal colon. Heuckeroth and colleagues have reported that Ret+/- mice exhibit 
>90% reductions in longitudinal and circular gut muscle contractility and 70-95% reductions in the 
release of two neurotransmitters (substance P and VIP) compared to Ret+/+ animals despite having 
equivalent numbers of enteric neurons (Gianino et al., 2003). We found that conventionally raised 
wild-type (Ret+/+) mice have significantly slower transit times than their conventionally-raised 
heterozygous (Ret+/-) littermates (p=0.05, one-tailed Student’s t-test; Table S2F). 
We re-derived C57BL/6 Ret+/- mice as germ-free and colonized the heterozygotes and 
their wild-type littermates with either the 7-member BSHlo or 7-member BSHhi consortium� Ani-
mals were subjected to a three-phase diet oscillation as in the experiments described above (un-
supplemented è turmeric-supplemented è unsupplemented Bangladeshi diet; 10 days/phase). 
We hypothesized that if enteric neurons were key mediators of the observed phenotypes, then the 
difference in transit times seen between wild-type mice colonized with the two different 7-mem-
ber consortia (Figure 3B) might be mitigated in Ret+/- animals� Indeed, in contrast to wild-type 
mice, transit times were not significantly different between Ret+/- mice harboring the two different 
consortia (Table S2D) despite the same pattern of differences in fecal bile acids concentrations 
documented by UPLC-MS in wild-type mice: Ret+/- mice colonized with the BSHlo consortium 
had significantly lower fecal concentrations of unconjugated bile acids compared to Ret+/- mice 
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colonized with the BSHhi consortium in the setting of turmeric consumption (p=0�009, one-tailed 
Student’s t-test)� As in wild-type mice, COPRO-Seq analysis showed that no bacterial strains in the 
Ret+/- mice were significantly correlated with turmeric consumption. Notably, a significant differ-
ence in transit times between Ret+/- and wild-type mice was only seen in mice colonized with the 
BSHhi bacterial consortium (diet phase 1: p=0�009, phase 2: p=0�02, phase 3: p=0�09, one-tailed 
Student’s t-test; p>0�05 in all analogous comparisons of Ret+/- versus wild-type mice colonized 
with the BSHlo consortium)� Thus, while turmeric consumption has a cholekinetic effect in both 
wild-type and Ret+/- mice, the transit time phenotype it produces in wild-type mice is mediated by 
gut microbial bile acid metabolism and a functionally intact ENS�
DISCUSSION
Intestinal motility is a key physiologic parameter impacting nutritional status and gut health. The 
travel-associated diet changes that we model here is increasingly relevant to our daily lives during 
this period of rapid globalization, in which a day spent entirely in one’s hometown may nonethe-
less consist of consumption of foods representing several of the world’s cultures. A gnotobiotic 
mouse model of global travel might also incorporate additional factors that impact the gut micro-
biota, such as disruption of circadian rhythm (Thaiss et al., 2014) or the order in which different 
diets are experienced. Using gnotobiotic mice colonized with microbiota obtained from healthy 
individuals representing different geographic and cultural traditions and diets representative of 
those consumed by these donors, we were able to dissect factors that interact to define a motil-
ity phenotype. These diet-microbiota-metabolic interactions were resolved in the context of Ban-
gladeshi microbiota through a multi-pronged strategy that involved (i) manipulating the dietary 
representation of a single culturally relevant spice, turmeric, (ii) selecting members of a clonally 
arrayed culture collection generated from a Bangladeshi donor’s microbiota, based on whether 
they were or were not able to support BSH-mediated bile acid deconjugation, and (iii) colonizing 
germ-free mice with or without a mutation in Ret, a key regulator of ENS function, with a BSHhi 
or BSHlo consortium. 
115
The simulation of global travel-associated short-term diet shifts revealed that (i) diet-dis-
criminatory bacterial strains were represented across microbiota from individuals raised in envi-
ronments that are geographically and culturally distinct, and (ii) correlations between individual 
bacterial species abundances and transit times are largely diet-dependent: e.g., a given bacterial 
strain can have contrasting correlations with transit times depending upon the diet context. These 
findings suggest that future use of bacterial strains derived from the human gut as probiotic agents 
for motility disorders will require thoughtful consideration of an individual’s dietary practices 
and/or adjunct dietary recommendations. Reciprocally, our preclinical data suggest that dietary 
treatments for motility disorders need to be calibrated based on structural and functional features 
of an individual’s microbiota. In this respect, we find that unconjugated bile acids resulting from 
bacterial metabolism are consistently correlated with faster transit times across different diets and 
microbiota. In patients with irritable bowel syndrome, a limited number of clinical trials have sug-
gested that a subset of patients respond to oral administration of the unconjugated bile acid che-
nodeoxycholate with accelerated transit times (Odunsi-Shiyanbade et al., 2010; Rao et al., 2010), 
consistent with our observations. Our results point to fecal BSH activity as a functional microbiota 
parameter that could be useful for categorizing individuals with motility disorders, allowing cor-
relation analyses to be performed between the levels of its conjugated substrates and/or its various 
unconjugated bile acid products and transit time. If significantly correlated within a population, 
this metabolic activity could be used as a target or biomarker in clinical studies testing the effects, 
both short and long-term, of various therapeutic interventions.
The imperfect recovery of transit times following consumption of ‘travel’ diets, initially 
noted in the context of the 6-phase and 3-phase travel experiments, was also seen in our experi-
ments involving sequential presentation of an unsupplemented, turmeric-supplemented, and un-
supplemented Bangladeshi diet. Across ecosystems, history (i.e., order and temporal features of 
perturbations) is well known to impact community structure and function (Chase, 2003; Fukami 
and Morin, 2003; Pagaling et al., 2014). In this context, turmeric may influence alternative stable 
states (Staver et al., 2011) of the gut microbiota and ENS. Despite our practice of changing bed-
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ding between diet phases to limit carryover of ingredients, turmeric may have long-lived effects on 
host physiology. A sustained increase in total bile acid pool size evoked by turmeric’s cholekinetic 
effects seems an unlikely explanation for these observations, as bile acid concentrations in the 
final diet phase returned to pre-turmeric levels (Figure 3C). Follow-up experiments examining 
the duration of turmeric’s effects on the transcriptome of purified enteric neurons (including the 
TGR5 bile acid receptor (Alemi et al., 2013)) in combination with analyses of the microbiota and 
its metabolic features, localization of motility effects (i.e., gastric, small intestinal, and/or colonic), 
and production of neuroactive compounds such as serotonin by enteroendocrine cells (Yano et al., 
2015), could reveal and help characterize this postulated turmeric-induced alternative stable state. 
Other dietary ingredients (e.g., polysaccharides (Kashyap et al., 2013)) and products of 
bacterial metabolism (e.g., butyrate (Soret et al., 2010)) have been previously described to impact 
motility in mouse models. Populations experiencing shifting cultural/culinary traditions through 
travel, immigration or emigration, are susceptible to marked changes in their gut microbiota, both 
structural and functional, which may have downstream health consequences. In principle, our ap-
proach could be used to identify and characterize the biological activities and microbiota interac-
tions of dietary components characteristic of dietary/cultural traditions established over centuries 
but now vulnerable to diminished use due to Westernization. Their exclusion from modern diets 
may represent a loss of key food ingredients that could be used to promote health in contemporary 
societies. These ingredients may also serve as valuable tools for identifying and characterizing 
mechanisms by which food and the microbiota interact to affect various features of our physiology. 
EXPERIMENTAL PROCEDURES
Measurement of gastrointestinal transit times using non-absorbable red carmine dye
Carmine red (Sigma-Aldrich, St. Louis, MO) was prepared as a 6% (w/v) solution in 0.5% meth-
ylcellulose (Sigma-Aldrich) and autoclaved prior to import into gnotobiotic isolators. Mice were 
maintained on a strict 12h light cycle (lights on between 06:00 and 18:00) and gavaged with 150 
µL of the carmine solution between 08:00 and 08:30 local time. Animals were not fasted before-
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hand. Feces were collected every 30 minutes (up to 8 hours from time of gavage) and streaked 
across a sterile white napkin to assay for the presence of the red carmine dye. The time from ga-
vage to initial appearance of carmine in the feces was recorded as the total intestinal transit time 
for that animal. 
Generating a clonally arrayed culture collection of anaerobic bacterial strains from the fe-
cal microbiota of a healthy 24-month-old Bangladeshi child 
A clonally arrayed culture collection was generated using methods described in an earlier publica-
tion (Goodman et al., 2011). A given well of the 96-well plate used to archive the collection con-
tained a monoculture of a single isolate. Each isolate’s genome was sequenced using an Illumina 
MiSeq or HiSeq instrument [250 nucleotide (nt) and 101 nt paired end reads, respectively; 53±4.8-
fold (mean±s.e.m.) genome coverage]. Genomes were assembled using MIRA (Chevreux et al., 
1999) (N50 contig length: 23,253± 2,669 bp; range, 735-112,622 bp). Assemblies were annotated 
using Prokka (version 1.10) (Seemann, 2014). Predicted genes were mapped to KEGG pathways 
by querying the KEGG reference database (release 72.1) and assigning their protein products to 
KEGG Ortholog (KO) groups (BLAST 2.2.29+, blastp E-value threshold ≤10-10, single best hit 
defined by E-value and bit score) (Kanehisa and Goto, 2000; Kanehisa et al., 2014). Species-
level taxonomic identities of bacterial isolates were defined by Sanger capillary sequencing of 
full-length 16S rRNA gene amplicons generated using the universal 8F and 1391R PCR primers, 
with classifications performed using the Ribosomal Database Project (RDP) version 2.4 classifier 
(Ridaura et al., 2013). Strain-level taxonomic classifications were subsequently determined based 
on a minimum 96% genome identity [calculated by the software package NUCmer (Kurtz et al., 
2004)] between sequenced isolates bearing the same 16S rRNA-based taxonomy. A total of 53 
unique strains were identified using this 96% identity cutoff threshold and grown in modified gut 
microbiota medium (mGMM) containing ingredients described in a previous publication (Good-
man et al., 2011) but without short chain fatty acid supplementation. Strains were stored at -80°C 
in 15% glycerol (v/v) in reduced PBS until used for gavage of germ-free mice.
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In vitro assays for bile acid deconjugation
We screened each of the 91 isolates, comprising 53 strains, in the clonally arrayed culture collec-
tion for their capacity to deconjugate bile acids. The two predominant primary bile acids in mice, 
taurocholic acid (TCA; Sigma-Aldrich, St. Louis, MO) and tauro-beta-muricholic acid (TbMCA; 
Santa Cruz Biotechnology, Santa Cruz, CA), were dissolved in water at concentrations of 100 mg/
mL and 10 mg/mL, respectively. Each isolate was first incubated in 1 mL of mGMM containing 
100 µM TCA for 48 h in an anaerobic Coy chamber (75% N2, 20% CO2, and 5% H2) with growth 
monitored based on OD600. Cells were then pelleted by centrifugation (17,900 x g for 7 minutes 
at 4°C), and the resulting supernatant subjected to ultra high performance liquid chromatography-
mass spectrometry (UPLC-MS; see details below) to assess levels (peak intensities) of unconju-
gated and conjugated bile acids (cholic acid and taurocholic acid [TCA], respectively). For the 
vast majority of isolates, bile acid profiles at 48 hours were either all conjugated or unconjugated. 
Growth of bacterial isolates was simultaneously assessed by measuring optical densities at 600 nm 
to ensure that a lack of deconjugation was not simply a reflection of a lack of bacterial viability. If 
no deconjugation was observed, we performed a secondary screen where isolates were incubated 
in 1 mL of mGMM containing 100 µM tauro-beta-muricholic acid (TbMCA) for 48 hours in 
an anaerobic chamber, followed by UPLC-MS quantitation of the levels of unconjugated (beta-
muricholic acid) and conjugated (TbMCA ) bile acids. Bacterial isolates that did not deconjugate 
either bile acid in vitro were considered as eligible for the BSHlo consortium. See Supplemental 
Information for additional protocols.
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FIGURE LEGENDS
Figure 1. Diet and microbiota significantly impact intestinal transit times� (A) Schematic of 
6-phase travel experiment. Groups of adult germ-free C57BL/6 mice were colonized with fecal 
microbiota from six healthy donors and fed diets representative of those consumed by all donors in 
the sequence shown in panel B� (B) The central squares of this heat map represent means of transit 
times for each diet-microbiota combination as measured by carmine red dye assay; the frames of 
the squares represent s�e�m� (n=6 mice/donor microbiota). Microbiota are represented along rows, 
diet phases along columns� Each group of mice consumed human diets in the order shown from left 
to right; home diets were always consumed during the initial and final diet phases but skipped in 
the intervening travel diet progression (primal diet è unrestricted American diet è Bangladeshi 
diet è Malawian diet è Amerindian diet)� (C) Histogram showing distribution of all transit times 
recorded throughout the 6-phase travel experiment� (D) The most contrasted diet-by-microbiota 
effects on transit times were observed in mice colonized with a Bangladeshi or USAunrestricted mi-
crobiota and fed Bangladeshi versus primal diets� Results for USAunrestricted (lean) and USAunrestricted 
(obese) were aggregated and are represented together as USAunrestricted� Results from the ‘home’ and 
‘return home’ phases for mice colonized with a Bangladeshi microbiota and fed a Bangladeshi diet 
were also aggregated. Statistical significance was determined using a two-tailed Student’s t-test; *, 
p<0�05� See also Figures S1,S2,S3,S4 and Tables S1,S2,S3,S4,S5�
Figure 2. Significant correlations between fecal bile acid metabolite concentrations and the 
relative abundances of bacterial 97%ID OTUs. Bile acid metabolite profiling and 16S rRNA 
analysis was performed on fecal samples collected from mice in the 3-phase travel experiment 
(Figure S2)� Spearman rank correlations were calculated between bile acid concentrations and rel-
ative abundances of 97%ID OTUs. Unsupervised hierarchical clustering was applied. Significant 
associations (p<0�05 calculated by two-tailed Student’s t-test, with Bonferroni correction) between 
microbiota/diet and bile acids/OTUs are represented in the vertical and horizontal side panels. 
Associations between bile acids and motility were calculated by linear modeling with stepwise 
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backward feature selection, as detailed in the text and Supplemental Experimental Procedures� See 
also Figures S2,S5 and Tables S4,S6,S7,S8�
Figure 3. An interaction between diet, bile acid metabolism, and gut motility revealed by col-
onizing germ-free mice with a BSHhi or BSHlo consortium and feeding them a representative 
Bangladeshi diet with or without turmeric� (A) Turmeric consumption resulted in significantly 
slower motility in mice colonized with the BSHlo but not the BSHhi consortium� (B) While consum-
ing the turmeric-supplemented Bangladeshi diet, BSHhi mice had transit times comparable to mice 
colonized with the complete 53 strain culture collection (“CC”) and faster motility (i�e�, shorter 
transit times) than BSHlo mice (n=5 animals/microbiota). (C) Turmeric consumption is associated 
with a significant increase in total fecal unconjugated bile acid concentrations in gnotobiotic wild-
type mice colonized with the BSHhi consortium but not the BSHlo consortium� (D) Transit times 
(mean±s.e.m.) measured for two groups of gnotobiotic mice colonized with BSHlo consortium and 
fed the unsupplemented or turmeric-containing Bangladeshi diet� Measurements occurred at the 
end of the single (monotonous) 10-day diet experiment. Statistical significance was determined 
using a one-tailed Student’s t-test� *, p<0�05� See also Tables S4,S6,S9,S10,S11�
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SUPPLEMENTAL INFORMATION
SUPPLEMENTAL DATA
Turmeric alters ileal expression of anti-helminthic immune functions 
In the terminal ileum, a total of 96 genes exhibited significant differential expression in the face 
of turmeric consumption (Table S11A), including genes involved in gut mucosal immune/barrier 
function: (i) 410-fold higher expression (p=0.003) of Retnlb (resistin-like molecule β), (ii) 23-
fold higher expression (p=0.0009) of Siglec5 (sialic acid binding Ig-like lectin 5, an eosinophil 
marker), (iii) 15-fold higher expression (p=0.009) of Fut2 [α-1,2-fucosyltransferase; a null allele 
of this gene in humans confers non-secretor status and is associated with Crohn’s disease (Franke 
et al., 2010; Tong et al., 2014) while Fut2 deficiency in mice enhances susceptibility to infection 
with eukaryotic and bacterial pathogens (Goto et al., 2014; Hurd and Domino, 2004)], (iv) 7.8-
fold higher expression (p=0.0004) of Nfil3 [nuclear factor, interleukin 3, a transcription factor that 
directs development of innate lymphoid cells (ILC) (Geiger et al., 2014; Klose et al., 2014; Seillet 
et al., 2014; Yu et al., 2014)], (v) 4.3-fold greater expression (p=0.00006) of Cd55 (involved in 
regulation of the complement cascade), (vi) 2.8-fold higher expression (p=0.02) of Tnfrsf21 (tu-
mor necrosis factor receptor superfamily member 21 involved in T helper cell function), and (vii) 
2.2-fold higher expression (p=0.02) of Irf2 (interferon regulatory factor 2).
Retnlb is expressed by intestinal goblet cells and enterocytes (Hogan et al., 2006) and 
appears to have various effects on immunity, including maintenance of mucosal barrier function 
(Hogan et al., 2006), macrophage activation to produce TNF-α (McVay et al., 2006; Steinbrecher 
et al., 2011), and protection from gut helminthic infections [e.g., by inhibiting migration of worms 
(Artis et al., 2004; Herbert et al., 2009)]. Eosinophils, which, as noted above, express Siglec5, 
contribute to protective immunity against parasites (Knott et al., 2007). Nfil3 expression is linked 
to ILC accumulation; group 2 ILCs have been implicated in development of protective immunity 
to parasites (Oliphant et al., 2014) while group 3 ILCs promote Fut2 expression and mediate resis-
tance to bacterial pathogens such as Salmonella (Goto et al., 2014). Turmeric’s ability to modulate 
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the distal ileal transcriptome is interesting in light of the South Asian Ayurvedic tradition of using 
crushed turmeric as an anti-helminthic (Handral et al., 2013; Nadkarni and Nadkarni, 1976). The 
burden of parasitic infection in this population is great (Roy et al., 2011); our findings offer one po-
tential biological insight about why turmeric came to be ubiquitously represented in Bangladeshi 
cuisine. Though it is unclear whether these findings relate to our observed motility phenotypes, 
they may be of anthropologic significance. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Collection of fecal samples from human microbiota donors 
Human fecal specimens were collected, de-identified, and stored in a biorepository in accordance 
with protocols approved by the Washington University Human Research Protection Office and 
local IRBs for now completed observational studies conducted in the United States, Bangladesh, 
Malawi, and Venezuela (Yatsunenko et al., 2012; Ridaura et al., 2013; Subramanian et al., 2014; 
Mondal et al., 2012; Smith et al., 2013; Turnbaugh et al., 2009). Specimens were maintained at 
-80°C until use. Except for the fecal samples acquired from 10 raw primal dieters for the present 
study, all previously collected samples had been analyzed by 16S rRNA sequencing and the results 
described in previous reports (Yatsunenko et al., 2012; Ridaura et al., 2013; Subramanian et al., 
2014).
A subset of samples from healthy adult microbiota donors representing each geographic 
region and culinary tradition were selected from our biorepository using the following criteria: (i) 
the donor was in his/her third-to-fifth decade of life; (ii) if female, the donor was not known to be 
pregnant or was greater than 6 months post-partum; (iii) the body mass index of the donor was 
greater than 21 kg/m2; (iv) there was no reported past medical history of systemic or gastrointes-
tinal diseases; (v) the donor was on his/her current diet for at least five years; (vi) the donor was 
not known to have consumed antibiotics or probiotics for at least three months prior to sampling; 
and (vii) the bacterial phylogenetic configuration of the sample was representative of samples 
collected from the geographic/culinary cohort (i.e., near the centroid of their cohort in principal 
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coordinates space based on unweighted UniFrac analysis of fecal bacterial 16S rRNA datasets). 
“Primal” dieters were defined as group that had consumed a “raw primal” diet (i.e., raw meats and 
vegetables) for 8 to 11 years. In addition to adult microbiota donors, a fecal microbiota sample was 
obtained from a 24-month-old Bangladeshi child from the Mirpur thana of Dhaka city (23.8042°N 
90.3667°E) who had a healthy growth phenotype as defined by serial anthropometry (Subramanian 
et al., 2014). Microbiota donor features are reported in Table S1a.
Production of gnotobiotic mouse diets representative of those consumed by the human mi-
crobiota donors 
Diets used in the current study are described in Figure S2 and Table S1b. All ingredients were 
purchased at local grocery stores (Whole Foods Market, Global Foods Market, and Schnuck’s 
Markets, all in St. Louis, MO). Organic products were purchased whenever possible to minimize 
any effects of residual fertilizers and pesticides. Fruits, vegetables, and meats were de-pitted or de-
boned as needed and then chopped manually. Any requisite cooking was performed at this point. 
All ingredients were ultimately ground and mixed for 10 minutes in an industrial food processor 
(Robot Coupe Model R23, Jackson, MS), then further homogenized in an industrial mixer (Globe 
Equipment Company, Port Washington, NY). 
The Bangladeshi diet was based on dietary analyses performed by the Institute of Nutrition 
and Food Science at the University of Dhaka (Islam et al., 2010). Rice was cooked in a standard 
commercial rice cooker. Tilapia fish was simmered on a hot plate (Corning Life Sciences, Tewks-
bury, MA; heat setting of 2) for 30 minutes with minimal water added to prevent burning prior to 
the addition of the vegetables (potato, spinach, tomato, cauliflower, okra, and Indian cucumber). 
Yellow lentils were cooked separately in a glass beaker on a hot plate for 90 minutes, with oc-
casional stirring and minimal water periodically added to prevent burning. Ingredients were then 
mixed as above. For experiments involving turmeric, the Bangladeshi diet was split into two por-
tions immediately after it was cooked. One portion was set aside as the “unsupplemented” diet. 
Turmeric was heated in vegetable oil (at a 1:1 volume-to-weight ratio, e.g., 1.0 mL oil to 1.0 g 
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turmeric) in a glass beaker on a hot plate for 10 min with occasional stirring, then added to the 
Bangladeshi diet and mixed in the industrial mixer for an additional 10 minutes. The amount of 
turmeric added to the Bangladesh diet (0.8 mg/g diet) was equivalent to 20 times the median daily 
consumption in South Asia (Ferrucci et al., 2010). The raw primal diet was based on an analysis of 
the most commonly consumed foods and overall nutritional intake gleaned from the food diaries of 
seven individuals living in the USA. Ingredients were not cooked in keeping with the food prepa-
ration habits of these people. An American diet was based on analyses of food journals, obtained 
from four individuals living in the USA with no self-imposed dietary restrictions, detailing 31 
cumulative days of food intake (eight days each from three subjects and seven days from another). 
A dietician analyzed these journals with the Nutrition Data System for Research (NDS-R; version 
4.03_31) to quantify the macronutrients and micronutrients consumed by each subject. The means 
of daily consumption of dietary energy (kilocalories), carbohydrates, proteins and fats were calcu-
lated. These mean values served as the benchmarks against which in silico menus were evaluated. 
Randomly generated menus were created by sampling 41 of the journal entries. Thousands of 
randomized menus were produced; the representative diet used for our study was the one whose 
calculated values was closest to the means. All in silico diet design was conducted in software R 
version 3.1.2 (R Development Core Team, 2013). The Malawian diet was based on staple foods 
consumed by individuals living in rural southern Malawi, and cooked using procedures described 
in an earlier publication (Smith et al., 2013). The Amerindian diet was based on foods consumed 
by individuals from the Guahibo Amerindian families living in villages near Puerto Ayacucho in 
the Amazonas State of Venezuela (Yatsunenko et al., 2012). Catfish and eggs were simmered on 
a hot plate for 20 minutes with minimal water added to prevent burning, prior to addition of the 
remaining ingredients (corn flour, cassava flour, and powdered whole milk). Minimal modifica-
tions to the recipes were made as needed to ensure that all diets satisfied the recommended daily 
intake of macro- and micronutrients for mice (National Research Council (US) Subcommittee on 
Laboratory Animal Nutrition, 1995).
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Aliquots (250 g or 500 g) of each diet type were double-sealed (vacuum packed) and 
double-bagged before sterilization by irradiation (dose 20-50 kGy; Steris Isomedix Corporation, 
Chicago, IL). Sterility was confirmed by (i) spore strips (North American Science Associates Inc, 
Northwood, OH) that were placed in each box of bagged food prior to irradiation and (ii) culturing 
aliquots of a representative bag from each irradiated box for 7 days at 35°C under aerobic condi-
tions in BHI broth (BD Diagnostics, Sparks, MD), nutrient broth (BD Diagnostics, Sparks, MD), 
and Sabouraud dextrose broth (BD Diagnostics, Sparks, MD) prior to plating on blood agar plates. 
The nutritional content of diets was confirmed by direct analyses of micronutrients and macronu-
trients (N-P Analytic Laboratories, Nestlé Purina Petcare, St. Louis, MO; see Table S1b). Irradi-
ated, vacuum-packed diets were stored at 4°C until use.
Preparation of human fecal microbiota for transplantation into gnotobiotic mice 
Clarified fecal microbiota suspensions were prepared from previously frozen human fecal samples 
in an anaerobic chamber (Coy Lab Products, Grass Lake, MI; atmosphere composed of 75% N2, 
20% CO2, and 5% H2) using a protocol detailed in an earlier report (Ridaura et al., 2013) that was 
modified as follows: in place of pulverization with a mortar and pestle, samples (500 mg) were 
diluted in 15 mL of reduced PBS (PBS supplemented with 0.1% Resazurin (w/v) and 0.05% L-
cysteine-HCl), homogenized in a blender for 1 minute, and passed through a 40 µm pore diameter 
nylon cell strainer (BD Falcon, Franklin Lakes, NJ). Clarified fecal microbiota suspensions were 
stored in reduced PBS with 15% glycerol at -80°C until use. 
Animal husbandry
All gnotobiotic mouse experiments were performed using protocols approved by the Washington 
University Animal Studies Committee. Conventionally raised C57BL/6 Ret +/- mice were re-de-
rived as germ-free by embryo transfer (Faith et al., 2011) and maintained in sterile, flexible, plastic 
gnotobiotic isolators (Class Biologically Clean Ltd., Madison, WI) under a strict 12-hour cycle. 
All mice used in our experiments were 8-12 weeks old.
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In each of the experiments described this report, feeding of the initial diet was started three 
days prior to colonization with uncultured fecal microbiota samples or with cultured bacterial 
consortia. Age-matched male germ-free C57BL/6 mice within a given isolator were gavaged with 
the same bacterial community, or maintained as germ-free. Mice were co-housed as described 
below. Autoclaved Aspen hardwood lab bedding (NEPCO, Warrensburg, NY) was replaced with 
new bedding at the start of each new diet phase to limit carryover of ingredients from the prior diet 
phase. Total intestinal transit times were measured at the end of each diet phase by gavaging mice 
with red carmine dye and recording the time from gavage to first appearance of the dye in their 
feces (see below for details)
Six-phase travel experiment. Six groups of mice (n=6 mice per group) were colonized 
with uncultured fecal microbiota samples obtained from six healthy adults representing different 
cultural/culinary traditions and geographic locations. Each group of mice designated to receive the 
same donor’s microbiota was placed in a separate gnotobiotic isolator prior to gavage; within each 
isolator, mice were triply housed (n=3 mice per cage). Mice were fed a sequence of sterilized diets 
formulated to represent those consumed by the microbiota donors (ingredients and preparation 
detailed above). The starting and ending ‘home’ diets were given for 14 and 8 days, respectively, 
while each of the four intermediate ‘travel’ diets was administered for 8 days. 
Three-phase travel experiment. Six groups of mice (n=5 mice per group) were colonized 
with uncultured fecal microbiota samples obtained from healthy adults living in Bangladesh (n=3 
donors) and the USA (specifically, USAunrestricted; n=3 donors). Each group of mice resided in a 
separate flexible film gnotobiotic isolator where they were co-housed in two cages (n=2-3 mice 
per cage). Mice were fed a sequence of sterilized Bangladeshi and primal diets with the starting 
and ending diet representing a ‘local’ diet of the microbiota donor: mice colonized with a USAun-
restricted microbiota were fed the primal diet, while mice colonized with a Bangladeshi microbiota 
were fed the Bangladeshi diet. The starting and ending phase diets were given for 14 and 8 days, 
respectively, while the second (intermediate) phase ‘non-native’ diet was administered for 8 days. 
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Assessing the effects of turmeric in germ-free mice versus those colonized with the clonally 
arrayed bacterial culture collection. Two groups of mice (n=6 mice per group) were either main-
tained as germ-free or colonized with the clonally arrayed culture collection derived from the fecal 
microbiota of the Bangladeshi child with a healthy growth phenotype. Each group of mice resided 
in a separate gnotobiotic isolator (n=3 mice per cage). Mice were fed a sequence of sterilized diets 
formulated to represent Bangladeshi diet, with or without turmeric. Each diet phase was 10 days 
in length. The starting and ending diets were unsupplemented (i.e., lacked turmeric), while the 
intermediate phase diet contained turmeric. 
Comparing the effects of BSHhi and BSHlo consortia with and without turmeric in wild-type 
Ret+/+ and heterozygous Ret+/- C57BL6/J mice. Three groups of mice (n=5 mice per group) were 
colonized with (i) the entire clonally arrayed culture collection, (ii) the 7-member BSHhi consor-
tium, or (iii) the 7-member BSHlo consortium. Each group of mice was housed in a separate gnoto-
biotic isolator containing two cages (n=2-3 mice per cage). Mice were fed a sequence of sterilized 
diets formulated to represent the Bangladeshi diet, with or without turmeric. Each diet phase was 
8 days in length. The starting and ending diets were unsupplemented while the intermediate diet 
contained turmeric. Two additional groups of Ret+/- mice (n=5 mice per group) were colonized 
with either the BSHhi or BSHlo consortium. Recipient mice containing a given consortium were 
housed in the same isolators (but in separate cages) as wild-type mice harboring the same consor-
tium (n=2-3 mice per cage). 
Effects of turmeric on host gene expression in mice harboring the BSHlo consortium. Two 
groups of wild-type mice (n=3-4 mice per group; 1 cage per group) were colonized with the “BSH-
lo” consortium. Mice were fed the Bangladeshi diet, with or without turmeric, over the course of 
a single diet phase that was 10 days long. Distal ileum and liver samples collected at the time of 
sacrifice were used for mouse RNA-Seq, performed as described below.
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Sample collection from gnotobiotic mice
Before colonization and throughout each experiment, fecal pellets were collected from mice at 
pre-established time points, including on the days of transit time measurements, with care taken 
to collect pellets prior to the passage of carmine dye. Samples were snap frozen in liquid nitrogen 
within 30 minutes of their collection and stored at -80°C until use. At the conclusion of each ex-
periment (>48 hours after the last carmine dye assay), the following biospecimens were procured 
after weighing and sacrificing each animal: liver, small intestine, cecal contents, colon, and feces. 
The small intestine was partitioned into 8 equal-sized segments. Segment 8 was operationally de-
fined as ‘terminal ileum’. Samples were immediately snap frozen in liquid nitrogen and stored at 
-80°C until use. 
Multiplex sequencing and analysis of PCR amplicons generated from bacterial 16S rRNA 
genes
Genomic DNA was extracted from mouse fecal pellets as described previously (Turnbaugh et al., 
2009). Primers 515F and 806R with sample-specific barcodes were used to generate PCR ampli-
cons spanning variable region 4 (V4) of bacterial 16S rRNA genes present in the fecal samples. Li-
braries of these V4-16S rRNA amplicons were subjected to multiplex sequencing on the Illumina 
MiSeq platform (250 nt paired-end reads; see Table S4 for details regarding multiplexing and 
sequencing depth). Paired-end reads were trimmed to 200 base pairs to retain the highest-quality 
sequences, and aligned using the flash aligner (Magoč and Salzberg, 2011). 16S rRNA reads were 
grouped into operational taxonomic units based on whether they shared ≥97% nucleotide sequence 
identity (97%ID OTUs). We employed an open-reference OTU-picking strategy (QIIME; ver-
sion 1.5.0) (Caporaso et al., 2010), where reads were clustered against the Greengenes reference 
database (DeSantis et al., 2006) using the UCLUST algorithm (Edgar, 2010). Any reads that did 
not match entries in the reference dataset were clustered de novo. OTUs were picked using the 
combined V4-16S rRNA sequence datasets from all mouse experiments, so that OTU IDs and as-
sociated taxonomic annotations would be uniform across the corresponding analyses. OTUs with 
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proportional abundances of at least 0.1% in at least 1% of all samples were retained for down-
stream analysis. Taxonomy was assigned to OTUs using the Ribosomal Database Project (RDP) 
version 2.4 classifier, which enabled classifications at the phylum, class, order, family, genus, and 
species level (Ridaura et al., 2013). Samples were rarefied to a depth of 4080 reads per sample. Un-
weighted and weighted UniFrac was used to calculate beta diversity indices; principal coordinates 
analysis (PCoA) plots were generated using these data. 
Community profiling by sequencing (COPRO-Seq) 
Genomic DNA was extracted from mouse fecal pellets (Turnbaugh et al., 2009) that had been 
collected throughout experiments involving mice colonized with either the complete culture col-
lection, or the BSHhi or BSHlo consortia. Multiplexed DNA libraries were prepared from genomic 
DNA samples as described (Faith et al., 2011; McNulty et al., 2011) and subjected to shotgun 
sequencing using an Illumina MiSeq platform to generate 75 nt unidirectional reads (see Table S4 
for details regarding multiplexing and sequencing depth). The analytic pipeline described in a pre-
vious publication (McNulty et al., 2011), and available at https://github.com/nmcnulty/COPRO-
Seq, was used to map reads to the sequenced genomes of members of the culture collection and 
calculate their relative abundances in the fecal microbiota of gnotobiotic mice.
Profiling the fecal meta-transcriptomes of gnotobiotic mice using microbial RNA-Seq
Bacterial community transcriptional responses to turmeric were profiled in fecal samples collected 
from eight male age-matched wild-type C57BL/6 mice, colonized with the 7-member BSHhi or 
BSHlo 7- consortia, at two time points (8 and 16 days after gavage, which corresponded to periods 
where animals were consuming the Bangladeshi diet lacking and containing turmeric, respec-
tively). Multiplexed cDNA libraries were prepared as described previously (Faith et al., 2011; 
McNulty et al., 2011; Ridaura et al., 2013) with the following modification: after removal of 5S 
rRNA and tRNA with a MEGAclear column (Life Technologies, Carlsbad, CA) remaining rRNA 
was depleted using the Ribo-Zero™ rRNA Removal Kit for Bacteria (Epicentre, Madison, WI). 
Multiplexed libraries were sequenced using a Illumina NextSeq instrument to generate 75 nt uni-
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directional reads (see Table S4 for details regarding multiplexing and sequencing depth). Analysis 
was performed as previously described (Ridaura et al., 2013) with the custom reference database 
consisting of the 14 genomes of the 14 strains that comprised the two BSH consortia. Following 
gene assignments, pathway analysis was performed using the KEGG reference database (release 
72.1) (Kanehisa and Goto, 2000; Kanehisa et al., 2014).
Profiling the host transcriptome using RNA-Seq
We used RNA-Seq to characterize gene expression in the livers and ileums of seven age-matched 
wild-type C57BL/6 mice colonized with the BSHlo consortium and fed the Bangladeshi diet with 
or without turmeric. For each sample, 20-30 mg of tissue was placed in pre-cooled RNAlater®-
ICE (Life Technologies, Carlsbad, CA) and stored at -20°C for at least 16 hours. Total RNA was 
extracted using the RNeasy Mini Kit (Qiagen, Venlo, Limburg) after tissue disruption and homog-
enization (TissueLyser, Qiagen). 5S rRNA and tRNA were depleted from the sample (MEGAclear 
column purification) followed by treatment with RNase-free TURBO™ DNase (Life Technolo-
gies). Cytoplasmic and mitochondrial rRNA were then depleted using the Ribo-Zero™ rRNA Re-
moval Kit for Human/Mouse/Rat (Epicentre, Madison, WI). (This approach was used rather than 
poly(A) enrichment to obtain more even coverage since Ribo-Zero™ does not have a 3’ end bias). 
RNA was precipitated with ethanol, followed by a second DNase treatment (Baseline-ZERO™ 
DNase; Epicentre, Madison, WI). First strand cDNA synthesis was accomplished using Super-
Script II Reverse Transcriptase (Life Technologies), followed by second strand cDNA synthesis 
with E. coli DNA polymerase, E. coli DNA ligase, and RNase H (all from New England Biolabs, 
Ipswich, Massachusetts). Double-stranded cDNA was purified using QIAquick purification col-
umns (Qiagen) before shearing (BioRuptor XL sonicator; Diagenode, Denville, NJ). ~250 bp frag-
ments were size-selected by extraction from 2% agarose gels. Multiplex libraries were prepared 
and subjected to sequencing on the Illumina NextSeq platform to generate 75 nt unidirectional 
reads. 
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Analysis was limited to reads that contained exact 5’ sequence matches to barcodes uti-
lized for multiplexing and no more than 1 expected error, as calculated by Q scores via usearch 
(version 8.0.1517) (Edgar, 2010). (See Table S4 for details regarding multiplexing, sequencing 
depth, filtering, and mapping of the resulting high-quality sequences). Reads were mapped to the 
Mus musculus C57BL/6J strain genome (UCSC mm10) using Bowtie2 (version 2.2.4) (Langmead 
and Salzberg, 2012), with subsequent alignment and splice junction mapping (TopHat2, version 
2.0.13) (Kim et al., 2013). 81.8%- 89.0% of input sequences could be mapped. These data were 
imported into R (version 3.1.2) (R Development Core Team, 2013) for analysis using the edgeR 
package (version 3.8.5) (Robinson et al., 2010). Separate analyses were conducted for liver and 
distal ileum RNA-Seq datasets. Low-expression genes were filtered out: only those with an abun-
dance of at least 1 count per million reads in more than one sample and at least 10 counts per mil-
lion reads in one sample were retained. Trimmed mean of M-values (TMM) normalization was 
applied. The coefficient of biological variation (the square root of dispersion under the negative 
binomial model) was estimated across the entire dataset for each tissue and for each gene. Dif-
ferentially expressed genes were then identified using the exact negative binomial test, which is 
appropriate since a single variable (turmeric consumption) was being investigated. Significance 
was corrected for multiple comparisons using the method of Benjamini-Hochberg (Benjamini and 
Hochberg, 1995), as reported in Table S11.
Ultra High Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS)
Sample processing - Frozen fecal samples were combined with 20 volumes of ice cold methanol 
and 1 volume of cholic acid-13C1 (200 mg/ml; Sigma-Aldrich, St. Louis, MO), and then shaken 
for 2 minutes in a bead beater (Biospec Products; maximal setting; no beads added) before incu-
bation at -20°C for 1 hour. Samples were then centrifuged at 4°C for 10 minutes at 20,800 x g. 
The supernatant (200 µL) was collected and dried in a SpeedVac at room temperature (requiring a 
spin time of 2-3 hours). Dried samples were re-suspended in 100 µL of 5% ethanol (in water) by 
a combination of pipetting, vigorous shaking in a bead beater, and sonication. After centrifugation 
for 5 minutes at 20,800 x g at 4°C, the supernatant was separated for UPLC-MS. Analyses were 
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performed on a Waters Acquity I Class UPLC system (Waters Corp., Milford, MA) coupled to an 
LTQ-Orbitrap Discovery (Thermo Fisher Corporation). For the 150 mm x 2.1 mm Waters BEH 
C18 1.7 mm particle column, injection volume was 5 µL, and the flow rate was 0.3 mL per minute. 
Mobile phases for positive ion mode were (i) 0.1% formic acid in water and (ii) 0.1% formic acid 
in acetonitrile, whereas negative ion mode used (i) 5 mM ammonium bicarbonate in water and (ii) 
5 mM ammonium bicarbonate in 95/5 acetonitrile/water. The capillary column was maintained at 
325°C with a sheath gas flow of 40 (arbitrary units), an aux gas flow of 5 (arbitrary units) and a 
sweep gas flow of 3 (arbitrary units) for both positive and negative injections. The spray voltage 
was 4.5 kV for the positive ion injection and 4 kV for the negative ion injection.
Data pre-processing - Data in instrument specific format (.D) were converted to common 
data format (.cdf) files using MSD ChemStation (E02.01, Agilent Technologies, Santa Clara, CA). 
The .cdf files were extracted using Bioinformatics Toolbox in MATLAB 7.1 (The MathWorks, 
Inc., Natick, MA), along with custom scripts (Cheng et al., 2011) for alignment of data in the time 
domain, automatic integration, and extraction of peak intensities. The resulting three-dimension 
data set included sample information, peak retention time, and peak intensities. Data were then 
mean-centered and unit variance-scaled for multivariate analysis, which was performed in R (ver-
sion 3.1.2) (R Development Core Team, 2013) using custom scripts. 
Quality control of metabolomics data - Pooled quality control (QC) samples were prepared 
from 8-10 µL aliquots of 10 samples and analyzed together with the other samples. QC samples 
were inserted and analyzed every 10 samples. Metabolite identification was done by co-character-
ization of standards. 
Statistical analyses
Routine statistical analyses were performed in R (version 3.1.2) (R Development Core Team, 
2013) using custom scripts that are available upon request. Linear modeling, including stepwise 
backward feature selection, statistical correlations and comparisons, and Bonferroni corrections 
for multiple comparisons were performed using functions within the default stats package (version 
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3.1.2). 
Diet-discriminatory OTUs were identified using the Random Forests supervised machine 
learning algorithm as implemented in the randomForest package (version 4.6-10) (Liaw and Wie-
ner, 2002) following 100 replications per diet-microbiota combination (parameters: ntree, 1000; 
importance scores tracked; otherwise default values). Initial modeling was performed to identify 
diet-discriminatory taxa in fecal samples obtained from mice colonized with the same donor mi-
crobiota. Mean importance scores were then aggregated, and hierarchical clustering was applied 
to examine whether OTUs were diet-discriminatory across different microbiota. The accuracy of 
the model built on the basis of the 6-phase travel experiment results was tested on experimen-
tal data from the 3-phase travel using 10,000 replications (parameters: ntree, 1000; importance 
scores tracked; otherwise default values). Out-of-bag error estimations were determined by iterat-
ing through OTUs that had been ranked by mean importance score to determine the performances 
of the resulting Random Forests models.
Figures were generated using R, employing for several figures ggplot2 (version 1.0.0) 
(Wickham, 2009) and pheatmap (version 0.7.7) (Kolde, 2013) packages.
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SUPPLEMENTAL FIGURE LEGENDS
Figure S1. Compositions of diets used in the 6-phase travel experiment (related to Figure 1). 
In the foreground, word clouds convey the specific ingredients used: font sizes depict the weight-
based proportional representations of ingredients within each diet. Pie charts in the background 
present the macromolecular compositions. 
Figure S2. Three-phase travel experiment (related to Figures 1D, 2). (A) Experimental design. 
Six groups of gnotobiotic mice (n=5 animals/donor microbiota) were colonized with intact fecal 
microbiota from one of six healthy adults (three from Bangladesh, three from the USA) and then 
subjected to the three serial diet phases shown. (B) The most contrasted diet-by-microbiota effects 
originally observed in the 6-phase travel experiment (Figure 1D) were reproducible across micro-
biota donors living in a given geographic area. The results from the initial and final ‘local’ phases 
were aggregated. *, p<0.05 (two-tailed Student’s t-test).
Figure S3. Fecal microbiota transplantation is reproducible and results in significant with-
in-group similarity (related to Figures 1). Principal coordinates analysis (PCoA) plots of un-
weighted UniFrac distances calculated from the fecal microbiota 16S rRNA profiles of gnotobiotic 
mice in the 6-phase travel experiment (A,B) and the 3-phase travel experiment (C,D). PC1, the 
principal coordinate that explains the greatest amount of variance, is shown as a function of days 
post gavage of the donor microbiota, with diet phases annotated (panels A and C) and with relation 
to PC2 (panels B and D). Each dot represents a single fecal sample, color-coded by microbiota do-
nor. Microbiota donor is the major determinant of clustering of fecal microbiota in recipient mice. 
Figure S4. Diet-discriminatory OTUs are robust to different donor microbiota and motil-
ity phenotypes (related to Figure 1). (A) Out-of-bag estimated error rates in a Random Forests 
model for predicting diet, stratified by donor microbiota, as a function of numbers of diet-discrim-
inatory OTUs. For each microbiota, 40 OTUs were sufficient to discriminate diet, yielding a total 
of 87 unique OTUs across six microbiota donors from five cultural/dietary traditions in the 6-phase 
travel experiment. (B) Evidence for the robustness of diet-discriminatory OTUs to donor micro-
150
biota and motility phenotype. Feature importance scores of 87 diet-discriminatory OTUs in each 
diet-microbiota context are represented in this heat map. A sparse Random Forests model built 
using these diet-discriminatory OTUs accurately predicted diet in the 3-phase travel experiment.
Figure S5. Fecal bile acid levels predict gut transit time (related to Figure 2). In the 3-phase 
travel experiment representing six microbiota donors from two cultural/dietary traditions, a linear 
model built using fecal levels of five bile acids (7-ketodeoxycholic acid, muricholic acid, tauro-
cholic acid, tauro-beta-muricholic acid, and tauro-muricholic acid sulfate) can predict transit times 
accurately, out-performing a linear model built using five randomly selected metabolites that were 
not individually correlated with transit times.
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SUPPLEMENTAL FIGURES
Figure S1.
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Figure S4.
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SUPPLEMENTAL TABLES 
Table S1. Donor features and diets used in all experiments (related to Figure 1). (A) Demo-
graphics and IDs of microbiota donors. (B) Bacterial 16S rRNA-based analysis of the efficiency of 
transplantation of 97%ID OTUs present in the donors’ microbiota in the 6-phase travel experiment. 
(C) Compositions of diets modeled after those consumed by microbiota donors. (D) Nutritional 
analyses of diets modeled after those consumed by microbiota donors, performed immediately 
after sterilization by irradiation and again after storage at 4°C for 2 months.
Table S2. Transit times and body weights of individual mice (related to Figure 1). (A) The 
6-phase travel experiment. (B) The 3-phase travel experiment. (C-E) Experiments assessing the 
effects of turmeric on transit time. (F) Experiment comparing conventionally-raised specified 
pathogen free wild-type (Ret+/+) versus Ret+/- littermates.
Table S3. Diet, microbiota, and their interaction are significant factors impacting transit 
times (related to Figure 1). (A) Analysis of factors impacting transit times in 6-phase travel 
experiment: Repeated measures ANOVA. (B) 97%ID OTUs with significant diet-dependent cor-
relations with transit times in an analysis of the highly contrasted diet-microbiota combinations 
(Bangladeshi/primal diets and Bangladeshi/USAunrestricted microbiota).
Table S4. DNA and RNA sequencing datasets from the 6-phase travel experiment, the 3-phase 
travel experiment, and experiments assessing the effects of turmeric (related to Figures 1-3). 
(A) Mouse fecal bacterial V4-16S rRNA datasets. (B) Mouse fecal bacterial COPRO-Seq datasets. 
(C) Mouse fecal microbial RNA-Seq dataset. (D) Mouse liver and distal ileum RNA-Seq sequenc-
ing dataset.
Table S5. Diet-discriminatory bacterial 97%ID OTUs identified by Random Forests (ma-
chine learning) analysis of datasets from 6-phase travel experiment (related to Figure 1). 
(A) For a given microbiota, the top 40 diet-discriminatory OTUs (n=5 diets tested). (B) 87 diet-
discriminatory OTUs across, robust to microbiota and motility phenotypes.
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Table S6. UPLC-MS analysis of bile acids in feces collected from gnotobiotic mice (related 
to Figure 2-3). (A) The 3-phase travel experiment, described in Figure S2A, involving wild-type 
C57BL/6 mice colonized with intact uncultured fecal microbiota from adult USAunrestricted or Ban-
gladeshi donors fed Bangladeshi or primal diets. (B) Germ-free wild-type mice fed a Bangladeshi 
diet with and without turmeric. (C) Mice from the same experiment as in panel B but colonized 
with all members of the clonally arrayed bacterial culture collection from a Bangladeshi donor. (D) 
Mice from the 3-phase diet experiment described in Figure 3A colonized with either all members 
of the culture collection or the BSHhi or BSHlo consortium and fed the Bangladeshi diet with or 
without turmeric. (E) Wild-type mice were colonized with the BSHlo consortium and fed a Bangla-
deshi diet ± turmeric in a 10-day single phase diet experiment.
Table S7. Identifying correlations between fecal metabolites, OTUs and transit times that 
are robust to diet (related to Figure 2). Untargeted UPLC-MS analysis of metabolites in the fe-
cal microbiota of mice colonized with the uncultured fecal microbiota from adult USAunrestricted or 
Bangladeshi donors and fed Bangladeshi or primal diets. (A) Metabolites whose peak intensities 
are significantly correlated (by Spearman rank correlation) with transit times in the 3-phase travel 
experiment. Unadjusted p-values and Bonferroni-corrected p-values are shown. (B) Significant 
correlations (after Bonferroni corrections for multiple comparisons) between 97% ID OTUs, bile 
acids, and transit times in the 3-phase travel experiment. 
Table S8. Analysis of the relationships between fecal bile acids and transit times (related to 
Figure 2). Linear models of transit times were regressed against fecal bile acid levels, with sim-
plification by applying stepwise backward feature selection. (A) Results from the 3-phase travel 
experiment described in Figure S2A involving mice colonized with intact uncultured USAunrestricted 
and Bangladeshi microbiota and fed Bangladeshi and primal diets. (B) Analysis of datasets gen-
erated from the experiment in which mice colonized with the complete culture collection from a 
Bangladeshi child and germ-free controls were subjected to a 3-phase diet oscillation consisting of 
the Bangladeshi diet ± turmeric.
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Table S9. Bacterial culture collection generated from the fecal microbiota of a healthy Ban-
gladeshi child (related to Figure 3). List of 53 bacterial strains and their BSH enzyme activities 
as measured by an in vitro UPLC-MS based assay described in Experimental Procedures. 
Table S10. KEGG-annotated genome features (related to Figure 3). Members of (A) the two 
7-strain consortia and (B) the clonally arrayed bacterial culture collection generated from the fecal 
microbiota of a healthy 2-year-old Bangladeshi child from which the consortia were derived. 
Table S11. Host genes whose expression is significantly affected by turmeric consumption 
in mice colonized with the BSHlo consortium (related to Figure 3D). RNA-Seq datasets were 
generated from tissues harvested at the time of sacrifice. Animals were given a monotonous Ban-
gladeshi diet either with or without turmeric for ten days. (A) Distal ileum. (B) Liver.
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Chapter 4
Future Directions
160
One goal of using preclinical models of the type described in this thesis is to characterize microbe-
microbe and microbe-host interactions under highly controlled conditions where dietary, microbial 
community and host manipulations can be performed in order to (i) characterize microbe-microbe 
interactions, microbe-host interactions, (ii) identify mechanisms that underlie these interactions 
and affect disease pathogenesis, and (iii) provide preclinical proof of concept that specific manipu-
lations may mitigate or prevent disease (1, 2). 
Chapter 2 of this thesis supports the idea that intra- and interspecific competition plays a 
key role in preventing adverse outcomes from colonization with an enteropathogen such as entero-
toxigenic B. fragilis. Using more specific knowledge about the nature of these competitive interac-
tions may provide insight into building tools—whether they be specific bacterial strains, dietary 
ingredients, or both—that allow for extirpation or control of organisms without the risks inherent 
in broad-spectrum antibiotic treatment (3-5). 
One series of experiments can be envisioned that directly tests whether any of the putative 
competitor species revealed when ETBF was co-colonized with the healthy culture collection can 
prevent the weight loss seen in mice receiving the complete culture collection from the severely 
stunted/underweight child while consuming a Bangladeshi diet. A first test would be to colonize 
mice with the stunted donor culture collection plus the NTBF strains from the healthy donor’s cul-
ture collection, with the hypothesis being that NTBF-ETBF interactions and/or other interactions 
between NTBF strains and the stunted/underweight community members are sufficient to mitigate 
the ETBF-dependent weight loss and metabolic phenotypes transmitted through colonization with 
the underweight donor’s culture collection. However, given that ETBF did not induce weight loss 
in mice harboring the healthy culture collection ±NTBF, other taxa from the healthy donor’s cul-
ture collection may be required to prevent or ameliorate the ETBF-dependent phenotypes trans-
mitted to recipient mice by the stunted/underweight culture collection. Recently, Faith and Ahern 
described a screening method that helps overcome the large combinatorial challenge of identifying 
which strain or set of strains from the healthy donor culture collection might achieve this effect 
(6). Their approach involves generating random subsets of strains from a clonally arrayed culture 
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collection with overlapping membership and testing their effects on a given phenotype in a given 
microbial community context. Subsets of nominal size (e.g., 3-10 members, etc.) are generated 
with each subset of a given size representing a consortium of unique composition but overlapping 
membership. Biological repetition for each strain is achieved because subsets have overlapping 
membership. Strains whose presence in a consortium best explain phenotypic variation are ad-
vanced to a validation step where they alone, or in combination are tested. 
After determining whether an individual strain or a small consortium of strains from the 
healthy donor’s culture collection could mitigate weight-loss transmitted by the ETBF (+) stunted/
underweight donor culture collection, follow-up experiments could test the generalizability of the 
findings. In particular, hypotheses worthy of follow-up include: do other strains of ETBF from 
other Bangladeshi donors have the same community and host effects as the ETBF strain from the 
stunted donor in the context of that donor’s culture collection; do other strains of ETBF have the 
same effects on host phenotypes and community gene expression (including virulence gene ex-
pression) in the context of the healthy donor’s culture collection; do other NTBF strains or strains, 
identified via the previously described combinatorial screen, from other healthy individuals have 
the same effects on ETBF and ETBF-dependent transmissible host phenotypes in the context of the 
stunted/underweight donor’s community described in my thesis? Probiotic leads identified from 
studies involving culture collections could be advanced to testing intact uncultured microbiota 
from undernourished children with ETBF (and other enteropathogens) ± evidence of EED living 
in Mirpur, from other areas of Bangladesh, or conceivably from other countries where the burden 
of undernutrition is high.
These types of studies would require a variety of methods, a number of which were ap-
plied during the course of the work described in this thesis. A comprehensive analysis could in-
clude (i) comparative genomics of the strains to be tested, (ii) body composition phenotyping (us-
ing quantitative magnetic resonance) to ascertain the effects on adiposity versus lean body mass, 
(iii) microbial RNA-Seq of the various communities harbored by colonized gnotobiotic mice, (iv) 
careful monitoring of food consumption (using pelleted embodiments of the Bangladeshi diets) 
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and bomb calorimetry of feces (to define the efficiency of energy extraction from the diet by the 
microbiota), (v) serum assays of regulators of energy balance/nutrient utilization/immunoinflam-
matory responses); (vi) transcriptional profiling via RNA-Seq of distal intestine/colon, liver and 
gastrocnemius muscle (to better define host responses including those involving components of 
the innate and adaptive immune system, metabolic signaling, metabolic pathways critical for nutri-
ent processing and biosynthesis), (vii) mass spectrometry-based profiling of microbial community 
and host metabolism (to validate and discover new discriminatory biomarkers of host responses, 
and (viii) FACS-based studies characterizing immune cell populations and gut barrier function. 
Implementation of (ii)-(viii) would initially be prioritized based on those microbial manipulations 
that have the greatest effect size weight and identified discriminatory metabolic biomarkers. 
Other studies would involve diet manipulations. The intergenerational transmission experi-
ments described in Chapter 2 allude to a diet dependency of the pathogenic effects of ETBF. De-
veloping more efficacious food interventions for treating children with undernutrition is currently 
an active area of investigation. As noted in Chapter 1, while a number of protocols have been de-
veloped (7), efficacy has been limited for treating stunting, neurodevelopmental abnormalities and 
immune defects such as poor vaccine responsiveness. (1, 8-10). Adding additional experimental 
arms where diet is a variable should help identify locally sourced and culturally acceptable foods 
that can be used as complimentary feeding therapies along with, or potentially in lieu of, treatment 
with a targeted probiotic. These avenues of experimentation should enhance our understanding 
of the interactions of diet, the gut microbiota, and the enteric dysfunction that is often associated 
with severe stunting. Exploration of nutritional therapies along with newly identified probiotic 
candidates in preclinical animal models will hopefully guide clinical researchers toward mecha-
nistically-informed standardized methods for restoring healthy gut microbiota function to mitigate 
the long-term sequelae of childhood stunting precipitated by undernutrition.
Finally, an intriguing finding obtained from the microbial RNA-Seq studies described in 
Chapter 2 was that expression of a large set of putative virulence factors from multiple strains 
comprising the healthy donor’s culture collection was significantly affected by ETBF (virulence 
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gene expression was not affected by the presence or absence of ETBF in the context of the stunted/
underweight culture collection which shared only one strain with the healthy culture collection). 
These findings raise the question: What are the underlying mechanisms by which ETBF influences 
expression of these factors in members of the healthy culture collection? Quorum sensing regu-
lates microbial gene expression in response to population density (11) and plays an integral role 
in signaling among the gut microbiota (12) as well as between the commensal gut bacteria and the 
enteropathogen Vibrio cholera (13). Quorum sensing regulates microbial gene expression in re-
sponse to population density (11) and plays an integral role in signaling among the gut microbiota 
(12) as well as between the commensal gut bacteria and the enteropathogen Vibrio cholera (13). 
The quorum-sensing pathway identified by RNA-Seq was the LuxQ pathway that senses signal-
ing pathways occur through the autoinducer 2 (AI-2) pathway, also encoded by numerous Bacte-
roides species (14). At low cell density, and thus low concentrations of of AI-2, LuxQ has kinase 
activity, while at high cell density, in the presence of AI-2, kinase activity is inactivated and the 
LuxQ switches to a phosphatase activity. These changes between LuxQ enzymatic activities are 
responsible for transmitting information about the surrounding environment to the cytoplasm (15). 
Expression of luxQ in ETBF was dramatically increased by the presence of NTBF in the healthy 
culture collection context: this finding is of interest given the lower relative abundances of the B. 
thetaiotaomicron, E. avium, and B. caccae strains as a result of ETBF and NTBF co-colonization. 
LuxQ is not a well-characterized AI-2 sensing kinase in Bacteroides fragilis and presents an inter-
esting target for genetic manipulation in both ETBF and NTBF to ascertain its role in regulating 
community structure and gene expression; especially in light of recent work demonstrating E. coli 
engineered to express high levels of AI2 dramatically lowered the relative abundance of Bacte-
roidetes in vivo (12). 
Both avenues of research may offer deeper insight into mechanistic interactions of the gut 
microbiota and its influence on host health. Through a better mechanistic understanding of the gut 
microbiota, we should be able to develop therapeutics using dietary and microbial interventions 
that target health-related factors influenced by the microbiota.
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